This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Date Title   06/06/13 Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference MADISON, N.J., June 6, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President and CEO, presented at the Jefferies 2013 Global Healthcare Conference in New York City today. During the presentation, Mr. Rusckowski reaffirmed the company's guidance for its results from continuing operations, before special items, for the full-year 2013:   Revenues are expected to approximate th...  06/06/13 Quest Diagnostics and Hologic Form Strategic Alliance to Improve Women's Health Collaboration features national availability of the APTIMA HPV mRNA-based cervical cancer screening test as well as a focus on developing and expanding access to diagnostic solutions for women's health MADISON, N.J. and BEDFORD, Mass., June 6, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imagin...  06/05/13 Quest Diagnostics To Speak At The Jefferies 2013 Global Healthcare Conference MADISON, N.J., June 5, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President and CEO, is scheduled to speak at the Jefferies 2013 Global Healthcare Conference in New York City on Thursday, June 6, 2013 at 1:00 p.m. Eastern Time. During the conference, Mr. Rusckowski will reaffirm the company's full-year 2013 guidance.  Revenues are expected to approximate the prior-year level...  05/21/13 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 21, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share, payable on July 17, 2013, to shareholders of record of Quest Diagnostics common stock on July 2, 2013. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make bette...  05/16/13 Quest Diagnostics Acquires Concentra's Laboratory Business, Enters into Services Agreement Patients, physicians and employers to benefit from greater access to broader menu of innovative diagnostic information services MADISON, N.J., May 16, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc. (NYSE: HUM).  In addition, Quest Diagnostics has entered into a long-term ag...  05/13/13 Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds Largest study of LDL blood levels, based on tests of nearly 105 million Americans, suggests improvements in cardiovascular health may have stalled in recent years MADISON, N.J., May 13, 2013 /PRNewswire/ -- Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE. The study, by researchers at Quest Diagnostics (NYSE: DGX), examine...  05/07/13 Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2013 Health Care Conference MADISON, N.J., May 7, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas. The presentation is scheduled for Wednesday, May 15, 2013 at 11:40 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site:  http://www...  04/17/13 Quest Diagnostics Reports First Quarter 2013 Financial Results MADISON, N.J., April 17, 2013 /PRNewswire/ -- Adjusted diluted EPS from continuing operations of $0.89, vs. $1.05 in 2012 Reported diluted EPS from continuing operations of $0.72, vs. $0.97 in 2012 Revenues from continuing operations of $1.8 billion, 6.4% below prior year Full year 2013 adjusted EPS and cash flow guidance unchanged Full year 2013 revenues now expected to approximate the prior year level Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider o...  04/17/13 Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada Transaction expected to deliver innovative and high-quality diagnostic information services at lower costs to patients MADISON, N.J. and SAN FRANCISCO, April 17, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has entered into a definitive agreement to acquire lab-related clinical outreach service operations of Dignity Health, a hospital system based in California. Under the agreement, Quest Dia...  04/16/13 Quest Diagnostics Names Jim Davis, Senior Vice President, Diagnostic Solutions MADISON, N.J., April 16, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice president for three GE healthcare businesses, has joined Quest Diagnostics as Senior Vice President, Diagnostic Solutions. In this role, Mr. Davis will lead the company's Diagnostic Solutions business. In this role, he will oversee Diagnostic Products, Insurer Services, Clinical Trials and Healthcare Informat...  04/09/13 Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS MADISON, N.J., April 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances. HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide. In February 2013, Quest Diagnos...  04/09/13 Quest Diagnostics Launches Novel Rheumatoid Arthritis Tests Based on 14-3-3eta protein biomarker for aiding early RA diagnosis through an exclusive license with Augurex Life Sciences MADISON, N.J., April 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests for aiding the early diagnosis of rheumatoid arthritis (RA), an autoimmune disorder that can cause debilitating joint damage. The lab-developed tests are based on the prop...  04/08/13 Recreational Marijuana Users More Likely To Misuse Prescription Drugs, According to National Study by Quest Diagnostics Quest Diagnostics Health Trends™ analysis also finds marijuana is the most commonly abused drug in the United States, but medical marijuana users are not more likely to misuse other drugs MADISON, N.J., April 8, 2013 /PRNewswire/ -- Individuals who use marijuana recreationally are more likely to misuse other drugs, including pain-controlling, but potentially addictive narcotics, sedatives and other prescription medications, than individuals who do not use marijuana, according to a new natio...  04/05/13 Quest Diagnostics To Release First Quarter 2013 Financial Results On April 17 MADISON, N.J., April 5, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2013 results on Wednesday, April 17, 2013 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests parti...  04/03/13 Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics Quest Diagnostics Health Trends™ analysis of a quarter million test results finds three out of five Americans tested misused their prescription medications, including through potentially dangerous drug combinations MADISON, N.J., April 3, 2013 /PRNewswire/ -- Despite increased public attention on the epidemic of prescription medication abuse, about three in five Americans tested misused their prescription drugs in 2012, virtually the same as in 2011, according to a national study issued tod...  04/02/13 Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs MADISON, N.J., April 2, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sukumar Nagendran, M.D., has joined Quest Diagnostics as vice president, medical affairs, a new position. In this role, Dr. Nagendran will provide medical oversight for the company's diagnostic information services. He reports to Jon R. Cohen, M.D., senior vice president and chief medical officer, and will be based at the company's h...  03/27/13 Federal Guidelines Recommend New HIV Testing Method U.S. Department of Health and Human Services issues medical guidelines recommending genotypic testing to aid HIV therapy selection MADISON, N.J., March 27, 2013 /PRNewswire/ -- A new test based on gene sequencing may be used to assess a patient's suitability for treatment with CCR5 antagonists, a class of HIV antiretroviral therapies, under new medical guidelines issued by the U.S. Department of Health and Human Services (DHHS). The new genotypic test performs comparably to the standard...  03/18/13 Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines Test to be unveiled at the American Academy of Neurology Annual Meeting in San Diego, March 16-23, 2013 MADISON, N.J. and WORCESTER, Mass., March 18, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of the first clinical test panel for aiding the diagnosis of suspected dementia due to treatable forms of cognitive impairment. The test panel is believed to be the first commercial service from ...  03/14/13 Quest Diagnostics Announces Chief Financial Officer Transition Plan MADISON, N.J., March 14, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, plans to leave the company at the end of May 2013.  The company is launching a search for a new CFO that will consider both internal and external candidates, and Mr. Hagemann will assist in identifying his successor.  Mr. Hagemann will continue in his capacity as...  03/14/13 Quest Diagnostics Supports New Chronic Kidney Disease Guideline Focused on Predicting and Managing Risk Public Encouraged to Learn About Their Kidneys and Understand Their Risks on World Kidney Day, March 14, 2013 MADISON, N.J., March 14, 2013 /PRNewswire/ -- On World Kidney Day, Quest Diagnostics, the world's leading provider of diagnostic information services, today announced its support of the updated global version of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) Chronic Kidney Disease (CKD) guideline recently released by Kidney Disease: Improving G...  03/07/13 Pre-Employment Drug Test Positives Increase More Than 5%, According to New Data from Quest Diagnostics Drug Testing Index™ Marijuana Remains Most Commonly Detected; Oral Fluid Finding More Positives MADISON, N.J., March 7, 2013 /PRNewswire/ -- Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in all of 2011, according to Drug Testing Index™ (DTI) data released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The positivity rate from pre-employment urine drug s...  03/05/13 Quest Diagnostics to Showcase Its Award-Winning Healthcare IT Connectivity Solutions at HIMSS13 IT solutions enable physicians, hospitals, patients, ACOs and payers to be smart, synchronized and connected NEW ORLEANS, March 5, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is presenting its award-winning healthcare information technology (HIT) connectivity solutions at HIMSS13.  Quest Diagnostics offers the broadest access to diagnostic information services through its network of laboratories and through it...  03/04/13 Quest Diagnostics Ranks No. 1 in Industry Category on FORTUNE's World's Most Admired Companies List MADISON, N.J., March 4, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that that it has been recognized in FORTUNE magazine's "World's Most Admired Companies" list as the No. 1 company in the Health Care industry category of "Pharmacy and Other Services."  "We are proud that Quest Diagnostics has rejoined FORTUNE's World's Most Admired Companies as the leader in our category," said Steve Rusckowski, Pres...  02/28/13 ChartMaxx® and Appian Announce Partnership to Bring Next Generation Business Process Management to the Healthcare Industry at HIMSS13 Upgrade in functionality solves critical IT priorities, enables better patient experience, improves efficiency and provides greater return on investment for hospitals MASON, Ohio, Feb. 28, 2013 /PRNewswire/ -- In line with its reputation for being on the forefront of tools that provide insights for better healthcare, Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced a partnership between ChartMaxx®, its leading Document Management...  02/26/13 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb. 26, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share, payable on April 16, 2013, to shareholders of record of Quest Diagnostics common stock on April 2, 2013. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to mak...  02/25/13 Quest Diagnostics to Sell HemoCue Business to Radiometer Medical ApS MADISON, N.J., Feb. 25, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances. HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide. "The HemoCu...  02/20/13 Quest Diagnostics to Provide Nationwide Access to Natera's New Non-Invasive Prenatal Test MADISON, N.J. and SAN CARLOS, Calif., Feb. 20, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Natera, a leading innovator in prenatal genetic testing, today announced that Quest Diagnostics will offer physicians access to Panorama™, a new non-invasive prenatal test developed by Natera. Panorama uses cell-free fetal DNA in circulating maternal blood to screen for chromosomal abnormalities associated with trisomy 21 (Dow...  02/11/13 Quest Diagnostics Names Tracy L. Cinco-Abela Vice President and Treasurer MADISON, N.J., Feb. 11, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Tracy L. Cinco-Abela has been named vice president and treasurer. Ms. Cinco-Abela has responsibility for all treasury activities, including capital planning, capital markets and funding, financial risk management and treasury operations. Most recently, she served as the company's assistant treasurer. She reports to Robert A. Hage...  02/08/13 Quest Diagnostics To Speak At The Leerink Swann Global Healthcare Conference 2013 MADISON, N.J., Feb. 8, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Leerink Swann Global Healthcare Conference in New York City. The presentation is scheduled for Thursday, February 14, 2013 at 11:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://leerin...  01/23/13 Quest Diagnostics Reports Fourth Quarter And Full Year 2012 Financial Results; Announces 2013 Guidance -- Full year record cash from operations of $1.2 billion and expanded operating margins -- Fourth quarter adjusted diluted EPS from continuing operations of $1.01, vs. $1.20 in 2011 -- Fourth quarter reported diluted EPS from continuing operations of $0.87 vs. $1.16 in 2011 -- Fourth quarter revenues from continuing operations of $1.8 billion, 4% below prior year -- 2013 guidance before special items: Diluted EPS between $4.35 - $4.55; revenues to grow between 0% and 1% MADISON,...  01/16/13 Quest Diagnostics Plans to Sell HemoCue Diagnostic Products Business as Part of its Strategy to Refocus on Diagnostic Information Services -- Fourth Quarter Charge to be Recorded in Discontinued Operations -- -- Company Finalizes Estimated Impact from Hurricane Sandy -- MADISON, N.J., Jan. 16, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it plans to sell its HemoCue diagnostic products business, as part of the company's strategy to refocus on diagnostic information services. HemoCue develops, produces and markets point-...  01/08/13 Quest Diagnostics To Speak At The 31st Annual J.P. Morgan Healthcare Conference MADISON, N.J., Jan. 8, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco.  The presentation is scheduled for Wednesday, January 9, 2013 at 2:30 p.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site:  http://jpm...  01/07/13 Quest Diagnostics To Release Fourth Quarter And Full Year 2012 Financial Results On January 23 MADISON, N.J., Jan. 7, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2012 results and provide financial guidance for 2013 on Wednesday, January 23, 2013 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed i...  01/02/13 Quest Diagnostics Acquires UMass Memorial Medical Center's Clinical and Anatomic Pathology Outreach Laboratory Businesses Finalizes Lease to Build 200,000 Square Foot "Lab of the Future" in Marlborough, Massachusetts MADISON, N.J. and WORCESTER, Mass., Jan. 2, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Worcester-based clinical outreach laboratory business of UMass Memorial Medical Center, a member of UMass Memorial Health Care, the largest health care system in ...  12/31/12 Quest Diagnostics Sells OralDNA Labs to Access Genetics MADISON, N.J., Dec. 31, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has sold substantially all of the assets of its OralDNA® Labs salivary-diagnostics business to Access Genetics, a leading clinical laboratory with advanced molecular diagnostics test development and information technology capabilities. Terms of the transaction were not disclosed. The divestiture of OralDNA represents a step i...  12/04/12 Quest Diagnostics Clinical Trials' Biorepository Accredited by the College of American Pathologists Signifies achievement of highest quality standards for management of biological specimens and molecular material used in new drug development MADISON, N.J., Dec. 4, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that the specimen biorepository of its Quest Diagnostics Clinical Trials business, a leader in laboratory testing services to advance drug discovery and development, has been accredit...  11/16/12 Quest Diagnostics Details Strategy at 2012 Investor Day -- Increases Invigorate Cost Reduction Goal by $100 Million to $600 Million -- -- Announces 76% Increase in Dividend to $1.20 per Share Annually -- MADISON, N.J., Nov. 16, 2012 /PRNewswire/ -- As previously announced, Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will host its Investor Day today, November 16, 2012 in New York City.  During the event, Quest Diagnostics executives will share their views of the industry and ...  11/09/12 Quest Diagnostics Confirms Investor Day on November 16 MADISON, N.J., Nov. 9, 2012 /PRNewswire/ -- As previously announced, Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will host an Investor Day on Friday, November 16, 2012 at The Hudson Theatre at the Millennium Broadway Times Square, 145 West 44th Street, New York, NY.  During the event, Quest Diagnostics' new executive leadership team will discuss the company's strategy, performance and plans to drive shareholder...  10/19/12 Quest Diagnostics Announces First EHRs Certified Under Laboratory-based Health IT Quality Solutions™ Program Program designed to help facilitate rigorous industry-wide standards for quality and interoperability of physician-practice electronic health records with the company's laboratory data system MADISON, N.J., Oct. 19, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the first electronic health record (EHR) solutions to be certified under its Health IT Quality Solutions™ Program. The program is des...  10/17/12 Quest Diagnostics Reports Third Quarter 2012 Financial Results -- Adjusted diluted EPS of $1.18, unchanged from prior year -- Reported diluted EPS of $1.01, 6% below prior year -- Revenues of $1.9 billion, 2.9% below prior year -- Full year adjusted EPS guidance of $4.45 - $4.55; revenue growth outlook of approximately 0.5% MADISON, N.J., Oct. 17, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that for the third quarter ended...  10/16/12 Quest Diagnostics to Acquire Clinical Outreach Laboratory from UMass Memorial Medical Center; Plan to Build 'Lab of the Future' to Serve Massachusetts Health Care Community --Relationship will provide innovation, resources, and expanded access and connectivity for patients and doctors' offices, all at reduced costs-- MADISON, N.J. and WORCESTER, Mass., Oct. 16, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world leader in diagnostic testing, information and services, signed a definitive agreement today to purchase the clinical outreach laboratory business of UMass Memorial Medical Center, a member of UMass Memorial Health Care and the largest ...  10/11/12 Quest Diagnostics Launches New Organizational Structure To Drive Operational Excellence and Restore Growth; Appoints New Senior Leaders MADISON, N.J., Oct. 11, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, launched a major management restructuring aimed at driving operational excellence and restoring growth. In addition, the company appointed senior leaders to head its new Commercial, Operations and Human Resources functions. The key element of the organization change will be to eliminate existing business structures and repl...  10/09/12 Focus Diagnostics and 3M Launch FDA-Cleared Simplexa™ Test on 3M™ Cycler for Molecular Influenza and Respiratory Virus Testing by Moderate Complexity Healthcare Facilities First moderate-complexity Simplexa™ assay developed through funding by U.S. Department of Health and Human Services' BARDA BAA program for public health preparedness CYPRESS, Calif. and SAINT PAUL, Minn., Oct. 9, 2012 /PRNewswire/ -- Focus Diagnostics, a business of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and 3M, a global diversified technology company (NYSE: MMM), today announced that the U.S. Food and Drug Administration...  10/04/12 Quest Diagnostics To Release Third Quarter 2012 Financial Results On October 17 MADISON, N.J., Oct. 4, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it will report third quarter 2012 results on Wednesday, October 17, 2012 before the stock market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the conference call through a live audio webcast availabl...  10/02/12 PLOS ONE Study Finds HIV Genotypic Sequencing Test Performs Comparably to Standard Phenotypic Test in Predicting Potential Response to CCR5 Antagonist Genotypic HIV tropism laboratory-developed testing service now available nationally for HIV-infected patients MADISON, N.J., Oct. 2, 2012 /PRNewswire/ -- A laboratory-developed blood test that uses deep-sequencing technology performed comparably to the industry's standard phenotypic test in helping to predict potential clinical response to HIV-1 antiretroviral CCR5-antagonist therapy, according to a new study from researchers at Quest Diagnostics (NYSE: DGX) and Pfizer. The findings undersc...  09/28/12 Quest Diagnostics To Host Investor Day On November 16, 2012 MADISON, N.J., Sept. 28, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the  world's leading provider of diagnostic testing, information and services, will host an investor day with institutional investors and sell-side financial analysts in New York City on Friday, November 16, 2012. During the event, Quest Diagnostics executives will discuss the company's strategy, performance and plans to drive shareholder value.   Advanced registration is required for ...  09/14/12 Quest Diagnostics Marks Ninth Year on Dow Jones Sustainability Index MADISON, N.J., Sept. 14, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has again been named to the Dow Jones Sustainability World Index and North America Index. Quest Diagnostics is in its ninth year on the World Index (since 2004) and in its eighth on the North America Index (since 2005). "All of us at Quest Diagnostics are proud to have again earned a place on the Dow Jones Sustainability I...  08/30/12 Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Health's TERC Gene Marker May enhance evaluation of cancer risk in the up to 1.5 million women who receive an indeterminate Pap test result each year MADISON, N.J., Aug. 30, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer. The test is designed to help physicians i...  08/24/12 Quest Diagnostics Gazelle® Mobile Health App Earns 2012 CIO 100 Award MADISON, N.J., Aug. 24, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, accepted a 2012 CIO 100 award from International Data Group's (IDG) CIO magazine for its Gazelle® mobile health application. The 25th annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology. The Gazelle mobile application for Blackberry...  08/21/12 Quest Diagnostics Blueprint for Wellness® Earns URAC's Comprehensive Wellness Accreditation Endorsement recognizes wellness program for commitment to excellence MADISON, N.J., Aug. 21, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its Blueprint for Wellness® health risk assessment service earned Comprehensive Wellness Accreditation by meeting the highest standards for education, care and service delivery from URAC, a Washington, DC-based organization that establishes quality ...  08/09/12 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Aug. 9, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on October 16, 2012, to shareholders of record of Quest Diagnostics common stock on October 1, 2012. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and se...  07/27/12 Harvard and MIT Students Rally Boston to Join Global Guinness World Record Attempt on World Hepatitis Day Team HBV Chapters in Boston and Quest Diagnostics Urge City Residents and Visitors to Come Out and Be Counted at 'See No Evil, Hear No Evil, Speak No Evil' Viral Hepatitis Awareness Event, Boston Common, Noon Tomorrow BOSTON, July 27, 2012 /PRNewswire/ -- Students at Harvard and Massachusetts Institute of Technology aren't the type to take the summer off. Those who comprise a group called Team HBV, while working well-earned and prized internships, are also dedicating their off...  07/19/12 Quest Diagnostics Reports Second Quarter 2012 Financial Results -- Adjusted diluted EPS of $1.17, up 4.5% -- Reported diluted EPS of $1.11, up 8.8% -- Revenues of $1.9 billion, essentially unchanged from prior year -- Full year adjusted earnings guidance unchanged; revenue growth outlook lowered to 1.0% - 2.0% MADISON, N.J., July 19, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that for the second quarter ended June 30, 2012, adjust...  07/17/12 Vitamin D Supplementation May Not Reduce Cholesterol-Related Heart Disease Risk, New Study Finds Analysis published in Circulation by researchers at Quest Diagnostics and Rockefeller University contradicts prior research suggesting optimal vitamin D levels may have a beneficial impact on heart health MADISON, N.J., July 17, 2012 /PRNewswire/ -- Raising vitamin D to optimal from deficient blood levels may not improve total cholesterol and other blood lipids, key markers of cardiovascular disease risk, according to a study published today in Circulation, a publication of the American Hea...  06/28/12 National Business Group on Health Honors Quest Diagnostics as Platinum-Level Best Employer for Healthy Lifestyles HealthyQuest Program Recognized for Eighth Straight Year MADISON, N.J., June 28, 2012 /PRNewswire/ -- The National Business Group on Health (NBGH) has honored Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, with its 2012 Best Employer for Healthy Lifestyles Award. This is the fourth consecutive year Quest Diagnostics has earned Platinum distinction, the highest level award, for its commitment to improving the health of employees a...  06/27/12 Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19 MADISON, N.J., June 27, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it will report second quarter 2012 results on Thursday, July 19, 2012 before the stock market opens. It will hold its quarterly conference call to discuss the results beginning at 8:00 a.m. Eastern Time on that day. The public may access the conference call through a live audio webcast availab...  06/15/12 Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference MADISON, N.J., June 15, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Wells Fargo Securities 2012 Healthcare Conference in Boston.  The presentation is scheduled for Tuesday, June 19, 2012 at 9:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site: http...  06/01/12 Quest Diagnostics Launches New Molecular Test Panel for Enhanced Thyroid Cancer Detection Results of a study of the test panel to be unveiled at the 2012 ASCO Annual Meeting on June 4; new test may reduce risk of surgical removal of healthy thyroids for some patients MADISON, N.J., June 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed...  05/23/12 Many Pregnant Women Not Screened For Chlamydia and Gonorrhea Study by Quest Diagnostics of 1.3 million pregnant women also found that 16% of pregnant 16-year olds tested positive for chlamydia, higher than any other age group MADISON,  N.J., May 23, 2012 /PRNewswire/ -- Many women are not screened for chlamydia and gonorrhea infection during their pregnancy, and follow-up testing is not always performed as medically recommended for those who test positive for chlamydia, according to a study published online in the American Jou...  05/17/12 Quest Diagnostics Extends Endocrine Diagnostic Menu with New Congenital Adrenal Hyperplasia (CAH) Steroid Screening Panels Features newborn screening panel that measures all 13 CAH-associated steroids by tandem mass spectrometry in a single analysis MADISON, N.J., May 17, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. The p...  05/16/12 Quest Diagnostics Reminds Women to Make Their Health a Priority During National Women's Health Week Company Distributes 10,000 Vouchers for Free Wellness Screenings in May in Support of American Cancer Society Choose You® Women's Health Movement MADISON, N.J., May 16, 2012 /PRNewswire/ -- This week, National Women's Health Week, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, joins the American Cancer Society Choose You® movement and the U.S. Department of Health and Human Services' (HHS) Office on Women's Health (OWH) in remind...  05/11/12 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 11, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on July 18, 2012, to shareholders of record of Quest Diagnostics common stock on July 3, 2012. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and services...  05/01/12 Quest Diagnostics Sponsors American Cancer Society Choose You® Women's Health Movement Company Offers 10,000 Vouchers for Free Wellness Screenings as National Presenting Sponsor NEW YORK, May 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced its national presenting sponsorship of the American Cancer Society Choose You® movement, which encourages women nationwide to live well today and stay well tomorrow. In support of the Choose You movement and in recognition of National Women'...  04/27/12 Three in Five Americans Misuse Their Prescription Drugs, Finds National Study of Prescription Medication Lab Testing Quest Diagnostics Health Trends(TM) analysis finds many women and men of all ages, income levels and health plan coverage use pain and other prescription medications contrary to clinician orders, potentially putting their health at risk MADISON, N.J., April 27, 2012 /PRNewswire via COMTEX/ --Results of a national study of nearly 76,000 laboratory tests for monitoring prescription drug use indicate that the majority of Americans tested misused their prescription drugs, including potentially ad...  04/27/12 Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date MADISON, N.J., April 27, 2012 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced it has begun an effort to assign a unique Patient Identifier - a secure 16 digit identification number - to every Quest Diagnostics patient. In what is believed to be the largest effort of its kind in the area of assigning health IDs, the company has assigned unique identifiers to approximately 80 million Quest Diagnostics...  04/25/12 Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrig's Disease) The company's Athena Diagnostics business unit to unveil the new test at the American Academy of Neurology Annual Meeting this week in New Orleans MADISON, N.J. and WORCESTER, Mass., April 25, 2012 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new genetic testing service from its Athena Diagnostics business unit, a leader in neurology diagnostics, for amyotrophic lateral sclerosis (ALS),...  04/18/12 Quest Diagnostics Reports First Quarter 2012 Financial Results -- Revenues of $1.9 billion, up 6.3% -- Adjusted diluted EPS of $1.07, up 7.0% -- Reported diluted EPS of $0.99 in 2012 compared to a loss of $0.33 per diluted share in 2011 -- Full year adjusted earnings outlook increased to $4.45 - $4.60 per diluted share MADISON, N.J., April 18, 2012 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that for the first quarter ended March 3...  04/11/12 Quest Diagnostics Names Steve Rusckowski as President and CEO -- Daniel C. Stanzione, Ph.D. is appointed Non-Executive Chairman of the Board of Directors -- MADISON, N.J., April 11, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that Stephen H. Rusckowski will succeed Surya N. Mohapatra, Ph.D. as President and Chief Executive Officer, effective May 1, 2012. Dr. Mohapatra will remain in his role through April 30 to ensure a smooth leadership transition. Mr. Rusckowski will also become a member of the Board of Directors....  04/11/12 FDA Clears the Quest Diagnostics Simplexa® C. difficile Molecular Test Test eliminates nucleic-acid sample extraction, for faster results MADISON, N.J. and CYPRESS, Calif., April 11, 2012 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M™ Integrated Cycler.  The test, from the company's Focus Diagnostics business, is intended to ...  04/09/12 Institute for Health and Productivity Management Honors Quest Diagnostics Company receives Level 1 Corporate Health and Productivity Award for its Commitment to Employee Health MADISON, N.J., April 9, 2012 /PRNewswire/ -- The Institute for Health and Productivity Management (IHPM) honored Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, with the Level 1 Corporate Health and Productivity Award earlier this month at its 12th annual conference in Orlando, Florida. "With its HealthyQuest employee wellnes...  04/03/12 Quest Diagnostics to Release First Quarter 2012 Financial Results MADISON, N.J., April 3, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it will report first quarter 2012 results on Wednesday, April 18, 2012 before the stock market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the conference call through a live audio webcast available on Quest Diag...  03/27/12 Quest Diagnostics Supports 'Diabetes Alert Day' Americans Encouraged to Use American Diabetes Association Diabetes Risk Test, and Take Action for Their Health MADISON, N.J., March 27, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today joins the American Diabetes Association (ADA) in recognizing the 24th annual Diabetes Alert Day. This one-day "wake-up call" encourages the public to take the Diabetes Risk Test to learn if they are at risk for developing T...  03/22/12 Redesigned Quest Diagnostics Website Features New Tools to Educate and Engage Healthcare Providers and Patients MADISON, N.J., March 22, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has unveiled its redesigned corporate website at www.QuestDiagnostics.com. The site provides several new features, technologies and resources to help healthcare professionals and patients interact with the company online and access a broad span of information on diagnostic testing and health issues. The site features a new Test Center t...  03/15/12 Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection Based on exclusive biomarker licenses with Beth Israel Deaconess Medical Center and Weill Cornell Medical College MADISON, N.J., March 15, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of the industry's first molecular blood test for identifying renal (kidney) organ-transplant rejection. The Renal Transplant Monitoring laboratory-developed test is designed to help physicians ...  03/13/12 Cocaine Positives Spike 33% After New Government Rule for Safety-Sensitive Workers Amphetamines Positives Jump Nearly 26% After New Rule, Continuing Upward Trend, Shows Quest Diagnostics Drug Testing Index™ MADISON, N.J., March 13, 2012 /PRNewswire/ -- Safety-sensitive workers have been subject to more stringent government drug testing rules over the past year, and the crackdown may be paying off, according to annual Drug Testing Index™ data released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. New d...  03/07/12 Quest Diagnostics to Speak at the 2012 Barclays Capital Global Healthcare Conference MADISON, N.J., March 7, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2012 Barclays Capital Global Healthcare Conference in Miami.  The presentation is scheduled for Wednesday, March 14, 2012 at 4:15 p.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site: h...  02/28/12 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb. 28, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on April 17, 2012, to shareholders of record of Quest Diagnostics common stock on April 3, 2012. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and servic...  02/28/12 Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference MADISON, N.J., Feb. 28, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2012 RBC Capital Markets Healthcare Conference in New York City.  The presentation is scheduled for Wednesday, February 29, 2012 at 10:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following...  02/23/12 Care360® EHR From Quest Diagnostics Honored by Black Book's 2012 Rankings and Capterra's Top 20 List EHR is Ideal Solution for Small to Medium-Sized Physician Practices Across the Nation LAS VEGAS, Feb. 23, 2012 /PRNewswire/ -- The highly-acclaimed Care360® Electronic Health Record (EHR) solution from Quest Diagnostics (NYSE: DGX) has been honored by receiving the top spot in the Single Physician Practice and ePrescribing categories in Black Book's 2012 Rankings of Top EHR and Electronic Medical Record (EMR) Vendors. In addition, Care360 EHR was ranked eighth on Capterra's To...  02/22/12 Trinity Health to Improve Revenue Cycle Through ChartMaxx® Implementation Enterprise-Wide Content Management Helps Organization to Realize Greater Efficiencies Throughout the Continuum of Care LAS VEGAS, Feb. 22, 2012 /PRNewswire/ -- Trinity Health of Novi, Michigan, the fourth-largest Catholic healthcare system in the country, operating 49 acute-care hospitals, 379 outpatient facilities and 26 long-term care facilities throughout seven states, has selected Quest Diagnostics' (NYSE: DGX) ChartMaxx® Enterprise Content Management (ECM) solution to provide its staff...  02/21/12 Quest Diagnostics Offers Industry-First 30-Day Ambulatory EHR Implementation Guarantee for Hospitals and IDNs Care360® EHR Streamlines the Development of Hospital Physician Referral Networks LAS VEGAS, Feb. 21, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, launched today at HIMSS the industry's first 30-day electronic health record (EHR) implementation guarantee for hospitals looking to quickly enable bi-directional data exchange with their ambulatory physicians through its award winning Care360® EHR we...  01/24/12 Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 -- Revenues of $1.9 billion, up 3% -- Adjusted diluted EPS of $1.23, up 19%; reported diluted EPS of $1.19, up 23% -- Cash flow from operations of $338 million compared to $340 million in 2010 -- 2012 guidance before special items: Diluted EPS between $4.40 and $4.55; revenues to grow between 2% and 2.5% -- Board approves $1 billion share repurchase authorization MADISON, N.J., Jan. 24, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), ...  01/24/12 Quest Diagnostics Increases Share Repurchase Authority by $1 Billion -- Increase brings current authorization to $1.1 billion -- MADISON, N.J., Jan. 24, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $1 billion. This action increases the current share repurchase authorization to $1.1 billion. During 2011, the company repurchased approximately 17  million shares of co...  01/20/12 Quest Diagnostics STRATIFY JCV(TM) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients Based on exclusive collaboration with Biogen Idec, the test is only available in the U.S. through Quest Diagnostics' Focus Diagnostics lab MADISON, N.J., Jan. 20, 2012 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted a de novo classification petition to its STRATIFY JCV(TM) Antibody ELISA testing service. STRATIFY JCV is the first b...  01/20/12 Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients Based on exclusive collaboration with Biogen Idec, the test is only available in the U.S. through Quest Diagnostics' Focus Diagnostics lab MADISON, N.J., Jan. 20, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted a de novo classification petition to its STRATIFY JCV™ Antibody ELISA testing service. STRATIFY JCV is the first blood test t...  01/18/12 Quest Diagnostics Launches National EHR Grant Program for Physicians Program Offers Subsidies Equivalent to an 85 Percent Discount on Care360® EHR Physicians can receive a certified EHR solution for less than $100 per month MADISON, N.J., Jan. 18, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that, beginning January 23rd and throughout 2012, it is offering to eligible physician practices subsidies of 85 percent off the re...  01/09/12 ChartMaxx® Earns 2011 'Best in KLAS' for Healthcare Document Management and Imaging Software Healthcare Professionals Honor MedPlus Enterprise-wide Electronic Patient Record System with Top Ranking for Eight of Last 10 Years CINCINNATI, Jan. 9, 2012 /PRNewswire/ -- MedPlus, the healthcare IT subsidiary of Quest Diagnostics (NYSE: DGX), announced today that its ChartMaxx® enterprise-wide electronic patient record system has been ranked the top healthcare Document Management and Imaging (DMI) software product, according to the 2011 Best in KLAS Awards: Software ...  01/06/12 Quest Diagnostics Completes Acquisition of S.E.D. Medical Laboratories MADISON, N.J., Jan. 6, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the successful completion of its previously announced agreement with Lovelace Health System to acquire S.E.D. Medical Laboratories. Under the terms of the transaction, Quest Diagnostics has acquired the assets of S.E.D. Medical Laboratories and will manage in-patient labs for the four Lovelace ho...  01/05/12 Quest Diagnostics to Release Fourth Quarter and Full Year 2011 Financial Results MADISON, N.J., Jan. 5, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it will report fourth quarter and full year 2011 results and provide financial guidance for 2012 on Tuesday, January 24, 2012 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the confere...  01/04/12 One in Six Pregnant Women Tested Are Positive for Hypothyroidism Study of half a million pregnant women in the United States finds 15.5% of those tested were positive for gestational hypothyroidism, much higher than prior estimates MADISON, N.J., Jan. 4, 2012 /PRNewswire/ -- As many as one in six pregnant women tested were positive for gestational hypothyroidism, or underactive thyroid during pregnancy, under new clinical guidelines for detecting the disorder, according to a study published in The Journal of Clinical Endocrinology & M...  01/03/12 S.E.D. Labs to be Acquired by Quest Diagnostics --Transaction will provide innovation, resources and expanded access and connectivity for patients-- --Synergistic lab purchase to enable Quest Diagnostics to significantly increase its presence in New Mexico-- ALBUQUERQUE, N.M. and MADISON, N.J., Jan. 3, 2012 /PRNewswire/ -- S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated (NYSE: DGX), the world leader in diagnostic testing, information and services, through a definitive ag...  12/09/11 Quest Diagnostics Care360™ Named Top e-Prescribing Platform by Black Book Rankings - Care360™ Ranked #1 in Customer Experience and Satisfaction - More than 92 Percent of Care360™ Clients Are On Track for Meaningful Use MADISON, N.J., Dec. 9, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that Care360™, the company's electronic health platform, has been named the leading stand-alone e-Prescribing software system by Black Book Rankings, a leading sou...  12/08/11 One in Three First-Time Participants in Laboratory-Based Wellness Program Learn of High Risk for Chronic Disease, Quest Diagnostics Study Shows Eighty-Nine Percent of Those at High Risk for Chronic Kidney Disease, 59 Percent of Those at High Risk for High Cholesterol, and 28 Percent of Those at High Risk for Diabetes First Learned of Health Condition through Lab-Based Wellness Program MADISON, N.J., Dec. 8, 2011 /PRNewswire/ -- One in three first-time participants in a company-sponsored, lab-based wellness program were not aware they were at high risk for a serious medical condition, according to an article publis...  12/07/11 Quest Diagnostics Adds Timothy M. Ring to Board of Directors MADISON, N.J., Dec. 7, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors has elected Timothy M. Ring to serve as a director, effective immediately. Including Mr. Ring, the Board has nine members. Mr. Ring is Chairman and Chief Executive Officer of C. R. Bard, Inc., a leading multinational developer, manufacturer and marketer of innovative, life-e...  12/06/11 Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nation's Public and Private Health Testing Country's public health labs now evaluating the test's potential for aiding clinical management of the country's nearly one million Dengue fever cases MADISON, N.J. and CYPRESS, Calif., Dec. 6, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ Dengue molecular test kit developed by its Focus Diagnostics products business has been registered for distribution in Braz...  11/15/11 Quest Diagnostics CE Marks Simplexa(TM) Test for Cytomegalovirus for Sale in Europe With the new Focus Diagnostics' Simplexa molecular test on the 3M(TM) Integrated Cycler, the company now offers one of the most comprehensive molecular transplant-testing menus in Europe MADISON, N.J. and CYPRESS, Calif., Nov. 15, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics business has CE marked its new Simplexa Cytomegalovirus (CMV) molecular test k...  11/11/11 Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference MADISON, N.J., Nov. 11, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 8th Annual Healthcare Conference in New York City.  The presentation is scheduled for Tuesday, November 15, 2011 at 11:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2011 outlook before future special items. The company expects re...  11/08/11 Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th Company Applauds American Cancer Society for Working to Inform the Fight Against Cancer for Future Generations DENVER, Nov. 8, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics joined the American Cancer Society today to encourage Denver-area residents to participate in the American Cancer Society's historic Cancer Prevention Study - 3 (CPS-3). The Denver enrollment period for this national, longitudinal study is between November 8 and 19, 2011. The CPS-3 Study focuses on uncovering the lifes...  11/01/11 Quest Diagnostics Announces Launch of Simplexa(TM) Direct Test for Influenza and Respiratory Viruses in Europe Focus Diagnostics product eliminates nucleic-acid sample extraction with proprietary technology, for faster testing CYPRESS, Calif. and MADISON, N.J., Nov. 1, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the CE mark and European availability of the Simplexa Flu A/B & RSV Direct test on the 3M(TM) Integrated Cycler. The new test, from the company's Focus Diagnostics ...  10/25/11 Quest Diagnostics Reports Third Quarter 2011 Financial Results -- Revenues of $1.9 billion, up 2.2% -- Adjusted diluted EPS of $1.18, up 4%; reported diluted EPS of $1.08, down 4% -- Cash flow from operations of $338 million, up $8 million -- Quarterly dividend increased by 70% to $0.17 per share MADISON, N.J., Oct. 25, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that for the third quarter ended September 30, 2011, adjusted income from co...  10/25/11 Quest Diagnostics Increases Quarterly Cash Dividend MADISON, N.J., Oct. 25, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors has increased the quarterly cash dividend to $0.17 per share, payable on January 24, 2012, to shareholders of record of Quest Diagnostics common stock on January 9, 2012. The dividend represents a 70% increase from the current $0.10 per share level. "This increase in our di...  10/25/11 Quest Diagnostics Initiates CEO Succession Process Surya Mohapatra to Remain Chairman and CEO to Ensure Smooth Transition -- MADISON, N.J., Oct. 25, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX) today announced that its Board of Directors has begun the process of identifying a successor to Surya N. Mohapatra, Ph.D., President, Chairman and Chief Executive Officer. The Board of Directors has formed a search committee, engaged a leading executive recruitment firm and will consider both external and internal candida...  10/13/11 Quest Diagnostics to Release Third Quarter 2011 Financial Results MADISON, N.J., Oct. 13, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report third quarter 2011 results on Tuesday, October 25, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Qu...  10/11/11 Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index(TM) Hydrocodone and oxycodones remain most detected prescription opiates in U.S. general workforce Random drug tests for hydrocodone and oxycodones find nearly double the positives than pre-employment screening MADISON, N.J., Oct. 11, 2011 /PRNewswire via COMTEX/ --American workers continue to use prescription opiates at relatively high levels, according to Drug Testing Index(TM) (DTI) data released today by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic t...  09/27/11 Quest Diagnostics Named Healthiest Employer in Philadelphia, Baltimore and Washington, D.C. Regions Regional honors follow company's Platinum-Level 'Best Employer for Healthy Lifestyles' distinction from National Business Group on Health MADISON, N.J., Sept. 27, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services has been ranked as top healthy employer in the Philadelphia, Baltimore and Washington, D.C. regions. These honors follow the company's selection in May as a Platinum-level 'Best Employer for Heal...  09/13/11 New Rules Opening Access to Lab Test Results Will Empower Patients to Understand Their Health Better MADISON, N.J., Sept. 13, 2011 /PRNewswire via COMTEX/ --New rules proposed by the U.S. Department of Health and Human Services (HHS) to expand the rights of Americans to access their personal health information will empower patients to understand their health condition better, according to Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostics testing, information and services. "Patient engagement in healthcare decision making is vital to promoting better health outcomes...  09/09/11 Quest Diagnostics Selected as Member of Dow Jones® Sustainability Index Company Again Named to Both World and North American Indexes MADISON, N.J., Sept. 9, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones® Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). "Quest Diagnostics is proud to be included in the Dow Jones Sustainability Index," sa...  09/08/11 Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference MADISON, N.J., Sept. 8, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City. The presentation is scheduled for Tuesday, September 13, 2011 at 10:55 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the follow...  09/02/11 Hawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals Quest Diagnostics Drug Testing Index(TM) Five-year data suggest methamphetamine's national decline has halted and that the drug's stronghold may be moving eastward MADISON, N.J., Sept. 2, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today issued its annual report on U.S. worker drug use, the Quest Diagnostics Drug Testing Index(TM). The study includes its first state-by-state analysis of methamphetamine positives, based on mor...  08/12/11 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Aug. 12, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 24, 2011, to shareholders of record of Quest Diagnostics common stock on October 7, 2011. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information ...  07/25/11 Quest Diagnostics to Unveil Extensions to its Women's Health and Personalized Medicine Test Offerings at the 2011 AACC Annual Meeting and Clinical Lab Expo Athena Diagnostics' spinal muscular atrophy (SMA) testing menu is broadly available nationally to Quest Diagnostics' clients for the first time Quest Diagnostics will also present novel scientific research and host the "What's New in Laboratory Medicine?" scientific speaker series in booth 3130 MADISON, N.J., July 25, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced it will...  07/20/11 Quest Diagnostics Reports Second Quarter 2011 Financial Results -- Revenues of $1.9 billion, up 1.5% -- Adjusted diluted EPS of $1.12, up 5%; reported diluted EPS of $1.02, down 5% -- Updated 2011 adjusted guidance before special items: Diluted EPS between $4.25 and $4.35; revenues to grow 1.5% -- New initiative to reduce cost structure by $500 million and position company for the future MADISON, N.J., July 20, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and ...  07/14/11 Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests Genomic Vision's Molecular Combing genomic-analysis technique to provide basis for developing new clinical testing services for cancer, neurology and other diseases MADISON, N.J. and PARIS, July 14, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Genomic Vision, a biotechnology company dedicated to the development of molecular diagnostics, today announced a multi-year exclusive collaboration involv...  07/06/11 Quest Diagnostics to Release Second Quarter 2011 Financial Results MADISON, N.J., July 6, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report second-quarter 2011 results on Wednesday, July 20, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Que...  06/27/11 Poll: One in Three Adults 60-70 Years of Age Screened for Colon Cancer Have Only Done So Once, Suggesting Failure to Follow Periodic Testing Guidelines Poll also finds while most screened opt for colonoscopy, those who do not cite unpleasant bowel preparation and side effects as the chief reasons they prefer a different colon cancer test WASHINGTON, June 27, 2011 /PRNewswire via COMTEX/ -- Results from a nationwide research poll released today by the Colon Cancer Alliance and Quest Diagnostics (NYSE: DGX) suggest that one in three of men and women age 60-70 who have been screened for colon cancer have done so only once, suggesting a failure t...  06/22/11 Quest Diagnostics Gazelle® Mobile Health Platform Now Available for Android Smartphones MADISON, N.J., June 22, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new version of Gazelle, the company's mobile health platform, which now features compatibility with the fast-growing Google Android® smartphone operating system. (Photo: http://photos.prnewswire.com/prnh/20110622/NY24398) Gazelle for Android is now available for download free of charge at Gazelleapp.com and in...  06/16/11 Nearly One in Three Men and Women Age 50 and Over Have Not Been Screened for Colon Cancer; One in Four Say their Healthcare Provider Didn't Recommend Screening Poll respondents also report "too busy" and "fear" as reasons they haven't been screened, but most claim they would be screened if a blood test were available WASHINGTON, June 16, 2011 /PRNewswire via COMTEX/ --Results from a nationwide research poll released today by the Colon Cancer Alliance and Quest Diagnostics (NYSE: DGX) show that 31 percent of men and women age 50 years and over have never been screened for colon cancer by standard screening methods such as a colonoscopy, fecal occult ...  06/09/11 Quest Diagnostics Wins Gold Medical Design Excellence Award (MDEA) for Diagnostic Innovation Focus Diagnostics Simplexa(TM) molecular test on the 3M(TM) Integrated Cycler Wins Highest MDEA Award for in vitro diagnostics MADISON, N.J., June 9, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Simplexa(TM) molecular diagnostic test on the 3M(TM) Integrated Cycler won a gold award in the in vitro diagnostics category at the 2011 MDEA awards ceremony yesterday i...  06/03/11 Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference MADISON, N.J., June 3, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 2011 Global Healthcare Conference in New York City. The presentation is scheduled for Monday, June 6, 2011 at 8:30 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site:...  05/25/11 Men May Have Greater Allergy Risk Than Women, Suggests Largest Ever National Allergy Study Quest Diagnostics Health Trends analysis raises possibility that men are underdiagnosed for allergies MADISON, N.J., May 25, 2011 /PRNewswire via COMTEX/ -- A study of nearly 14 million blood tests for aiding allergy diagnosis shows that men exhibited higher sensitivity to 11 common allergens than women when tested, contradicting other research suggesting women experience allergies more frequently than men. The study's findings raise the possibility that men have a higher risk for allergies t...  05/24/11 OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment Second study in Obstetrics & Gynecology showcases OVA1's role in evaluating women with an ovarian mass MADISON, N.J. and AUSTIN, Texas, May 24, 2011 /PRNewswire via COMTEX/ -- A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative assessment alone. The study is the second published online this month in the journal, ...  05/24/11 Quest Diagnostics Earns Platinum Honor as "Best Employer for Healthy Lifestyles" for Third Consecutive Year National Business Group on Health Recognizes HealthyQuest Program for Seventh Straight Year WASHINGTON, and MADISON, N.J., May 24, 2011 /PRNewswire/ -- The National Business Group on Health (NBGH) has awarded its 2011 Best Employers for Healthy Lifestyles Platinum Award to Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. The 2011 award, in recognition of the company's HealthyQuest employee wellness initiative, marks the ...  05/23/11 Ragweed and Mold Lead Overall Upswing in Allergy Prevalence; Climate Change Suspected Quest Diagnostics Health Trends analysis of nearly 14 million allergy tests ranks "30 Worst Big Cities for Ragweed" (Click here for ranking) MADISON, N.J., May 23, 2011 /PRNewswire via COMTEX/ -- Early results from the largest cross-sectional national allergy study ever conducted, to be released later this week, suggest that allergies have increased in America, but that most of the increase was due to two environmental allergens, ragweed and mold. The study, based on nearly 14 million test res...  05/19/11 Quest Diagnostics Finalizes Agreement to Settle California Lawsuit Related to Medi-Cal Billing MADISON, N.J., May 19, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX) today announced it has finalized an agreement to settle a previously disclosed civil lawsuit, brought by a California competitor against a number of California clinical laboratories, in which the State of California intervened, for a payment of $241 million. The company had announced an agreement in principle to resolve the lawsuit on May 9, 2011. In the lawsuit, the plaintiffs alleged, among other t...  05/17/11 Quest Diagnostics Successfully Completes Acquisition of Celera MADISON, N.J., May 17, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the successful completion of its acquisition of Celera Corporation (NASDAQ: CRA). The acquisition was completed by means of a short-form merger under Delaware law, under which a wholly owned subsidiary of Quest Diagnostics was merged with and into Celera, with Celera surviving the merger as a wholly owned ...  05/17/11 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 17, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on July 19, 2011, to shareholders of record of Quest Diagnostics common stock on July 5, 2011. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and ser...  05/17/11 Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study Quest Diagnostics Health Trends(TM) Report also finds economically disadvantaged children tested for allergies at later ages MADISON, N.J., May 17, 2011 /PRNewswire via COMTEX/ -- Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold, are more common in older children and adults. The study, bas...  05/12/11 OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass Obstetrics & Gynecology study also considers OVA1's place in future surgical referral guidelines MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire via COMTEX/ -- A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the...  05/11/11 Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger MADISON, N.J., May 11, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), announced today the completion of the final extension of the subsequent offering period with respect to Spark's cash tender offer for all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA). The final extension of the subsequent o...  05/11/11 Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2011 Healthcare Conference MADISON, N.J., May 11, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America Merrill Lynch 2011 Healthcare Conference in Las Vegas. The presentation is scheduled for Thursday, May 12, 2011 at 12:50 p.m. Eastern Time. During the conference, the company will reaffirm its adjusted 2011 outlook before future special items. The company ...  05/09/11 Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement National Sponsor of Society Initiative to Prevent Cancer-Related Deaths MADISON, N.J., May 9, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX), today announced its national sponsorship of Choose You®, the American Cancer Society's movement that inspires women to stay well by putting their health first and making healthy lifestyle choices to help prevent cancer. According to the American Cancer Society, 1...  05/09/11 Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10th MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended the cash tender offer for all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA).  The expiration date of the subsequent offering period has been ext...  05/09/11 Quest Diagnostics Reaches Agreement in Principle to Settle California Lawsuit Related to Medi-Cal Billing MADISON, N.J., May 9, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced it has reached an agreement in principle to settle a previously disclosed civil lawsuit, brought by a California competitor, in which the State of California intervened. In the lawsuit, the plaintiffs alleged, among other things, that the company did not comply with California's "comparable charge" regulations, resulting in overpayments for laboratory testing services by Medi-Cal, Cal...  05/06/11 Quest Diagnostics Care360 EHR Customer Successfully Completes Meaningful Use Attestation to Receive the Medicare EHR Incentive MADISON, N.J., May 6, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics® (NYSE: DGX) today announced that Care360 user Paulo Andre, M.D., a neurologist in Framingham, MA, was the first Care360 EHR customer to successfully complete the attestation process for demonstrating Meaningful Use of an electronic health record with an ONC-ATCB certified complete EHR* in accordance with the Centers for Medicare and Medicaid Services (CMS) EHR incentive program. Dr. Andre was the 25th physician in the U...  05/05/11 Quest Diagnostics Launches Simplexa(TM) C. Difficile Universal Direct Test in Europe First test from the Focus Diagnostics' Simplexa product line for the hospital-acquired infection (HAI) market MADISON, N.J. and CYPRESS, Calif., May 5, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile Universal Direct test on the 3M(TM) Integrated Cycler. The new CE marked in vitro diagnostic (IVD) Simplexa test enable...  05/04/11 Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera MADISON, N.J., May 4, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), successfully completed the cash tender offer for all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA), which expired at 5:00 p.m., New York City time, on Tuesday, May 3, 2011. Computershare Trust Company, N.A.,...  05/03/11 Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed Shares MADISON, N.J., May 3, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended the expiration of its tender offer to acquire all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA) for $8.00 per shar...  05/03/11 Quest Diagnostics to Speak at the Deutsche Bank 36th Annual Healthcare Conference MADISON, N.J., May 3, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Deutsche Bank 36th Annual Healthcare Conference in Boston. The presentation is scheduled for Wednesday, May 4, 2011 at 10:40 a.m. Eastern Time. During the conference, the company will reaffirm its adjusted 2011 outlook before future special items. The company expects reven...  04/28/11 Quest Diagnostics CE Marks Simplexa(TM) Tests for Epstein Barr and BK Viruses for Sale in Europe Focus Diagnostics' Simplexa molecular tests on the 3M(TM) Integrated Cycler aid in detecting infectious disease viruses for organ transplant and other immunocompromised patients MADISON, N.J., and CYPRESS, Calif., April 28, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that two new Simplexa-branded molecular test kits developed by its Focus Diagnostics business have been ...  04/20/11 Quest Diagnostics Reports First Quarter 2011 Financial Results - Total revenues of $1.8 billion, up 1% - Adjusted diluted earnings per share of $1.00 - Reported diluted earnings per share of $0.86 MADISON, N.J., April 20, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2011, adjusted income from continuing operations was $164 million, or $1.00 per diluted share, compared to $182 million, or $0.99 ...  04/18/11 Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants AccuType(R) IL28B test now available to physicians and for clinical trials research MADISON, N.J., April 18, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType(R) IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection. Quest Diagnostics is now offering the test to p...  04/18/11 Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2, 2011 Enters into Memorandum of Understanding Providing for the Settlement of Merger Agreement Litigation MADISON, N.J., April 18, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostics testing, information and services, announced today that, in connection with the entry by it and Celera Corporation (NASDAQ: CRA) into a memorandum of understanding (the "MOU") providing for the settlement of previously consolidated purported class actio...  04/13/11 Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera MADISON, N.J., April 13, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired in connection with the $8 per share all cash tender offer by its wholly-owned subsidiary, Spark Acquisition Corporation, to purchase all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA). Expiration of the waiting period under the HSR Act satisfi...  04/12/11 Quest Diagnostics to Release First Quarter 2011 Financial Results MADISON, N.J., April 12, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report first-quarter 2011 results on Wednesday, April 20, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Q...  04/06/11 Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards Simplexa(TM) molecular diagnostic test on the 3M(TM) Integrated Cycler wins bronze for best new product, science and medical diagnostic MADISON, N.J., April 6, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa(TM) molecular test on the 3M(TM) Integrated Cycler was honored with a bronze award for best new science and medical diagnostic product during the 2011...  04/04/11 Quest Diagnostics Completes Acquisition of Athena Diagnostics Solidifies leadership in growing market for neurology diagnostics MADISON, N.J., April 4, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific (NYSE: TMO). Athena Diagnostics will contin...  03/28/11 Quest Diagnostics Commences Tender Offer for Acquisition of Celera MADISON, N.J., March 28, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash...  03/22/11 Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR Small Practice Physicians Can Learn About the Benefits of EHR Adoption During 12-Week Care360 EHR Road Test Tour MADISON, N.J., March 22, 2011 /PRNewswire via COMTEX/ -- Later this month, Quest Diagnostics (NYSE: DGX) will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360(TM) EHR. The 12-week, 10-city Care360 EHR Road Test tour was developed to help hospitals and physician practices across the nation experience first-hand the operational and fi...  03/21/11 Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering MADISON, N.J., March 21, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $1,250,000,000 in aggregate principal amount of four series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The notes will be fully and uncon...  03/18/11 Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development -- Provides Immediate Access to Proprietary Genetic Tests and Pipeline of Biomarkers to Drive Sustainable Growth -- -- Berkeley HeartLab Brings Unique Esoteric Cardiovascular Test Offering and Specialized Sales Force -- -- Adds Leading Genetic IVD Products and Development Capability -- -- Transaction Valued at Approximately $344 Million, Net of Acquired Cash and Short-Term Investments -- MADISON, N.J. and ALAMEDA, Calif., March 18, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorpor...  03/17/11 New York State Approves the Quest Diagnostics ColoVantage(TM) Colorectal Cancer Blood Test Test designed to promote colorectal cancer evaluation of the nearly 53 million patients in the U.S. who resist recommended screening MADISON, N.J., March 17, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing onsamples of patients in the state. It is believed to be the first molecular colorectal cancer detectio...  03/14/11 Quest Diagnostics to Speak at the Barclays Capital 2011 Global Healthcare Conference MADISON, N.J., March 14, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Barclays Capital 2011 Global Healthcare Conference in Miami. The presentation is scheduled for Tuesday, March 15, 2011 at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2011 guidance. Excluding the impact of the acquisition of Athena Diagno...  03/04/11 Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' for Fourth Consecutive Year MADISON, N.J., March 4, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has been included on FORTUNE magazine's "World's Most Admired Companies" list. Quest Diagnostics moved to second in the "Health Care" industry category of "Pharmacy and Other Services." The 2011 ranking is the fourth consecutive year that the company has been included on FORTUNE magazine's we...  02/28/11 Quest Diagnostics to Speak at the Citi 2011 Global Healthcare Conference MADISON, N.J., Feb. 28, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Citi 2011 Global Healthcare Conference in New York City. The presentation is scheduled for Wednesday, March 2, 2011 at 11:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2011 guidance. The company expects revenues to grow approximately 1%, oper...  02/24/11 Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market Addition of Premier Provider of Neurology Testing to Complement Quest Diagnostics' Leadership in Testing for Cancer, Infectious Disease and Cardiovascular Disease -- MADISON, N.J., Feb. 24, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has signed a definitive agreement to acquire Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurol...  02/22/11 Quest Diagnostics Care360(TM) Becomes First Certified, Commercially Available EHR to Include Direct Project Specifications Enhancements to Care360(TM) EHR Provide Physicians with the Ability to Securely Share Patient Information Across Disparate Systems ORLANDO, Fla., Feb. 22, 2011 /PRNewswire via COMTEX/ -- HIMSS 2011 -- At HIMSS 2011 in Orlando, Florida, Quest Diagnostics (NYSE: DGX) announcedthe availability of the next release of its Care360(TM) Electronic Health Record (EHR) solution, which is the first certified, commercially available EHR to include the Direct Project specifications established under the c...  02/16/11 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb. 16, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on April 19, 2011, to shareholders of record of Quest Diagnostics common stock on April 5, 2011. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and ...  02/10/11 Quest Diagnostics and Withings Announce Availability of Integrated WiFi Weight Tracking for the Gazelle Mobile Health Platform MADISON, N.J., Feb. 10, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics and Withings announced that the Withings WiFi Body Scale, the world's first WiFi connected personal weight scale, can now automatically import body weight data directly into Gazelle(TM), the secure mobile health platform from Quest Diagnostics. With Gazelle, users can electronically receive their Quest Diagnostics laboratory results and manage their personal health information directly from their Apple(R) iPhone, BlackBer...  02/02/11 Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference 2011 MADISON, N.J., Feb. 2, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS Global Healthcare Services Conference 2011 in New York City. The presentation is scheduled for Tuesday, February 8, 2011 at 8:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2011 guidance. The company expects revenues to grow approximately 1...  02/01/11 Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder MADISON, N.J., Feb. 1, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced the pricing of the previously announced secondary public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of GlaxoSmithKline plc ("GSK") at a price to the public of $56.25. Quest Diagnostics has not sold any shares of common stock in the offering and will not receive any of the proceeds from th...  01/31/11 /C O R R E C T I O N -- Quest Diagnostics Incorporated/ MADISON, N.J., Jan. 31, 2011 /PRNewswire via COMTEX/ --In the news release, Quest Diagnostics Announces Offering of Common Stock by the Company's Largest Stockholder, issued 31-Jan-2011 by Quest Diagnostics Incorporated over PR Newswire, we are advised by the company that the third paragraph should read, "Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC are joint bookrunners for the offering" rather than, "Deutsche Bank Securities Inc. will act as lead manager for the offering, and J...  01/31/11 Quest Diagnostics Agrees to Repurchase 15.4 Million Shares From Largest Shareholder MADISON, N.J., Jan. 31, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX) today announced that it had agreed to repurchase at a negotiated price 15.4 million shares of its common stock from its largest shareholder, an affiliate of GlaxoSmithKline plc (GSK). Subsequent to the transaction, GSK will no longer hold any shares of common stock of Quest Diagnostics. "Through this transaction, we are taking advantage of a unique opportunity to enhance shareholder value and d...  01/31/11 Quest Diagnostics Announces Offering of Common Stock by the Company's Largest Stockholder MADISON, N.J., Jan. 31, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX) today announced the underwritten public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of GlaxoSmithKline plc ("GSK"). After giving effect tothe proposed offering andthe company's repurchase from GSK of15,377,551 shares of Quest Diagnostics common stock also announced today, it isexpected that GSK will no longer...  01/25/11 Quest Diagnostics Reports Fourth Quarter 2010 Financial Results; Provides Guidance for 2011 - Diluted EPS of $0.97, unchanged from 2009 - Revenues of $1.8 billion, 1.3% below 2009 - Cash flow from operations of $340 million - 2011 guidance before special items: Diluted EPS between $4.10 and $4.30; revenues to grow approximately 1% - Board approves $750 million share repurchase authorization, bringing total available to $1 billion MADISON, N.J., Jan. 25, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,...  01/25/11 Quest Diagnostics Increases Share Repurchase Authority by $750 Million Increase brings current authorization to $1 billion -- MADISON, N.J., Jan. 25, 2011 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $750 million. This action increases the current share repurchase authorization to $1 billion. During 2010, the company repurchased approximately 15 million shares of...  01/25/11 Oral Fluid Reveals More Heroin Use Than Previously Believed, According to Quest Diagnostics Drug Testing Index MADISON, N.J., Jan. 25, 2011 /PRNewswire via COMTEX/ --Oral fluid has revealed approximately five times more heroin use in the general U.S. workforce than previously believed, according to new data today released by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. In the company's first special report on oral fluid testing with more than 320,000 oral-fluid samples from the general U.S. workforce from January to June 2010, d...  01/13/11 Quest Diagnostics to Release Fourth Quarter and Full Year 2010 Financial Results MADISON, N.J., Jan. 13, 2011 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report fourth quarter and full year 2010 results and provide financial guidance for 2011 on Tuesday, January 25, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the confe...  12/20/10 Pregnant Women Are Not Screened Adequately for Gestational Diabetes, Obstetrics and Gynecology Study Finds Study also finds nearly one in five women with gestational diabetesare not screened for diabetes postpartum MADISON, N.J., Dec. 20, 2010 /PRNewswire via COMTEX/ --Nearly one third of pregnant women are not being screened by a simple laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online today in Obstetrics and Gynecology. The study, conducted by scientists at Quest Diagnostics (NYSE: DGX), suggests th...  12/16/10 Quest Diagnostics(R) Care360(TM) EHR Receives ONC-ATCB 2011/2012 Certification MADISON, N.J., Dec. 16, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Care360(TM) Electronic Health Record (EHR), Version 2010.2, is 2011/2012 compliant and was certified as a Complete EHR on Wednesday, December 15, 2010, by the Certification Commission for eligible Health Information Technology (CCHIT(R)), an ONC-ATCB, in accordance with the applicable eligible provider certifi...  12/02/10 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Dec. 2, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on January 25, 2011, to shareholders of record of Quest Diagnostics common stock on January 10, 2011. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, informatio...  12/01/10 FDA Clears Influenza and Respiratory Virus Test Kit from Quest Diagnostics' Focus Diagnostics Business Simplexa(TM) is first molecular test kit that does not require additional testing to confirm flu A, flu B or respiratory syncytial virus (RSV) infection MADISON, N.J., and CYPRESS, Calif., Dec. 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV te...  11/23/10 New Study Questions Value of Expanded Genetic Testing for Cystic Fibrosis Eight-year study in Genetics in Medicine shows core mutation panel reliably detects carriers MADISON, N.J., Nov. 23, 2010 /PRNewswire via COMTEX/ --Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).The findings raise ...  11/16/10 Quest Diagnostics to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference MADISON, N.J., Nov. 16, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 7th Annual Healthcare Conference in New York City. The presentation is scheduled for Wednesday, November 17, 2010 at 8:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance. The company expects revenues to be appr...  10/28/10 Quest Diagnostics Introduces Gazelle(TM) Secure Mobile Health Platform - First Mobile Health Platform From A Diagnostic Testing Company - Empowers Patients To Actively Manage And Take Personal Accountability For Their Health - Direct Patient Access To Quest Diagnostics Lab Results In 33 States - A Gateway That Welcomes Third Party Application Developers MADISON, N.J., Oct 28, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today introduced Gazelle, a secure mobile heal...  10/20/10 Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 - Diluted EPS of $1.13, 11% above 2009 - Revenues of $1.9 billion, 1.7% below 2009 - Cash flow from operations of $330 million - Full year guidance before special items: Diluted EPS between $3.95 and $4.00; revenues approximately 1.5% below prior year - Board authorizes new $250 million share repurchase program MADISON, N.J., Oct 20, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, anno...  10/20/10 Quest Diagnostics Increases Share Repurchase Authority By $250 Million MADISON, N.J., Oct 20, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $250 million. During the first three quarters of 2010, the company repurchased approximately 15 million shares of common stock for $750 million, fully utilizing its previous authorization, which was granted in January, 2010. ...  10/15/10 American Medical Association To Offer Quest Diagnostics Care360(TM) EHR On Its New Online Physician Platform Care360 EHR Offers Physicians Affordable Health Information Technology to Meet Clinical and Practice Needs and Help Demonstrate Meaningful Use MADISON, N.J., Oct 15, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics' (NYSE: DGX) healthcare information (IT) technology subsidiary MedPlus and the American Medical Association (AMA), the nation's largest physician organization, today announced they are partnering to expand the adoption of health information technology by offering Care360(TM) EHR, a...  10/05/10 Quest Diagnostics and HP Simplify Electronic Health Records for Physician Practices Companies Offer Comprehensive EHR Solutions to Accelerate Adoption Including a Nationwide Tour to Educate Small Physician Practices MADISON, N.J., Oct 05, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics' (NYSE: DGX) health information technology subsidiary MedPlus and HP today announced they are partnering to facilitate and simplify electronic health record (EHR) adoption for physician practices nationwide. Quest Diagnostics' web-based Care360(TM) EHR software and services coupled with ...  09/28/10 Quest Diagnostics to Release Third Quarter 2010 Financial Results MADISON, N.J., Sept 28, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report third quarter 2010 results on Wednesday, October 20, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on ...  09/16/10 U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index(TM) Post-accident tests find opiates up to four times more than pre-employment tests MADISON, N.J., Sept 16, 2010 /PRNewswire via COMTEX/ --More American workers and job applicants are testing positive for prescription opiates, according to U.S. general workforce data in the 2009 annual Drug Testing Index(TM) (DTI) released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services.Results from more than 5.5 million urine dru...  09/10/10 Quest Diagnostics Marks Seventh Year on Dow Jones Sustainability Index Company Named to Both World and North American Indexes MADISON, N.J., Sept 10, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its seventh year on the World Index (since 2004) and in its sixth on the North ...  08/23/10 Quest Diagnostics' Care360(TM) EHR Module Receives Preliminary ARRA IFR Stage 1 Certification MADISON, N.J., Aug 23, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Care360(TM) Electronic Health Record (EHR), Version 2010.1, has been inspected by the Certification Commission for Health Information Technology (CCHIT(R)) and is a certified EHR Module, IFR Stage 1, achieving all 14 of the requirements applied for of the 24 requirements for Eligible Providers published by the ...  08/11/10 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Aug 11, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 19, 2010, to shareholders of record of Quest Diagnostics common stock on October 4, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information ...  07/28/10 New York State Approves Quest Diagnostics' Fragile X Syndrome Test XSense(R) is the first laboratory test that may be suitable for population-based screening for Fragile X Syndrome, the leading inherited cause of mental retardation MADISON, N.J., July 28, 2010 /PRNewswire via COMTEX/ --An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited menta...  07/21/10 Quest Diagnostics Reports Second Quarter 2010 Financial Results; Updates Guidance for 2010 - Diluted earnings per share of $1.07, 7% above 2009 - Revenues of $1.9 billion, 1.4% below 2009 - Full year EPS expected to be between $3.90 and $4.00; full year revenues expected to be approximately 1% below prior year MADISON, N.J., July 21, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2010, income from continuing operations incr...  07/14/10 Quest Diagnostics To Release Second Quarter 2010 Financial Results MADISON, N.J., July 14, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report second quarter 2010 results on Wednesday, July 21, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Qu...  06/14/10 Quest Diagnostics Again Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' National Business Group on Health Recognizes HealthyQuest Program for Sixth Straight Year WASHINGTON, and MADISON, N.J., June 14, 2010 /PRNewswire via COMTEX/ --The National Business Group on Health (NBGH) has awarded its 2010 Best Employers for Healthy Lifestyles Platinum Award to Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. The 2010 award, in recognition of the company's HealthyQuest employee wellness initiative, m...  06/09/10 Quest Diagnostics to Speak at the William Blair & Company 30th Annual Growth Stock Conference MADISON, N.J., June 9, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the William Blair & Company 30th Annual Growth Stock Conference in Chicago. The presentation is scheduled for Tuesday, June 15, 2010 at 10:10 a.m. Central Time. The presentation will be webcast live during the conference and will be available to registered investors on the...  05/24/10 First FDA Clearance of a 2009 H1N1 Test Given to Quest Diagnostics' Focus Diagnostics Business Simplexa(TM) molecular RT-PCR test runs on the 3M Integrated Cycler MADISON, N.J., and CYPRESS, Calif., May 24, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Simplexa(TM) Influenza A H1N1 (2009) test on the 3M(TM) Integrated Cycler. The Simplexa test, developed and manufactured by Quest Di...  05/21/10 ONC Recognizes New Mexico as First State to Successfully Obtain HIE Implementation Funds Federal Funds and MedPlus Centergy Solution Accelerate New Mexico Health Information Collaborative's (NMHIC) Plan to Serve Two Million Patients Statewide ALBUQUERQUE, N.M., May 21, 2010 /PRNewswire via COMTEX/ --New Mexico is the first state to meet all requirements for strategic and operational planning as part of the American Recovery and Reinvestment Act (ARRA) state health information exchange (HIE) cooperative agreement program, according to the United States Office of the National Coord...  05/06/10 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 6, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on July 20, 2010, to shareholders of record of Quest Diagnostics common stock on July 6, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and servic...  04/29/10 H1N1 Crowds Out Other Flu Viruses, Higher Positive Trends in Children Tested The Quest Diagnostics Health Trends(TM) Report analyzes 195,000 H1N1 test results performed nationally since May 2009 MADISON, N.J., April 29, 2010 /PRNewswire via COMTEX/ --More than 99 percent of specimens tested for influenza were positive for H1N1 over approximately the past 11 months, according to a report released today from Quest Diagnostics Incorporated (NYSE: DGX). The Quest Diagnostics Health Trends(TM) Report suggests that H1N1 "crowded out" other influenza viruses to be the domina...  04/21/10 Quest Diagnostics Reports First Quarter 2010 Financial Results; Updates Guidance for 2010 - Diluted earnings per share of $0.89, and revenues of $1.8 billion, unchanged from 2009 - 2010 adjusted EPS guidance unchanged at between $4.10 and $4.30 - On a reported basis, 2010 EPS guidance is expected to be between $4.00 and $4.20 MADISON, N.J., April 21, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2010, income from continu...  04/12/10 Quest Diagnostics Moves Start of April 21 Financial Conference Call to 8 am ET MADISON, N.J., April 12, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has moved the start of its quarterly conference call scheduled for Wednesday, April 21, to 8 a.m. ET. The company had previously scheduled the call to begin at 8:30 a.m. ET on that day. The company plans to report first-quarter 2010 financial results earlier that morning. The public may access...  04/06/10 Quest Diagnostics To Release First Quarter 2010 Financial Results MADISON, N.J., April 6, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report first-quarter 2010 results on Wednesday, April 21, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Ques...  04/01/10 Quest Diagnostics Honored by CEO Roundtable on Cancer Company Granted CEO Gold Standard(TM) Accreditation for Its Commitment to Employee Health and the Fight Against Cancer MADISON, N.J., April 1, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leader in cancer diagnostics, announced today that the company has received CEO Cancer Gold Standard accreditation(TM) from The CEO Roundtable on Cancer. This prestigious designation recognizes Quest Diagnostics for taking important actions to reduce the cancer risk ...  03/17/10 Health Discovery Corporation and Smart Personalized Medicine Form Agreement for Developing Laboratory Tests for Breast Cancer Therapy Selection with Quest Diagnostics SAVANNAH, Ga. & MILFORD, Del., Mar 17, 2010 (BUSINESS WIRE) -- Health Discovery Corporation (OTCBB: HDVY) (HDC) and Smart Personalized Medicine, LLC (SPM) announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. Under the agreements, Quest Diagnostics will develop new laboratory tests for aiding in the selection of breast cancer therapies....  03/16/10 Quest Diagnostics To Speak at the Barclays Capital Global Healthcare Conference MADISON, N.J., March 16, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Barclays Capital Global Healthcare Conference in Miami. The presentation is scheduled for Wednesday, March 24, 2010 at 9:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site: ...  03/09/10 OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer FDA-cleared test helps direct women to the most appropriate surgeon, promoting better outcomesMADISON, N.J. and FREMONT, Calif., March 9, 2010 /PRNewswire via COMTEX/ -- OVA1(TM), the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc. (NYSE: DGX), the world's leading cancer diagnostics provider. With the availability of OVA1, physicians ...  03/05/10 Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' For Third Consecutive Year Company also ranked among top 100 Best Corporate Citizens by Corporate Responsibility MagazineMADISON, N.J., March 5, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has been included on FORTUNE magazine's 2010 "World's Most Admired Companies" list. Quest Diagnostics ranked third in the "Health Care" industry category of "Pharmacy and Other Services." The 2010 ranking...  03/04/10 Quest Diagnostics and Surescripts to Pioneer Integrated Service Combining Lab and Prescription Information to Improve Patient Safety and Clinical Outcomes ATLANTA, March 4, 2010 /PRNewswire via COMTEX/ -- Two of the nation's largest healthcare information networks, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Surescripts(R), The Nation's E-Prescription Network(TM), today announced an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians. The collaboration is designed to improve patien...  03/01/10 Quest Diagnostics to Speak at the RBC Capital Markets 2010 Healthcare Conference MADISON, N.J., March 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the RBC Capital Markets 2010 Healthcare Conference in New York City. The presentation is scheduled for Wednesday, March 3, 2010 at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance for revenue growth of 3% to 4%, operating income to app...  03/01/10 Quest Diagnostics Unveils Care360(TM) EHR --Company Empowers Physicians to Embrace Digital Healthcare, Connect with Peers, and Work Toward Meaningful Use One Step at a Time --90-Day Free Trial for Web-based Care360 EHR and Care360 ePrescribing Introduced at HIMSS10MADISON, N.J., March 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today introduced Care360(TM) EHR (Electronic Health Record), the next evolution of its innovative C...  02/11/10 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb 11, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on April 20, 2010, to shareholders of record of Quest Diagnostics common stock on April 6, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and ser...  02/05/10 Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference MADISON, N.J., Feb 05, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS 2010 Global Healthcare Services Conference in New York City. The presentation is scheduled for Wednesday, February 10, 2010 at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance for revenue growth of 3% to 4%, operating income to...  01/25/10 Quest Diagnostics Reports Strong Performance for Fourth Quarter and Full Year 2009; Provides Guidance for 2010 - Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million - Full year diluted EPS grew 20% on revenue growth of 2.8%; cash from operations totaled $1 billion - 2010 EPS expected to be between $4.10 and $4.30 per diluted shareMADISON, N.J., Jan 25, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended Dece...  01/25/10 Quest Diagnostics Increases Share Repurchase Authority By $750 Million MADISON, N.J., Jan 25, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $750 million. "The expansion of our share repurchase program reflects the company's financial strength and our ability to continue generating strong cash flows, and, in addition to continuing to invest in the growth of our bu...  01/19/10 Quest Diagnostics To Speak at the Jefferies 2010 Global Healthcare Services Conference MADISON, N.J., Jan 19, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 2010 Global Healthcare Services Conference in New York City. The presentation is scheduled for Tuesday, January 26, 2010 at 9:30 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the fol...  01/11/10 Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection MADISON, N.J., Jan 11, 2010 /PRNewswire via COMTEX/ -- A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths. The new test is based on DNA methylation of the Septin9 gene, a proprietary biomarker associated with colorectal cance...  01/08/10 Quest Diagnostics To Release Fourth Quarter and Full Year 2009 Financial Results MADISON, N.J., Jan 08, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report fourth-quarter and full year 2009 results and provide financial guidance for 2010 on Monday, January 25, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conferenc...  12/18/09 End of H1N1 'Second Wave' in Sight in the U.S., According to Quest Diagnostics Quest Diagnostics Health Trends(TM) Report shows 75 percent decline in rates of 2009 H1N1 influenza virus testing, but H1N1 is still the predominant influenza strain infecting AmericansMADISON, N.J., Dec 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the "second wave" of virus infection that sickened tens of millions of Americans since it began four months ag...  12/09/09 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Dec 09, 2009 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on January 22, 2010, to shareholders of record of Quest Diagnostics common stock on January 7, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, inform...  12/03/09 Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition Research to expand Leumeta(TM) line of blood plasma diagnostics; Scientists also describe technique for predicting response to Heparin surrogate MADISON, N.J., Dec. 3 /PRNewswire-FirstCall/ -- A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics (NYSE: DGX) will present duri...  11/24/09 Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference MADISON, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 21st Annual Piper Jaffray Healthcare Conference in New York City. The presentation is scheduled for Wednesday, December 2, 2009 at 9:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth to approximate 3%, operating inco...  11/20/09 Quest Diagnostics Announces Final Tender Offer Results MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes"). Additional terms and conditions of the Tender Offer are set forth in...  11/20/09 New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index(TM) MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- New data released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S. workforce has tracked sharp downward trends in cocaine and methamphetamine use from 2005 to the first half of 2009 that mirror similar drops shown by urine testing. Data in the Quest Diagnostics D...  11/20/09 H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. In its most recent Quest Diagnostics Health Trends(TM) Report "Testing for H1N1 in America," ...  11/18/09 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name Simplexa(TM) molecular RT-PCR test runs on the 3M Integrated Cycler; employs RT-PCR technologies comparable to 2009 H1N1 flu test used by World Health Organization MADISON, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test k...  11/17/09 Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes MADISON, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the determination of the pricing for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 (the "2010 Notes") and any and all of its 7.50% Senior Notes due 2011 (the "2011 Notes" and, together with the 2010 Notes, the "Note...  11/13/09 Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference MADISON, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 6th Annual Healthcare Conference in New York City. The presentation is scheduled for Tuesday, November 17, 2009 at 10:55 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth to approximate 3%, operatin...  11/12/09 Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes MADISON, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has commenced a cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 (the "2010 Notes") and any and all of its 7.50% Senior Notes due 2011 (the "2011 Notes" and, together with the 2010 Notes, the "Notes"). Additional terms and conditions of ...  11/12/09 Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering MADISON, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $750,000,000 in aggregate principal amount in two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The notes will be fully and unconditionall...  11/02/09 Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference MADISON, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Oppenheimer 20th Annual Healthcare Conference in New York City. The presentation is scheduled for Wednesday, November 4, 2009 at 11:25 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth to approximate 3%, operatin...  11/02/09 New ChartMaxx(R) V5.5 with Recovery Audit Contractor (RAC) Manager Helps Hospitals Handle RAC Audit Requests CINCINNATI, Nov. 2 /PRNewswire-FirstCall/ -- MedPlus®, the healthcare information technology subsidiary of Quest Diagnostics® Incorporated (NYSE: DGX), today announced the release of ChartMaxx® V5.5, an upgrade to its industry-leading ChartMaxx document management and imaging solution. With the new optional RAC Manager, ChartMaxx V5.5 helps health care providers tie together electronic forms, discrete data, color coded timers and e-mail alerts, dashboard reports, and release of infor...  10/27/09 New Mexico Health Information Collaborative (NMHIC) Appointed as State's Official Health Information Exchange (HIE) ALBUQUERQUE, N.M., Oct. 27 /PRNewswire-FirstCall/ -- Maggie Gunter, PhD, president of the New Mexico Health Information Collaborative (NMHIC), announced today that the organization has been appointed as the state's official health information exchange (HIE) by New Mexico Governor Bill Richardson. NMHIC will create the health information exchange infrastructure to connect New Mexico's health care providers through a contract with its technology partner, MedPlus, the healthcare info...  10/26/09 MedPlus Maintains Top Ranking in KLAS Industry Report MADISON, N.J., Oct. 26 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has been recognized as the health care industry's number one Document Management & Imaging (DMI) vendor for its ChartMaxx® enterprise-wide electronic patient record system in the KLAS (1) Enterprise DMI: Finding the Right Stepping-Stone to Full EMR report issued on October 2, 2009 (www.KLASresearch.com). Char...  10/22/09 Quest Diagnostics Health Trends (TM) Report on 2009 H1N1 Influenza Click here for the full report, including charts and tables - In 2009, the H1N1 influenza A virus emerged as the first influenza pandemic in forty years. As the leading diagnostic testing company in the U.S. - and the only provider of two commercial tests authorized by the FDA for emergency use* - Quest Diagnostics is uniquely positioned to provide insights into the behavior of this new pandemic virus and its impact on Americans. In our latest Quest Diagnostics Health TrendsTM Report, we ...  10/20/09 Quest Diagnostics Reports Strong Performance in Third Quarter 2009 - Total revenues of $1.9 billion, up 3.9% - Diluted earnings of $1.02 per share, up 26% - Cash flow from operations of $374 million, up 14% - 2009 EPS outlook increased to a range of $3.80 to $3.85 MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2009, income from continuing operations rose to $192 million, or $...  10/16/09 FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics' Focus Diagnostics MADISON, N.J., Oct. 16 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated (NYSE: DGX), for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA h...  10/07/09 Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health First saliva-based cardiovascular disease test from Quest Diagnostics identifies gene variants implicated in potentially lethal reaction to popular anti-clotting drug MADISON, N.J., Oct. 7 /PRNewswire/ -- DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics (NYSE: DGX) for Scripps Health patients electing to undergo coronary stent pro...  10/06/09 Quest Diagnostics to Release Third Quarter Financial Results on October 20, 2009 MADISON, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its third quarter results will be made public on Tuesday, October 20, before the market opens. The company will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the conference call through a live audio w...  10/05/09 Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs MedPlus Centergy(R) Clinical Portal and ChartMaxx(R) Enable Streamlined Chart Completion Online MADISON, N.J., Oct. 5 /PRNewswire-FirstCall/ -- Methodist Hospital of Arcadia, California, has launched an integrated deployment of innovative health care information technology (HIT) solutions designed to help improve the quality of patient care and deliver operational efficiencies. MedPlus®, the health care information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), pro...  09/23/09 Quest Diagnostics Empowers the Nation's Physicians to Immediately Embrace ePrescribing Company to Enable All Care360(TM) Labs & Meds Users to Use ePrescribing Feature; Invites All U.S. Physicians to Use Care360 ePrescribing Risk Free for Six Months MADISON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX) today announced plans to make it easy for every physician in the United States to quickly embrace digital healthcare technology with a six-month, risk-free trial of its Care360(TM) ePrescribing service. For physicians currently using its Care360 Labs & ...  09/11/09 U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass MADISON, N.J. and FREMONT, Calif., Sept. 11 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malig...  09/11/09 Quest Diagnostics To Speak at the Bank of America Merrill Lynch Global Healthcare Conference MADISON, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare Conference in London, United Kingdom. The presentation is scheduled for Tuesday, September 15, 2009 at 9:50 a.m. Greenwich Mean Time, 5:50 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance fo...  09/04/09 Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index MADISON, N.J., Sept. 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it was again selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its sixth year on the World Index (since 2004) and in its fifth on the North American Index (since 2005). According to Sustainabl...  08/20/09 Focus Diagnostics Launches 2009 H1N1 Flu Test Kit to Commercial Laboratories in the U.S. First test for detecting the new virus to be authorized by FDA for use by CLIA high-complexity labs during pandemic emergency CYPRESS, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its Influenza A H1N1 (2009) Real Time RT-PCR test is now available as a test kit for use by "high complexity" clinical laboratories in the U.S. The test quali...  08/12/09 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on October 19, 2009, to shareholders of record on October 2, 2009. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, info...  07/24/09 FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the company's Focus Diagnostics business for its test for detecting the 2009 H1N1 influenza virus (the "pandemic flu virus"), a strain of influenza A virus initially referred to as the swine flu virus. T...  07/21/09 Quest Diagnostics Reports Strong Performance in Second Quarter 2009 Total revenues of $1.9 billion, up 3.5%; Diluted earnings of $1.00 per share, up 20%; 2009 EPS outlook increased to between $3.70 and $3.80 MADISON, N.J., July 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2009, income from continuing operations rose to $188 million, or $1.00 pe...  07/20/09 Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care Patient-Based Record Improves Quality, Safety and Efficiency MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that NYCLIX is now sharing key patient data electronically among ten unaffiliated healthcare organizations across New York City using the company's Centergy(TM) suite of integrated health information exchange (HIE) solutions. NYCLIX partner hospital...  07/09/09 Quest Diagnostics To Release Second Quarter Financial Results MADISON, N.J., July 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its second quarter results will be made public on Tuesday, July 21, before the market opens. The company will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the conference call through a live audio...  06/24/09 Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' National Business Group on Health Recognizes HealthyQuest Program for Fifth Consecutive Year MADISON, N.J., June 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that the National Business Group on Health (NBGH) has awarded its 2009 Best Employers for Healthy Lifestyles Platinum Award to the company for its HealthyQuest employee wellness program. The Platinum Award...  06/22/09 Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems Agreement with Medical Automation Systems, Inc. Will Add RALS(R)-Plus Module to Company's Hemoglobin and Glucose Handheld Devices MADISON, N.J., June 22 /PRNewswire-FirstCall/ -- HemoCue Inc., the U.S. point-of-care testing distribution subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with Medical Automation Systems, Inc. (MAS) for the development of a RALS(R)-Plus module for the HemoCue 201 DM analyzer whole blood systems fo...  06/17/09 Quest Diagnostics Announces Final Tender Offer Results MADISON, N.J., June 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer to purchase up to $200 million total aggregate principal amount (the "Tender Cap") of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes"). The terms and conditions of the tender offer are describe...  06/15/09 Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference MADISON, N.J., June 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 3rd Annual Healthcare Conference in New York City on Thursday, June 18, 2009. The Quest Diagnostics presentation is scheduled to begin at 11:45 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registere...  06/12/09 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory developed test designed to help physicians determine whether a patient with a history of HIV drug resistance will respond to th...  06/12/09 Quest Diagnostics Announces Pricing of Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the determination of the pricing for its previously announced cash tender offer to purchase up to $200 million total aggregate principal amount (the "Tender Cap") of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes"). The terms and conditions of the tender off...  06/08/09 Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C MADISON, N.J., June 8, 2009 /PRNewswire-FirstCall via COMTEX/ -- A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test pane...  06/08/09 Quest Diagnostics to Speak at the William Blair & Company 29th Annual Growth Stock Conference MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the William Blair & Company 29th Annual Growth Stock Conference in Chicago on Tuesday, June 9, 2009. The Quest Diagnostics presentation is scheduled to begin at 8:10 a.m. Central Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth ...  06/04/09 Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology Health Information Exchange for Medicaid Beneficiaries, Powered by MedPlus Centergy(TM) Solutions, will Connect Physicians, Hospitals and Clinics to Accelerate Access to Patient Information and Better Health Outcomes WASHINGTON, and MADISON, N.J., June 4 /PRNewswire-FirstCall/ -- The Department of Health Care Finance, DHCF, the District's Medicaid agency, announced the selection of MedPlus, the health information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), ...  06/03/09 Quest Diagnostics Announces Early Tender Results of Offer to Purchase Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that, as of 5:00 p.m., New York City time, on June 2, 2009 (the "Early Tender Date"), the following principal amounts of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes") have been validly tendered and not validly withdrawn in connection with its previously ann...  06/03/09 Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program Quest4Health.com Lauded in Healthcare Category for 'Visionary Application of Information Technology to Promote Positive Social and Economic Progress' MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its subsidiary Quest Diagnostics India Pvt. Ltd. has been recognized as a Laureate by the International Data Group's (IDG) Computerworld Honors Program. The a...  06/02/09 Quest Diagnostics HemoCue AB Subsidiary to Add Avie(TM) Hemoglobin A1c to Diabetes Point-of-Care Test Suite Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring MADISON, N.J., June 2 /PRNewswire-FirstCall/ -- HemoCue AB, an international company in the field of point-of-care testing and a subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the Uni...  06/01/09 Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service EGFR Pathway Test analyzes in sequential reflex fashion more mutations potentially inhibiting anti-EGFR therapy response in metastatic colorectal cancer patients MADISON, N.J., June 1 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company, today launched the EGFR Pathway test (KRAS with reflex to NRAS, BRAF), the first laboratory-developed test from a national commercial reference laboratory for comprehensively identify...  05/28/09 Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting MADISON, N.J., May 28 /PRNewswire-FirstCall/ -- Quest Diagnostics scientists will present results of three studies revealing the effect of genomic abnormalities on the diagnosis and treatment of chronic myeloid leukemia (CML) and prostate cancer during the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), scheduled for May 29 through June 2 in Orlando, FL. Quest Diagnostics Incorporated (NYSE: DGX) is the world's leading provider of diagnostic testing, informatio...  05/19/09 Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has commenced a cash tender offer to purchase up to $200 million aggregate principal amount (the "Tender Cap") of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes"). The terms and conditions of the tender offer are described in the Offer to Purchase date...  05/15/09 Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online MADISON, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it will enable patients and their physicians to share diagnostic laboratory test results, using Microsoft HealthVault(TM). The connection will enable physicians who use Quest Diagnostics' Care360(TM) patient-centric physician portal to securely transfer, at a patient's request, diagnostic laboratory test results in a HIPAA-compliant format into the patient's protected account...  05/15/09 Quest Diagnostics to Speak at the Deutsche Bank 34th Annual Healthcare Conference MADISON, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Deutsche Bank 34th Annual Healthcare Conference in Boston on Tuesday, May 19, 2009. The Quest Diagnostics presentation is scheduled to begin at 11:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth of approxima...  05/14/09 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 20, 2009, to shareholders of record on July 6, 2009. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information ...  05/11/09 Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus Real-time PCR test validated using clinical specimens confirmed positive for Influenza A H1N1 Swine-origin flu virus MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction (PCR) test to aid in identifying Influe...  05/08/09 Quest Diagnostics Announces Annual Shareholders Meeting Webcast MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will conduct its annual meeting of shareholders on Thursday, May 14th at 10:30 am ET. An audio webcast will be accessible through the Investor Relations section of the company Web site at www.QuestDiagnostics.com/investor. For those unable to listen to the live broadcast, a replay will be available on the Web site...  05/07/09 Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference MADISON, N.J., May 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference in New York City on Tuesday, May 12, 2009. The Quest Diagnostics presentation is scheduled to begin at 1:20 p.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue...  05/06/09 Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) Methamphetamine Use Drops While Amphetamine Use Continues to Rise Random Drug Testing Programs May Deter Use, Data Show MADISON, N.J., May 6 /PRNewswire/ -- Cocaine use among U.S. employees and job applicants in the general U.S. workforce declined sharply in 2008, according to the annual Quest Diagnostics Drug Testing Index(TM) (DTI), based on 5.7 million urine drug tests performed last year by Quest Diagnostics (NYSE: DGX), the nation's leading provider of drug testing se...  04/27/09 Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening Company's Scientists also Enhance Industry Standards for Quality Screening in Three Articles Published in The Journal of Molecular Diagnostics MADISON, N.J., April 27 /PRNewswire-FirstCall/ -- Quest Diagnostics scientists provide new insights into genetic factors affecting the accuracy and quality of Cystic Fibrosis (CF) carrier and newborn screening in three separate articles published in the May 2009 issue of The Journal of Molecular Diagnostics. Quest Diagnostics Incorporated (N...  04/21/09 Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009 Diluted earnings per share of $0.89, up 24% Total revenues of $1.8 billion, up 1.3% Cash flow from operations of $273 million, up 73% 2009 EPS outlook increased to between $3.65 and $3.75 MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2009, income from continuing operations was $169 mi...  04/15/09 Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 MADISON, N.J., April 15, 2009 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced it finalized resolution of the previously disclosed federal government investigation related to certain test kits manufactured by NID, a test kit manufacturing subsidiary closed voluntarily in 2006. Quest Diagnostics cooperated with the government since its investigation began in 2004. Quest Diagnostics will pay $262 million to settle the civil investigation. While...  04/13/09 Quest Diagnostics to Release First Quarter Financial Results MADISON, N.J., April 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its first-quarter results will be made public on Tuesday, April 21, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The public may access the conference call through a live audio webcas...  04/03/09 MedPlus Centergy(TM) Suite for Hospitals and HIEs Paves a New, Faster Path to Healthcare Information Technology Benefits The Choice of Leading Nationwide Health Information Network Contractors and Health Information Exchanges Connects Physicians to the Nation's Largest Provider Network Visit MedPlus at HIMSS Booth 2362 in Chicago, April 5-9 CINCINNATI, April 3 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today introduced a suite of clinical portal and data exchange services for hospitals and health information ...  03/31/09 Quest Diagnostics to Support Walgreens and Take Care Health Systems' Offer of Free Health Services by Providing Certain Free Laboratory Testing MADISON, N.J., March 31 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will provide strep and urine cultures and other select laboratory testing services for free to qualified patients served through the Take Care Recovery Plan, which is an offer, announced by Walgreens (NYSE, Nasdaq: WAG) and Take Care Health Systems, to provide free health care services at Take Care Clinics. The offer...  03/17/09 Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State Test aiding diagnosis of mental retardation, birth defects, and autism spectrum and developmental disorders now approved for use on patients in New York MADISON, N.J., March 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its ClariSure(TM) microarray-based comparative genomic hybridization (aCGH) postnatal test is now available for testing on patients in th...  03/12/09 Jon R. Cohen, M.D., Named Senior Vice President and Chief Medical Officer at Quest Diagnostics Former Chief Policy Advisor to New York Governor David A. Paterson is distinguished vascular surgeon and healthcare policy expert MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that Jon R. Cohen, M.D., Senior Advisor to New York Governor David A. Paterson, will join the company as Senior Vice President and Chief Medical Officer on March 30, 20...  03/09/09 Quest Diagnostics to Speak at Barclays Capital Global Healthcare Conference MADISON, N.J., March 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Barclays Capital Healthcare Conference in Miami on Tuesday, March 10, 2009. The Quest Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2009 guidance for revenue growth of approximately 3%, ...  03/03/09 Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List Ranks second overall and first for long-term investment and social responsibility in industry category MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has again been named to FORTUNE magazine's list of the World's Most Admired Companies. Quest Diagnostics ranked second in the "Health Care" category of "Pharmacy and Other Services." The 2009 ranking is the seco...  02/20/09 Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis Study published in New England Journal of Medicine employs Quest Diagnostics' blood-based leukemia testing MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Testing of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine. The finding may lead to a better understanding of cellular changes that characterize the ...  02/11/09 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb 11, 2009 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share payable on April 20, 2009, to shareholders of record on April 6, 2009. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, informati...  01/26/09 Quest Diagnostics Reports Growth in Revenue and Earnings for Fourth Quarter 2008 and Provides 2009 Guidance MADISON, N.J., Jan 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- - Diluted earnings per share of $0.87, up 10% - Total revenues of $1.8 billion, up 1.7% - Cash flow from operations improved to $363 million - 2009 EPS expected to be between $3.50 to $3.70 per diluted share Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2008, income from continu...  01/26/09 Quest Diagnostics' Board Authorizes $500 Million in Share Repurchases MADISON, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors has authorized $500 million in share repurchases. The company had approximately 190 million common shares outstanding as of December 31, 2008. "This repurchase program demonstrates confidence in our performance and commitment to increasing shareholder value," said Surya N. M...  01/12/09 Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results MADISON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report fourth-quarter and full year 2008 results and provide financial guidance for 2009 on Monday, January 26, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the co...  12/19/08 MedPlus® ChartMaxx® Receives 2008 ‘Best in KLAS’ Ranking for Healthcare Document Management and Imaging Software Healthcare Professionals Rank ChartMaxx Number One DMI Solution for Fifth Time Cincinnati, OH – December 19, 2008 – Healthcare professionals have chosen MedPlus’ ChartMaxx® enterprise-wide electronic patient record system as the top healthcare Document Management and Imaging (DMI) software product, according to the 2008 Top 20 Best in KLAS Awards: Software & Professional Services report, an independent ranking based on customer feedback of top healthcare information technology (HIT) vendor...  12/18/08 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on January 26, 2009, to shareholders of record on January 9, 2009. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, info...  12/02/08 Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference MADISON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Piper Jaffray Healthcare Conference in New York City today, December 2, 2008. The Quest Diagnostics presentation is scheduled to begin at 4:00 p.m. Eastern Time. During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%,...  11/17/08 Quest Diagnostics' Laboratory in India Accredited by Two Leading Laboratory Accrediting Organizations - Less than one tenth of one percent of labs in India are CAP and NABL accredited - Quest Diagnostics' laboratory also becomes one of only five labs in India to achieve NGSP certification for Hemoglobin A1c testing for diabetes MADISON, N.J. and GURGAON, India, Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it...  11/10/08 Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Credit Suisse Healthcare Conference on Wednesday, November 12, 2008. The Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%, operat...  10/25/08 Rotavirus Infections Decline More than 70 Percent in Children in U.S. Quest Diagnostics Health Trends(TM) Report shows declines vary widely by state MADISON, N.J., Oct. 25 /PRNewswire-FirstCall/ -- The largest study of rotavirus laboratory data developed since an oral rotavirus vaccine was introduced in the U.S. in early 2006 shows that cases of rotavirus infection have decreased significantly, suggesting the vaccine is preventing infection in infants and young children. The latest Quest Diagnostics Health Trends(TM) Report also provides evidence fo...  10/21/08 Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 Total revenues of $1.8 billion, up 3.4% Adjusted diluted earnings per share of $0.86, up 12% Cash flow from operations improved to $329 million 2008 adjusted EPS guidance increased to $3.17 - $3.22 per diluted share Agreement in principle reached regarding previously disclosed NID-related matter MADISON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- , 2008-- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, informa...  10/08/08 Quest Diagnostics to Release Third Quarter 2008 Financial Results MADISON, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its third-quarter 2008 results will be made public on Tuesday, October 21, before the market opens, and that it will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast availa...  09/23/08 Quest Diagnostics to Speak at the 2008 UBS Global Life Sciences Conference MADISON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2008 UBS Global Life Sciences Conference on Wednesday, September 24, 2008. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors ...  09/10/08 Quest Diagnostics Again Named to Dow Jones Sustainability World and North American Indexes 2008 marks fifth year on World Index MADISON, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it was again selected to be part of the Dow Jones Sustainability (DJSI) World and North American Indexes. The company is in its fifth year on the World Index, first added in 2004, and has appeared on the North American Index since 2005. ...  08/05/08 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on October 20, 2008, to shareholders of record on October 3, 2008. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, infor...  07/22/08 Quest Diagnostics Reports Strong Revenue and Earnings Growth in Second Quarter 2008 - Total revenues of $1.8 billion, up 12%; - Diluted earnings of $0.83 per share, up 14%; - Cash flow improved to $213 million; - 2008 EPS guidance midpoint increased, new range $3.10 to $3.20 per diluted share. MADISON, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2008, income from con...  07/10/08 Quest Diagnostics to Release Second Quarter 2008 Financial Results MADISON, N.J., July 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its second-quarter 2008 results will be made public on Tuesday, July 22, before the market opens, and that it will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webc...  06/23/08 Quest Diagnostics to Speak at the Jefferies 2nd Annual Healthcare Conference MADISON, N.J., June 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies Healthcare Conference on Tuesday, June 24, 2008. The Quest Diagnostics presentation is scheduled to begin at 9:00a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following si...  06/20/08 Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program MADISON, N.J., June 20 /PRNewswire-FirstCall/ -- Women in Ireland will soon be able to take advantage of diagnostic testing services provided by Quest Diagnostics Incorporated (NYSE: DGX), the world's leader in cervical-cancer screening services. Through a contract with the Irish National Cancer Screening Service (NCSS), Quest Diagnostics will provide quality-assured screening services intended to improve medical outcomes and reduce anxiety wait time for women ages 25 to 60 who partici...  06/18/08 HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- HemoCue(R) AB, a global point-of-care diagnostic test manufacturer and wholly owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening for, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the U.S. Food and Drug Administration (FDA). With the FDA CLIA waiver, non-laboratory trained physicians and...  06/03/08 Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced results of a study that demonstrates that a novel diagnostic testing technique it has developed is the first to provide direct, accurate and reproducible physical measurement of both the size and concentration of a broad range of lipoproteins in blood plasma. Results of the study were published in the May 29, 2008, online edition of Clinical Chemistry. "Our data suggest that ...  05/21/08 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 18, 2008, to shareholders of record on July 3, 2008. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and ser...  05/20/08 Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- An interim analysis of a study presented today at the 39th Annual Digestive Disease Week (DDW) Conference found that, among patients at increased risk for colorectal cancer who completed an annual fecal immunochemical (FIT) test, detection of cancerous lesions occurred an average of 26.5 months earlier than would have occurred during the three- or five-year study-required colonoscopy. Detection of precancerous lesions in this group occurred 1...  05/19/08 Quest Diagnostics and Google Empower Patients and Physicians to Share Diagnostic Test Results Online With Launch of Google Health MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Patients and physicians have a new way to share diagnostic laboratory data online, thanks to Quest Diagnostics and Google Health, a product launched today by Google. More than 100,000 physicians in the U.S. who use Quest Diagnostics' family of Care360(TM) connectivity products will be able to securely provide diagnostic data with a brief explanation of test results to a patient's Google Health Account, where a patient can maintain medica...  05/13/08 Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' Company's "Biggest Loser" Bill Germanakos to Deliver NBGH Keynote Address MADISON, N.J., May 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that the National Business Group on Health (NBGH), an association of more than 300 large U.S. employers, has presented its 2008 Best Employers for Healthy Lifestyles Gold Award to the company for its HealthyQuest employee wellness progr...  05/12/08 Quest Diagnostics Announces Annual Shareholder's Meeting Webcast MADISON, N.J., May 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, will conduct its annual meeting of shareholders on Friday, May 16th at 10:30 am ET. An audio webcast will be accessible through the Investor Relations section of the company Web site at www.questdiagnostics.com/investor . For those unable to listen to the live broadcast, a replay will be available on the Web site beginni...  05/08/08 Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening - New test provides laboratory-quality results in physician's office - MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Enterix Inc., a wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced the availability of the InSure(R) Quik F I T(TM) fecal immunochemical test, a point-of-care version of the company's lab-based InSure(R) FIT(TM) test, that provides physicians with the sensitivity and specificity of the laboratory-based InSure FIT test. The av...  04/21/08 Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 - 2008 Outlook Reaffirmed - MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2008, income from continuing operations was $141 million, or $0.72 per diluted share, compared to $108 million, or $0.55 per diluted share, in the first quarter of 2007. Included in the results for the first qu...  04/07/08 Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call MADISON, N.J., April 7, 2008 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it will make public its first-quarter 2008 results on Monday, April 21, before the market opens, and that it will conduct it's first quarter investor conference call at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Quest Diagnostics...  03/31/08 Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 'Do You Have the Guts?' aims to reach five million in five yearsMADISON, N.J., March 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing information and services, today announced the launch of a novel campaign designed to help increase compliance with take-home colorectal screening tests. Titled "It's Time to Challenge Colon Cancer: Do You Have the Guts?," the campaign aims to break down ...  03/14/08 Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Wednesday, March 19, 2008, at The Loews Miami Beach Hotel, Miami, Florida. The Quest Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern Time. The presentation will be webcast live duri...  03/14/08 Quest Diagnostics to Speak at Cowen and Company 28th Annual Health Care Conference MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Cowen and Company Twenty Eighth Annual Health Care Conference on Tuesday, March 18, 2008, at the Marriott Copley Place, Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:45 a.m. Eastern Time. The presentation will be webcast live ...  03/12/08 Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- The percentage of positive tests for methamphetamine among U.S. job applicants and workers in the general U.S. workforce dropped more than 22 percent between 2006 and 2007. These findings, from the Quest Diagnostics Drug Testing Index(R), reflect the reversal of an upward trend in use of the drug by more than 73 percent from 2002 to 2004. These data were released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading...  03/12/08 Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Diabetes and hypertension are the two leading risk factors for chronic kidney disease (CKD), responsible for up to two-thirds of cases. Yet a new study that will be presented at a National Kidney Foundation Spring Clinical Meeting next month indicates there is wide discrepancy in diagnostic testing for kidney disease among patients with these conditions, with patients with high blood pressure (hypertension) tested at half the rate as th...  03/05/08 Quest Diagnostics Named to FORTUNE Magazine's America's Most Admired Companies List Only diagnostic testing company in rankingMADISON, N.J., March 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that it has been selected by FORTUNE magazine to the 2008 list of America's Most Admired Companies. Quest Diagnostics was ranked third among four companies in the "Health Care" category of "pharmacy and other services." 2008 marks the first year the company has been named to the list. "Our ranking as one of the m...  02/28/08 Quest Diagnostics to Collaborate with Google on New Health Offering Partnership will provide patients electronic access to their diagnostic laboratory data MADISON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Patients nationwide may soon have easy and secure access to their own medical diagnostic laboratory records as a result of a new collaboration between Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and Google, the world's leading Internet sear...  02/25/08 MedPlus Technology Driving Three New York Health Information Exchanges Clinical Portal & Data Exchange Engine Implementations Begin for HEAL 1 Grant Recipients CINCINNATI, Feb. 25 /PRNewswire/ -- MedPlus(R), the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has begun installations of its Clinical Portal & Data Exchange Engine for three health information exchanges (HIE) qualified for HEAL NY (Healthcare Efficiency and Affordability Law for New Yorkers) ...  02/21/08 Quest Diagnostics Reports Fourth Quarter and Full Year Results Company Provides 2008 Guidance MADISON, N.J., Feb. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2007, income from continuing operations was $154 million, or $0.79 per diluted share, compared to $151 million, or $0.77 per diluted share, in the fourth quarter of 2006. The fourth quarter of 2007 include...  02/20/08 Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the leading provider of diagnostic testing, information and services, today announced that its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd. has entered into a long-term agreement to provide health assessment services, including diagnostic laboratory testing, for Birla Sun Life Insurance Company Limited (Birla Sun Life), a joint venture between The Aditya Birla Group, one of the larg...  02/19/08 Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer Company Licenses Septin-9 DNA Methylation Biomarker from Epigenomics MADISON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, today announced that it has licensed rights to uses of the Septin 9 DNA methylation biomarker from Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, to develop a molecular-based laboratory test that can help physic...  02/15/08 Focus Diagnostics Launches Laboratory Test for Chikungunya Virus First Laboratory Developed Test in the U.S. for Detecting the Mosquito-Borne Infectious Disease CYPRESS, Calif., Feb 15, 2008 /PRNewswire via COMTEX News Network/ -- Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics (NYSE: DGX), today announced the first laboratory developed test in the U.S. for detecting the mosquito-borne chikungunya virus. Commercial availability of the molecular polymerase chain reaction (PCR) test will enable physicians in the U...  02/14/08 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on April 18, 2008, to shareholders of record on April 4, 2008. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and ...  01/29/08 Quest Diagnostics to Speak at Wachovia Securities 2008 Healthcare Conference MADISON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Wachovia Securities 2008 Healthcare Conference on Wednesday, January 30, 2008, at the Langham Hotel, Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2007 ...  01/17/08 Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results Reaffirms Previous Guidance for 2007 MADISON, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it will report results for the fourth quarter and year ended December 31, 2007 and provide financial guidance for 2008 on February 21, 2008, instead of the previously scheduled date of January 29. The company is rescheduling its report of f...  01/11/08 MedPlus to Implement Clinical Portal and Information Exchange for the Brooklyn Health Information Exchange MADISON, N.J., Jan. 11 /PRNewswire/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has been awarded a contract to implement a clinical portal and information exchange for the Brooklyn Health Information Exchange (BHIX). Organized by Maimonides Medical Center and other healthcare organizations in New York, the BHIX is a not-for-profit corporation that will offer health information exchange services in B...  01/07/08 Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference MADISON, N.J., Jan 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 11:00 a.m. Eastern Time. The presentation will be webcast ...  12/18/07 Quest Diagnostics Declares Quarterly Cash Dividend MADISON, N.J., Dec 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on January 23, 2008, to shareholders of record on January 9, 2008. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic te...  11/26/07 Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference MADISON, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Merrill Lynch Health Services Investor Conference at the Merrill Lynch Headquarters in New York City on Tuesday, November 27, 2007. The Quest Diagnostics presentation is scheduled to begin at 10:15 a.m. Eastern Time. During the conference, the company will reiterate ...  11/06/07 Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people with diabetes and/or high blood pressure -- the two leading causes of chronic kidney disease (CKD) -- are not receiving recommended tests to identify this disease early, when medical treatment can slow or halt disease progression, according to the latest Quest Diagnostics Health Trends(TM) Report. In addition, the report's findings suggest that patients with early-stage CKD are not being well managed for contributin...  11/01/07 Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance First step for performing important diagnostics in physician offices MADISON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its HemoCue and Focus Diagnostics subsidiaries have received FDA 510(k) clearance for two new point of care tests. The HemoCue(R) White Blood Cell (WBC) Analyzer is a whole-blood test performed on finger-stick samples that a...  10/26/07 Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics -First national diagnostic testing company to license proprietary technology- MADISON, N.J., Oct. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has entered into a non- exclusive license agreement for the heteroduplex tracking technology underlying Pathway Diagnostics' SensiTrop(TM) HIV co-receptor tropism test. Tropism refers to the way a virus targets host ...  10/24/07 Quest Diagnostics Reports Third Quarter Results - Operating performance improvement continues - MADISON, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2007, income from continuing operations was $150 million, or $0.77 per diluted share, compared to $164 million, or $0.82 per diluted share in the third quarter of 2006. The third quarter of 2007 inc...  10/09/07 Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI) Collaboration Expected to Drive Physician Adoption of Patient-Safety Technology eRx NOW(TM) Functionality Expanded to Include Quest Diagnostics Care360(TM) Physician Portal Lab Order and Results Capabilities LYNDHURST, N.J. and CHICAGO, Oct. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services and a leading developer of healthcare IT...  09/21/07 Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference LYNDHURST, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2007 UBS Global Life Sciences Conference in New York City on Monday, September 24, 2007. The Quest Diagnostics presentation is scheduled to begin at 4:30 p.m. Eastern Time. The presentation will be webcast live during the conference and will be available to regis...  09/10/07 Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bear Stearns Healthcare Conference in New York City on Tuesday, September 11, 2007. The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern Time. During the conference, the company will reiterate its 2007 guidance for revenues of between $...  09/10/07 Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World and North American Indexes LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that it was again selected to be part of the Dow Jones Sustainability (DJSI) World and North American Indexes. The company was first added to the World Index in 2004 and the North American Index in 2005. According to DJSI, companies were identified as "sustainability leaders" and ranked accord...  08/30/07 Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children First commercial test available nationally LYNDHURST, N.J., Aug. 30 /PRNewswire-FirstCall/ -- A molecular diagnostic test that detects chromosome abnormalities associated with 85 developmental disorders affecting children now is commercially available from a national diagnostic testing company, affording testing and reimbursement by leading health plans across the U.S. Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, inf...  08/17/07 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on October 17, 2007, to shareholders of record on October 3, 2007. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, informati...  08/09/07 Quest Diagnostics Drug Testing Index(R) Finds Cocaine Use at 10-Year Low Among U.S. Workers Double-digit declines reported across the U.S.LYNDHURST, N.J., Aug 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- An unprecedented decline in cocaine use by American workers drove use of the illicit drug to a new low during the first half of 2007, according to the "Quest Diagnostics Drug Testing Index: Cocaine Use Among America's Workers -- A Special 2007 Mid-Year Report." Released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic ...  07/24/07 Quest Diagnostics Reports Second Quarter 2007 Results LYNDHURST, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2007, income from continuing operations was $142 million, or $0.73 per diluted share, compared to $156 million, or $0.78 per diluted share, in the second quarter of 2006. The second quarter of 2007 includes the results of AmeriPath, Inc., which was acquired on Ma...  07/19/07 Quest Diagnostics Announces New Testing Technique for Improved Diagnosis of Metabolic And Nutritional Disorders LYNDHURST, N.J., July 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced a new, proprietary diagnostic testing technique to help physicians diagnose genetic metabolic disorders, such as phenylketonuria (PKU) and homocystinuria. Genetic metabolic disorders can impair a child's mental and physical development. The new technique measures amino acids in blood plasma, urine ...  07/17/07 Quest Diagnostics Launches National Patient Appointment Scheduling Industry's first national scheduling system provides convenient scheduling options and reduced wait times for patients LYNDHURST, N.J., July 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced the first national patient appointment-scheduling system in the diagnostic testing service industry. The new system gives patients the option to schedule appointm...  06/23/07 Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals Gains come soon after diagnosis then plateau; young male adults fare worse than females Test results found to worsen in winter Six-year data released from nation's largest laboratory testing database CHICAGO, June 23 /PRNewswire/ -- Over the last six years, Americans being treated for diabetes improved control of their disease by a significant 44.4 percent. As of December, 2006, more than half (54.6 percent) had reached ...  06/22/07 Quest Diagnostics to Speak at the Jefferies Healthcare Conference LYNDHURST, N.J., June 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies Healthcare Conference on Tuesday, June 26, 2007. The Quest Diagnostics presentation is scheduled to begin at 9:50 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following...  06/20/07 Quest Diagnostics Announces Pricing of Senior Notes LYNDHURST, N.J., June 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information, and services, announced today that it priced $800 million in aggregate principal amount of senior notes in a public offering. The notes were sold in two tranches, as follows: $375 million of 6.40% senior notes due 2017 and $425 million of 6.95% senior notes due 2037. The offering is expected to close on June 22, 2007. The net p...  06/19/07 Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information, and services, announced today that it intends to offer $800,000,000 in aggregate principal amount in two series of senior notes, in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The notes will be fully and unconditionally gu...  06/19/07 Quest Diagnostics Incorporated Announces Completion of Tender Offer for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc. LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostics testing, information and services, announced today that it has completed its cash tender offer for the outstanding $350 million, 10 1/2% Senior Subordinated Notes due 2013 (the "Notes") (CUSIP Nos. 03071D AC 3 and 03071D AA 7) of AmeriPath, Inc. ("AmeriPath"). The cash tender offer expired, as scheduled, on June 18, 2007, at 12:00 midnight, ET, (t...  06/07/07 Quest Diagnostics Extends Agreement With CIGNA Healthcare LYNDHURST, N.J., June 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has signed a multi-year contract extension with CIGNA HealthCare and will remain a participating provider in all markets for all products. Quest Diagnostics is the largest provider of laboratory services to CIGNA HealthCare, providing its members and providers with the nation's broadest acces...  06/05/07 Quest Diagnostics Incorporated Announces Pricing and Receipt of Requisite Consents for Cash Tender Offer and Consent Solicitation for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc. LYNDHURST, N.J., June 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostics testing, information and services, announced today the determination of pricing in connection with its cash tender offer and consent solicitation for any and all of the outstanding $350,000,000 principal amount 10 1/2% Senior Subordinated Notes due 2013 (the "Notes") (CUSIP Nos. 03071D AC 3 and 03071D AA 7) of AmeriPath, Inc. ("AmeriPath"). The...  05/31/07 Quest Diagnostics Completes Acquisition of AmeriPath LYNDHURST, N.J., MAY 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced that today it completed its previously announced acquisition of AmeriPath, Inc., a national diagnostic testing company. "This acquisition creates the world's premier cancer diagnostics company focused on dermatopathology, anatomic pathology and molecular diagnostics," said Surya N. Mohapa...  05/30/07 Quest Diagnostics Plans to Complete Acquisition of AmeriPath on May 31 LYNDHURST, N.J., May 30 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that it plans to complete its previously announced acquisition of AmeriPath, Inc. on May 31, 2007. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on May 29, 2007. About AmeriPath AmeriPath, a leading national provider of physician-based anatomic pathology, derm...  05/29/07 Quest Diagnostics to Speak at the Bank of America Healthcare Conference 2007 LYNDHURST, N.J., May 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America Healthcare Conference on Thursday, May 31, 2007, at the Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 5:40 p.m. Eastern Time. During the conference, the company will reiterate its 2007 guidance f...  05/21/07 Study Reports Point-of-Care Test to be as Accurate as Conventional Laboratory Analysis in Detecting Kidney Disease in Patients with Diabetes and Cardiovascular Disease CHICAGO, May 21 /PRNewswire-FirstCall/ -- A study presented today at the American Society of Hypertension, Inc. (ASH) Twenty-Second Annual Scientific Meeting and Exposition (ASH 2007) in Chicago reports that the HemoCue Albumin 201 system, a point-of-care diagnostic test developed by HemoCue AB, can detect microalbuminuria, a biological marker for kidney and cardiovascular disease as accurately as conventional laboratory tests. HemoCue, a Quest Diagnostics (NYSE: DGX) company, is the d...  05/21/07 Quest Diagnostics Commences Cash Tender Offer for AmeriPath 10 1/2% Senior Subordinated Notes Due 2013 LYNDHURST, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostics testing, information and services, announced today that it has commenced a cash tender offer for all of the outstanding $350,000,000 principal amount 10 1/2% Senior Subordinated Notes due 2013 (CUSIP Nos. 03071D AC 3 and 03071D AA 7) of AmeriPath, Inc. (AmeriPath). The tender offer is being made by Quest Diagnostics in connection with its previousl...  05/10/07 Award for 'Best Employer for Healthy Lifestyles' Given to Quest Diagnostics HealthyQuest Employee Wellness Program Features Unique Combination of Diagnostic Screening, Lifestyle Assessment and Health Education LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that the National Business Group on Health, an association of 266 large U.S. employers, has awarded its 2007 Best Employers for Healthy Lifestyles Gold Award to the...  05/08/07 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., May 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 18, 2007, to shareholders of record on July 5, 2007. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and se...  04/19/07 Quest Diagnostics Reports First Quarter 2007 Results LYNDHURST, N.J., April 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2007, income from continuing operations was $108 million, or $0.55 per diluted share compared to $155 million, or $0.77 per diluted share in the first quarter of 2006. Earnings in the first quarter were reduced by an estimated $0.17 per share as a result of...  04/17/07 Quest Diagnostics' MedPlus(R) Subsidiary Selected To Develop The Lab Information System For The Province of British Columbia's Electronic Health Record System One of North America's largest electronic health networks will deliver better care at lower costLYNDHURST, N.J., April 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that its healthcare information technology subsidiary MedPlus, Inc., has been selected as a subcontractor by Sun Microsystems (B.C.) Inc., a subsidiary of Sun Microsystems of Canada Inc., and subcontractors to develop and implement a comprehensive electronic ...  04/16/07 Quest Diagnostics to Acquire AmeriPath in a Transaction Valued at $2 Billion -- Establishes Leading Position in Cancer Diagnostics with a Focus on Dermatopathology, Anatomic Pathology and Molecular Diagnostics -- -- Strengthens Leadership in Hospital and Esoteric Testing -- -- Enhances Position as World's Premier Diagnostic Testing Company -- LYNDHURST, N.J. and PALM BEACH GARDENS, Fla., April 16 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and service...  03/22/07 Quest Diagnostics Selected as Sole Laboratory Service Provider to National Health Service Hospital and Primary Care Trust Agreement strengthens company's U.K. presence LYNDHURST, N.J., March 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading U.S. provider of diagnostic testing, information and services, announced today that it has been awarded a new, five-year contract with the U.K.'s National Health Service West Middlesex University Hospital Trust and the Hounslow Primary Care Trust of London to provide end-to-end diagnostic testing and related support se...  03/15/07 Quest Diagnostics to Speak at the Lehman Brothers Tenth Annual Healthcare Conference LYNDHURST, N.J., March 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lehman Brothers Tenth Annual Healthcare Conference on Monday, March 19, 2007, at the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics presentation is scheduled to begin at 4:15 p.m. Eastern Time. The presentation will be webcast live during the con...  03/07/07 Drug Use Hits New Low Among U.S. Workers in 2006, According to Quest Diagnostics' Drug Testing Index(R) -- Lowest levels since 1988 -- -- Significant decline in use of amphetamines and marijuana continues trend from previous year -- LYNDHURST, N.J., March 7 /PRNewswire-FirstCall/ -- A continued decline in drug positivity for the amphetamine class of drugs among safety-sensitive workers, coupled with a decrease in positive marijuana drug test results among the general U.S. workforce, drove workplace drug use to a new low in 2006. The...  03/05/07 Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect Monday March 5, 6:30 pm ET CYPRESS, Calif., March 5 /PRNewswire-FirstCall/ -- Focus Diagnostics, Inc., a wholly owned subsidiary of Quest Diagnostics Incorporated, (NYSE: DGX - News), today announced it has received FDA 510k clearance to market its new Plexus(TM) HerpeSelect® 1 and 2 IgG test kit, the first multiplex type- specific HSV serology panel using xMAP® technology from Luminex Corporation. Focus Diagnostics...  02/22/07 MedPlus' ChartMaxx(R) Earns Top Ranking in the '2006 Top 20 Year-End Best in KLAS' Report for Third Consecutive Year LYNDHURST, N.J., Feb. 22 /PRNewswire-FirstCall/ -- MedPlus' ChartMaxx(R), an enterprise-wide electronic health record solution for hospitals, Integrated Delivery Networks and healthcare communities, placed first in Document Management and Imaging (DMI) in the "2006 Top 20: Year-End Best in KLAS" report issued by KLAS Enterprises. ((C) 2006 KLAS Enterprises, LLC. All rights reserved). This marks the third consecutive year and fourth time in five years that ChartMaxx has placed first in...  02/14/07 National Survey Shows Physicians Have Clear Preference Between the Two Largest Diagnostic Laboratories - Results show overwhelming preference for Quest Diagnostics - LYNDHURST, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today results of a national physician study on preference and performance of medical laboratory services. When physicians were asked which of the two largest national laboratories they preferred, the majority of physicians expressed a preferenc...  02/13/07 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on April 18, 2007, to shareholders of record on April 4, 2007. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information an...  02/01/07 Quest Diagnostics Acquires HemoCue for Approximately $420 Million, Entering Market for Near Patient Testing LYNDHURST, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading U.S. provider of diagnostic testing, information and services, announced today that it has acquired HemoCue, a Swedish company specializing in near patient testing, also known as point-of- care testing, from the private equity firm EQT II B.V. in a cash transaction valued at approximately $420 million. The acquisition will allow Quest Diagnostics to enter the growing near patient t...  01/29/07 Quest Diagnostics to Speak at Wachovia Securities 2007 Healthcare Conference LYNDHURST, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Wachovia Securities 2007 Healthcare Conference on Tuesday, January 30, 2007, at the Langham Hotel, Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:30 a.m. Eastern Time. The presentation will be webcast live during the conferenc...  01/25/07 Quest Diagnostics Reports Strong Results for Fourth Quarter and Full Year 2006 - Company provides 2007 guidance - LYNDHURST, N.J., Jan. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2006, income from continuing operations was $151 million, or $0.77 per diluted share compared to $149 million, or $0.73 per diluted share for the prior year. Fourth quarter revenues from continuing...  01/19/07 Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome New Technology Will Allow for Widespread Population-Based Carrier Screenings LYNDHURST, N.J., Jan. 19 /PRNewswire-FirstCall/ -- In a move that promises to advance physicians' ability to widely screen for Fragile X Syndrome (FXS), the most common form of inherited mental retardation,(1) Quest Diagnostics Incorporated (NYSE: DGX) today announced the signing of a worldwide license agreement with U.S. Genomics. The terms grant Quest Diagnostics rights to develop an advanced screening meth...  01/09/07 Quest Diagnostics to Speak at the 25th Annual JPMorgan Healthcare Conference LYNDHURST, N.J., Jan 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 25th Annual JPMorgan Healthcare Conference on Wednesday, January 10, 2007, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 12:30 p.m. Eastern Time. The presentation will be web...  12/14/06 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on January 24, 2007, to shareholders of record on January 10, 2007. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, informat...  12/14/06 Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women with Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers SAN ANTONIO, Dec. 14 /PRNewswire-FirstCall/ -- Clinicians will have a new prognostic tool in the battle against breast cancer, as Quest Diagnostics Incorporated (NYSE: DGX) announced today that it has introduced its newly developed test, the Breast Cancer Gene Expression Ratio (HOXB13:IL17BR), to help physicians predict the risk of disease recurrence in women with estrogen receptor (ER)-positive, lymph node-negative breast cancer. Quest Diagnostics is the first company to develop a bre...  11/14/06 Ronald D. Luff, M.D., Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease - Quest Diagnostics Physician Receives 2006 Papanicolaou Award for Achievements in Cellular Pathology and Disease - LYNDHURST, N.J., Nov. 14 /PRNewswire-FirstCall/ -- A pioneer in the science and standardization of cervical disease diagnosis, Ronald D. Luff, M.D., M.P.H, and Director of Anatomic Clinical Trials at Quest Diagnostics (NYSE: DGX), recently received a lifetime achievement honor -- the 2006 Papanicolaou Award -- from the American Society of Cytopatholog...  11/02/06 New Study Shows InSure(R) Colorectal Cancer Screening Test Significantly Better at Detecting Early Stage Colorectal Cancers Compared to Traditional Test The InSure Test Should Help Reduce Colorectal Cancer Mortality and Incidence LYNDHURST, N.J., Nov. 2 /PRNewswire-FirstCall/ -- A study published in the journal CANCER found that InSure,(R) a Fecal Immunochemical Test (FIT) from Quest Diagnostics Incorporated (NYSE: DGX) detected three times as many early- stage colorectal cancers and nearly two times as many significant (pre- cancerous) adenomas compared to Hemoccult II Sensa(R)(1), the traditional guaiac fecal occult blood test.(2) ...  10/19/06 Quest Diagnostics Reports Strong Performance in Third Quarter 2006 on 16% Revenue Growth LYNDHURST, N.J., Oct 19, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2006, income from continuing operations was $164 million, or $0.82 per diluted share compared to $140 million, or $0.68 per diluted share for the prior year. Net income for 2006 was reduced by $13 million of pretax expenses, or $0.04...  10/03/06 Quest Diagnostics to No Longer Be a National Contracted Provider of Lab Services to UnitedHealthcare Effective 2007 - Quest Diagnostics expects to continue to service UnitedHealthcare members as a non-contracted provider of high quality convenient laboratory services - LYNDHURST, N.J., Oct. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it will not be a national contracted provider of laboratory services to UnitedHealthcare beginning January 1, 2007. UnitedHealthcare accounts for ...  09/22/06 Quest Diagnostics to Speak at the UBS Global Life Sciences Conference LYNDHURST, N.J., Sept. 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS Global Life Sciences Conference on Monday, September 25, 2006, at the Grand Hyatt New York Hotel. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be avail...  09/19/06 Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World Index - Company is also Selected for Inclusion in the DJSI North America Index - LYNDHURST, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it was again selected to be part of the Dow Jones Sustainability (DJSI) World and North American Indexes. The company was first added to the World Index in 2004 and the North American Index in 2005. "We are delighted t...  09/07/06 Quest Diagnostics Acquires Maker of InSure(R) Colorectal Cancer Screening Test LYNDHURST, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it has completed the acquisition of Enterix, Inc., the privately held Australian-based company that developed and manufactures the InSure(R) Fecal Immunochemical Test (F.I.T.), an FDA-cleared test for use in screening for colorectal cancer and other sources of lower gastrointestinal bleeding, for app...  09/06/06 Quest Diagnostics to Speak at the Thomas Weisel Partners Healthcare Conference 2006 LYNDHURST, N.J., Sept. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Thomas Weisel Partners Healthcare Conference on Thursday, September 7, 2006, at the Four Seasons Boston in Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 2:05 p.m. Eastern Time. During the conference, the company will reiterate i...  09/06/06 Cincinnati Children's Hospital Medical Center Selects ChartMaxx(R) for its Health Information Management Department LYNDHURST, N.J., Sept. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that Cincinnati Children's Hospital Medical Center has selected MedPlus' ChartMaxx(R) electronic health record solution to support its Health Information Management department with document management and imaging. ChartMaxx was developed by MedPlus, Quest Diagnostics' healthcare information technol...  08/21/06 Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Mid-Year Report For Its ChartMaxx(R) Electronic Patient Record Solution LYNDHURST, N.J., Aug. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus healthcare information technology subsidiary has been recognized as the number one Document Management and Imaging (DMI) vendor in the 2006 "Top 20: KLAS Mid-Year Report Card." ((C)2006 KLAS Enterprises, LLC. All rights reserved.) This top ranking position marks the fourth time the...  08/09/06 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., Aug. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on October 18, 2006, to shareholders of record on October 4, 2006. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, informatio...  08/02/06 Quest Diagnostics Reopens Louisiana Laboratory Damaged by Hurricane Katrina NEW ORLEANS, Aug. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced it has reopened its laboratory in Metairie, Louisiana, after successfully completing reconstruction to the facility following substantial damage to the building and testing equipment caused by Hurricane Katrina. Quest Diagnostics' Metairie laboratory performs rapid-response testing as well as anatomic pat...  07/24/06 Quest Diagnostics Reports Strong Performance In Second Quarter 2006 On 15% Revenue Growth LYNDHURST, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2006, net income was $156 million, or $0.78 per diluted share, excluding the performance of NID, the company's test kit manufacturing subsidiary, whose operations are being discontinued. NID's performance reduced pretax earnings by $35 million, or $0.12 per shar...  07/05/06 Quest Diagnostics Completes Acquisition of Focus Diagnostics, Inc., a World Leader in Infectious Disease Testing LYNDHURST, N.J., July 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, has completed the previously announced acquisition of Focus Diagnostics, Inc., in a cash transaction valued at approximately $185 million. Focus Diagnostics is recognized worldwide for its leadership in infectious and immunologic diseases and has established a reputation for being first to introduce new assays ...  06/19/06 Amphetamines Use Declined Significantly Among U.S. Workers in 2005, According to Quest Diagnostics' Drug Testing Index - Drug Use Among Workers Declines to 17-year Low in 2005 - LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Amphetamines use, which includes amphetamine and methamphetamine, declined significantly among general U.S. workforce employees during 2005, according to the semi-annual Drug Testing Index, released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. The findings were based on the results of...  05/19/06 Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing LYNDHURST, N.J., and HERNDON, Va., May 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, has agreed to acquire Focus Diagnostics, Inc., the premier infectious disease testing provider, in a cash transaction valued at approximately $185 million. Focus Diagnostics is privately held and based in Herndon, Virginia. The acquisition will add annual revenues of approximately $65 million. ...  05/15/06 Quest Diagnostics to Speak at the Bank of America Healthcare Conference 2006 LYNDHURST, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America Healthcare Conference on Wednesday, May 17, 2006, at the Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 11:40 a.m. Eastern Time. During the conference, the company will reiterate its 2006 guidance...  05/10/06 Quest Diagnostics Declares Quarterly Cash Dividend LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 21, 2006, to shareholders of record on July 7, 2006. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and s...  05/05/06 A.O. Fox Hospital Physicians Now Armed with ChartMaxx(R), an Electronic Health Record Solution, to Deliver Optimum Patient Care LYNDHURST, N.J., and ONEONTA, N.Y., May 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and A.O. Fox Hospital, Oneonta's largest healthcare provider, today announced the successful implementation of ChartMaxx(R), an electronic health record solution at A.O. Fox's hospital and offsite care centers. ChartMaxx was developed by MedPlus(R), Quest Diagnostics' healthcare information techno...  05/03/06 Patients Improved Diabetes Control Over 5-Year Period, But Many Fail to Achieve Treatment Goal Quest Diagnostics Health Trends(TM) Diabetes Report Is Based on 14.3 Million Test Results From 2001 - 2005 From the Nation's Largest Database of Clinical Lab Results LYNDHURST, N.J., May 3 /PRNewswire/ -- People with diabetes who visit health professionals are doing a better job of managing their disease, according to results from the Quest Diagnostics Health Trends (TM) Diabetes Report. However, the Report also found that nearly half of all test results in 2...  05/01/06 Quest Diagnostics' Healthcare Information Technology Subsidiary to Test ePrescribing Technology Standards in Two New Pilot Programs LYNDHURST, N.J., May 1 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that its healthcare information technology subsidiary, MedPlus, will test electronic prescribing standards in two new pilot programs starting in May. MedPlus will conduct testing in pilot programs in New Jersey and Florida that are designed to research the function and interoperability ...  04/20/06 Quest Diagnostics Reports Strong Performance in First Quarter 2006 - Revenues grew 18% and earnings per share grew 13% - LYNDHURST, N.J., April 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2006, net income increased to $145 million from $132 million in the first quarter of 2005. Earnings per diluted share increased 13% to $0.72 from $0.64 a year ago. Included in the 2006 results wer...  03/28/06 Quest Diagnostics Launches the First Tests to Help Doctors Assess Status of Leukemia and Lymphoma in Patients Using Blood Plasma Instead of Bone Marrow - LEUMETA Cancer Tests Are Less Invasive Than Bone Marrow Biopsies, Providing Doctors With New Tools to More Frequently Assess Disease Progress and Help the Physician Tailor Cancer Therapy to Individual Needs - LYNDHURST, N.J., March 28 /PRNewswire-FirstCall/ -- Nearly 1 million Americans who are battling or recovering from leukemia and lymphoma have a powerful new diagnostic tool available as Quest Diagnostics Incorporated (NYSE: DGX) today launches the first of its LEUMETA(TM) cancer ...  03/09/06 Quest Diagnostics to Speak at The Lehman Brothers Ninth Annual Healthcare Conference LYNDHURST, N.J., March 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lehman Brothers Ninth Annual Healthcare Conference on Friday, March 10, 2006, at the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. The presentation will be webcast live during the conf...  02/13/06 Quest Diagnostics' Enhanced Care360(TM) Physician Portal Combines Laboratory Test Results and Prescription Data to Help Doctors Evaluate Patients' Response to Medication Therapy - See an introductory demonstration at MedPlus booth # 2527 at the HIMSS conference, February 13 - 16 in San Diego - LYNDHURST, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services announced today that its enhanced Care360 Physician Portal now combines laboratory test results and prescription data to help doctors evaluate patients' response to medi...  01/26/06 Quest Diagnostics Reports Strong Financial Results in Fourth Quarter and Full Year 2005 - 2006 earnings per share expected to grow to $2.75 to $2.85, after $0.20 per share estimated cost of SFAS 123R - LYNDHURST, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2005, net income increased to $130 million, or $0.64 per diluted share, compared to $126 million, or $0.60 per share in 2004...  01/26/06 Quest Diagnostics Expands Share Repurchase Authorization by $600 Million and Increases Quarterly Dividend LYNDHURST, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors expanded its share repurchase authorization by an additional $600 million, bringing the total amount authorized and available for repurchases to $722 million. During 2005 the company repurchased 7.8 million common shares for $390 million. The company had approximately 199 milli...  01/13/06 Quest Diagnostics' MedPlus® Subsidiary Earns Top Ranking in KLAS Industry Report for Its ChartMaxx® Solution ChartMaxx Receives '2005 BEST IN KLAS' Award in the Document Management & Imaging CategoryLYNDHURST, N.J., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its MedPlus healthcare information technology subsidiary was recognized among healthcare IT executives, as the number one Document Management and Imaging (DMI) vendor in the 2005 "T...  01/09/06 Quest Diagnostics to Speak at the 24th Annual JPMorgan Healthcare Conference LYNDHURST, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 24th Annual JPMorgan Healthcare Conference on Tuesday, January 10, 2006, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 2:30 p.m. Eastern Time. The presentation will be webcast live during the conf...  12/13/05 Quest Diagnostics Declares Quarterly Dividend LYNDHURST, N.J., Dec. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors has declared a quarterly cash dividend on Quest Diagnostics common stock of $0.09 per share, payable on January 25, 2006 to shareholders of record on January 11, 2006. Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients an...  12/09/05 Quest Diagnostics Unveils New Data Confirming Benefits Of Leukemia Tests Using Blood Plasma, Compared With Conventional Tests Using Cells In Bone Marrow Or Blood, At American Society Of Hematology Meeting 23 Quest Diagnostics abstracts demonstrate scientific leadership with data highlighting effectiveness of newer, more sensitive, less invasive tests to diagnose and monitor hematologic disease LYNDHURST, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it is presenting new data on a new series of laboratory-developed diagnostic assays for hematologic di...  12/09/05 Quest Diagnostics Announces the Availability of a New Gene-Based Assay To Help Physicians Identify the Primary Site of a Metastatic Cancer of Unknown Origin LYNDHURST, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that it has developed a new gene- based assay to help physicians identify metastatic Cancers of Unknown Primary origin (CUP). This laboratory-developed assay is currently available to physicians through Quest Diagnostics Nichols Institute, the company's esoteric testing laboratory, in San Juan Capistra...  12/01/05 Amphetamines Drug-Test Positives Are Up Among Safety-Sensitive Workers in the First Half of 2005, According to Quest Diagnostics' Drug Testing Index(R) - Overall Decline in Positive Drug Tests Linked to Decrease in Marijuana Positivity - LYNDHURST, N.J., Dec. 1 /PRNewswire-FirstCall/ -- The proportion of drug- test positives for amphetamines increased among workers subject to federal testing regulations, while overall drug-test positives decreased among all U.S. workers in the first half of 2005, according to the semi-annual Drug Testing Index(R) released today by Quest Diagnostics Incorporated (NYS...  11/28/05 Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference LYNDHURST, N.J., Nov 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Merrill Lynch Health Services Investor Conference on Tuesday, November 29, 2005, at The Waldorf Astoria Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 8:45 a.m. Eastern Time. During the conference, the co...  11/22/05 Quest Diagnostics' Care360 Physician Portal Offers Electronic Prescribing Tools for Pennsylvania Physicians Participating in Highmark eHealth Collaborative ~ Foundation provides incentives for physicians to adopt electronic prescribing technology ~LYNDHURST, N.J., Nov 22, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services announced today that its Care360(TM) Physician Portal is one of the preferred electronic health tools for Pennsylvania physicians who receive funding from the Highmark eHealth Collaborative, a physician ...  11/17/05 Quest Diagnostics, in Cooperation with AARP, Opens Doors for Older Job Seekers Featured Employers Program Brings Value to 50+ Workers and Quest Diagnostics LYNDHURST, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that it has been named one of AARP's Featured Employers, a program designed to help Americans aged 50 and over remain in the workforce as desired. The new Featured Employers are committed to an aggressive program of recrui...  11/04/05 Quest Diagnostics to Speak at the CIBC World Markets Sixteenth Annual Healthcare Conference LYNDHURST, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the CIBC World Markets Sixteenth Annual Healthcare Conference on Tuesday, November 8, 2005, at The Waldorf Astoria Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern Time. The presentation will be webcast live during t...  11/03/05 Quest Diagnostics Offers Test to Detect Avian Influenza Virus LYNDHURST, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that it has developed a diagnostic test to detect the avian influenza virus and will participate in the government's preparedness efforts to provide rapid diagnosis and early surveillance of an outbreak, should the need arise. Quest Diagnostics has notified physicians and hospitals that it has be...  11/01/05 Quest Diagnostics Completes Acquisition of LabOne LYNDHURST, N.J., Nov 01, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it had completed the all-cash acquisition of LabOne, Inc. (Nasdaq: LABS) in a transaction valued at $934 million. The acquisition was funded primarily with proceeds from the sale of $900 million of senior notes on October 31, 2005. Headquartered in Lenexa, Kansas, LabOne provides health screening and risk assessment services to life insurance com...  10/27/05 LabOne Shareholders Vote to Approve Acquisition by Quest Diagnostics LYNDHURST, N.J., and LENEXA, Kan., Oct 27, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX) and LabOne, Inc. (Nasdaq: LABS) announced that LabOne shareholders approved the acquisition of LabOne by Quest Diagnostics in a vote held at a special meeting today. The shareholder vote followed regulatory clearance of the transaction in mid-October. The transaction is expected to be completed during the first week of November. "We are excited t...  10/25/05 Quest Diagnostics Announces Proposed Senior Notes Offering LYNDHURST, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information, and services, announced today that it intends to offer $900,000,000 in aggregate principal amount of senior notes, in a private placement, subject to market and other conditions. The net proceeds of the offering are expected to be used to complete the previously announced acquisition of LabOne, Inc. (Nasdaq: LABS). The no...  10/25/05 Quest Diagnostics Announces Pricing Of Senior Notes LYNDHURST, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information, and services, announced today that it priced $900 million in aggregate principal amount of senior notes in a private placement. The notes were sold in two tranches, as follows: $400 million of 5.125% senior notes due 2010 and $500 million of 5.45% senior notes due 2015. The offering is expected to close on October 31, 2005. ...  10/20/05 Quest Diagnostics Reports Strong Revenue Growth In Third Quarter 2005 - Earnings growth in third quarter and full year reduced by Gulf Coast hurricanes and performance of test kit manufacturing business - LYNDHURST, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2005, net income increased to $135 million or $0.66 per diluted share, compared to $130 million, or $0.62 per diluted sha...  10/10/05 Average LDL Cholesterol Levels Decreased Approximately 10 Percent Among People Under Doctors' Care from 2001 to 2004 - Quest Diagnostics launches Health Trends(R), a national source of patient health information that provides insights from the nation's largest private database of clinical test results - - Cholesterol levels decreased less in women than men - LYNDHURST, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it identified a significant ...  09/29/05 Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World Index - Company Also Selected for Inclusion in First DJSI North America Index - LYNDHURST, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it again was selected to be part of the Dow Jones Sustainability World Index (DJSI World). The company was first added to the index in 2004. In addition, Quest Diagnostics was selected...  09/28/05 Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Industry Report for Its ChartMaxx(R) Electronic Patient Record Solution LYNDHURST, N.J., Sept 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus healthcare information technology subsidiary has been recognized as the number one Document Management and Imaging (DMI) vendor for its ChartMaxx(R) electronic patient record solution in an industry report published by KLAS Enterprises, LLC. KLAS is a heal...  09/23/05 Quest Diagnostics to Speak at the UBS Global Life Sciences Conference LYNDHURST, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS Global Life Sciences Conferences on Monday, September 26, 2005, at The Grand Hyatt Hotel, in New York City. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will...  09/08/05 Fort Worth-Based North Texas Specialty Physicians Undertakes Major Technology Upgrade Among Its 600 Participating Doctors - Technology upgrade will help enhance patient care and facilitate physicians' move toward clinical integration - FORT WORTH, Texas, and LYNDHURST, N.J., Sept. 8 /PRNewswire-FirstCall/ -- North Texas Specialty Physicians (NTSP) and Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that NTSP physicians will use Quest Diagnostics' Care360 physician portal to better manage patients' laborat...  09/08/05 NID Wins Patent Dispute SAN CLEMENTE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Nichols Institute Diagnostics, Inc. (NID), a manufacturer of specialty diagnostic test kits and systems, announced that the U.S. District Court for the Southern District of California reversed part of a jury verdict and ruled decisively in favor of NID in its patent infringement case against Scantibodies Clinical Laboratory, Inc. and Scantibodies Laboratory, Inc. NID has an exclusive license to a patent for an assay for measurin...  09/08/05 Quest Diagnostics to Speak at the Thomas Weisel Partners Tailwinds 2005 Conference LYNDHURST, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Thomas Weisel Partners Tailwinds Conference on Friday, September 9, 2005, at The Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 9:45 a.m. Eastern Time. The presentation will be webcast live during the conferen...  09/02/05 Quest Diagnostics To Aid Hurricane Relief Efforts LYNDHURST, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced efforts to assist victims of Hurricane Katrina. The company has pledged $50,000 to the American Red Cross Hurricane 2005 Relief Fund. In addition, Quest Diagnostics employees have established a special relief fund to aid their fellow employees along the Gulf Coast who have been impacted by Hurricane Ka...  08/10/05 Quest Diagnostics Declares Quarterly Dividend LYNDHURST, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors has declared a quarterly cash dividend on Quest Diagnostics common stock of $0.09 payable on October 19, 2005 to shareholders of record on October 5, 2005. The per share dividend reflects an earlier two-for-one stock split. Quest Diagnostics is the leading provider of diagnost...  08/10/05 Quest Diagnostics Is Selected to Provide Confirmatory Testing for the California Department of Health Services Expanded Newborn Screening Program LYNDHURST, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has signed an agreement with the State of California Department of Health Services to provide follow-up laboratory testing under the recently expanded Newborn Screening Program of the agency's Genetic Disease Branch. As part of the state's expanded Newborn Screening Program, Quest Diagnos...  08/08/05 Quest Diagnostics to Acquire LabOne for $934 Million in Cash - Transaction to generate significant synergies and expand geographic reach - - Establishes leading position in testing-related business serving life insurance industry - LYNDHURST, N.J. and LENEXA, Kan., Aug 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has signed a definitive agreement to acquire LabOne, Inc. (Nasdaq: LABS). Under the terms of ...  08/08/05 Jenne K. Britell, Ph.D., Elected to Quest Diagnostics Board LYNDHURST, N.J., Aug 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its Board of Directors has elected Jenne K. Britell, Ph.D., to serve as a Director, increasing the Board to 11 members. Dr. Britell, 63, is Chairman and CEO of Structured Ventures, Inc., a private company which advises venture capital firms and financial institutions in both U....  08/03/05 Quest Diagnostics' Care360 Physician Portal Connects to Retail Pharmacies Using the SureScripts Electronic Prescribing Network - Connection Enables Two-Way Communication Between Physicians and Pharmacies - ALEXANDRIA, Va. and LYNDHURST, N.J., Aug. 3 /PRNewswire-FirstCall/ -- SureScripts, the nation's largest network provider of electronic prescribing services, and Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that Quest Diagnostics' Care360 physician portal has established a direct electronic connection to...  07/25/05 Quest Diagnostics Reports Strong Performance in Second Quarter 2005 LYNDHURST, N.J., July 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2005, net income increased to $149 million, compared to $135 million before special charges of $13.2 million pre-tax, or $0.04 per diluted share, in the second quarter last year. Earnings per diluted share increased 14% to $0.72 in 2005 from $0.63 before special char...  07/22/05 Ciphergen Biosystems and Quest Diagnostics Form Strategic Alliance to Develop and Commercialize Tests Using Ciphergen's Proteomics Technology FREMONT, Calif. and LYNDHURST, N.J., July 22 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH) and Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services in the U.S., announced the formation of a strategic alliance to develop and commercialize novel proteomic diagnostic tests based on Ciphergen's proprietary SELDI ProteinChip(R) technology. The strategic alliance will focus on the commercialization of selecte...  07/20/05 Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Mid-Year Report for Its ChartMaxx(R) Electronic Patient Record Solution LYNDHURST, N.J., July 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus healthcare information technology subsidiary has been recognized as the number one Document Management and Imaging (DMI) vendor in the 2005 "Top 20: KLAS Mid-Year Report Card." ((C) 2005 KLAS Enterprises, LLC. All rights reserved.) This top ranking marks the third time the company's Ch...  07/13/05 St. Joseph's Physicians Association Selects Quest Diagnostics' Care360 Physician Portal to Help Physicians Deliver Better Patient Care MILWAUKEE and LYNDHURST, N.J., July 13, 2005 /PRNewswire-FirstCall via COMTEX/ -- St. Joseph's Physicians Association (SJPA), an independent physicians association (IPA) that comprises nearly 400 doctors in the greater Milwaukee metropolitan area, today announced that it has selected Quest Diagnostics' Care360 physician portal to help its physician members deliver better patient care. The Care360 physician portal enables physicians to order diagnostic tests and review laboratory result...  06/29/05 Quest Diagnostics' Care360 Physician Portal Offers Electronic Health Tools for Physicians in Southeast Michigan E-Prescribing Initiative (Semi) - Technology by Quest Diagnostics Subsidiary, MedPlus, Enables Electronic Prescribing and Patient Recordkeeping - LYNDHURST, N.J., June 29 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Care360 physician portal is one of the preferred electronic health tools for physicians participating in the Southeast Michigan E-Prescribing Initiative (SEMI), a physician incent...  06/28/05 Quest Diagnostics to Speak at the Wachovia Securities Fifteenth Annual Nantucket Equity Conference LYNDHURST, N.J., June 28 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the Wachovia Securities Fifteenth Annual Nantucket Equity Conference on, Wednesday, June 29, 2005, at Harbor House Village, in Nantucket, Massachusetts. The Quest Diagnostics presentation is scheduled to begin...  05/16/05 Amphetamines Use in the Workplace Continued to Grow, According to Quest Diagnostics' 2004 Drug Testing Index LYNDHURST, N.J., May 16 /PRNewswire-FirstCall/-- The use of amphetamines among general workforce employees continued to grow in 2004, according to the semi-annual Drug Testing Index(R) released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. Amphetamines use, which grew rapidly between 2000 and 2003, continued to grow in 2004, although at a slower rate. Among general U.S. workforce employees, the inci...  05/16/05 Quest Diagnostics to Speak at The Banc of America Securities Healthcare Conference LYNDHURST, N.J., May 16 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the Banc of America Securities Healthcare Conference on Tuesday, May 17, 2005, at the Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 5:00 p.m. Eastern Time....  05/10/05 Quest Diagnostics Declares Two-For-One Stock Split and Quarterly Dividend LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors has declared a two-for-one stock split, in the form of a 100% stock dividend. All shareholders of record on June 6, 2005 will receive one additional share of common stock for each share held on that date. The additional shares of common stock will be distributed to shareholder...  04/29/05 The Health Alliance(TM) of Greater Cincinnati Selects ChartMaxx(R) Electronic Health Record Solution to Automate its Patient Financial Services Department LYNDHURST, N.J. and CINCINNATI, April 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and The Health Alliance of Greater Cincinnati, the region's largest healthcare provider, today announced that ChartMaxx has been selected to automate Health Alliance's patient financial services department. ChartMaxx is the electronic health record solution developed by MedPlus(R), Quest Diagnostics' h...  04/21/05 Quest Diagnostics Reports Strong Performance in First Quarter 2005 LYNDHURST, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2005, net income increased to $132 million from $116 million in the first quarter of 2004. Earnings per diluted share increased 19% to $1.28 from $1.08 a year ago. As previously disclosed, 2004 earnings per share reflect the required change in accounting for the com...  03/29/05 Quest Diagnostics to Speak at the Lehman Brothers Annual Global Healthcare Conference LYNDHURST, N.J., March 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the Lehman Brothers Annual Global Healthcare Conference on Wednesday, March 30, 2005, at the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics presentation is scheduled to begin at 3:45 p.m. Ea...  02/14/05 Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference TETERBORO, N.J., Feb 14, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the UBS Global Healthcare Services Conference on Tuesday, February 15, 2005, at The Plaza Hotel in New York City, New York. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m....  01/27/05 Quest Diagnostics Reports Strong Financial Results in Fourth Quarter and Full Year 2004 -- Earnings per Share Expected to Grow 14-16% in 2005 TETERBORO, N.J., Jan 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2004, net income increased to $126 million, compared to $108 million in 2003. Earnings per diluted share increased 21% to $1.23, before a required change in accounting for the company's contingent convertible debentures. After the change in accou...  01/27/05 Quest Diagnostics Increases Quarterly Dividend By 20% And Expands Share Repurchase Authorization By $350 Million TETERBORO, N.J., Jan 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors declared a quarterly cash dividend of $0.18 per common share, a 20% increase, payable on April 20, 2005, to shareholders of record on April 6, 2005. Additionally, the Board expanded its share repurchase authorization by an additional $350 million, bringing the total...  01/24/05 New Blood Tests to Soon Replace Painful Bone Marrow Biopsies for Leukemia and Lymphoma Patients - Quest Diagnostics is granted an exclusive license from The University of Texas M. D. Anderson Cancer Center to use proprietary technology based on blood proteins - TETERBORO, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that The University of Texas M. D. Anderson Cancer Center in Houston has granted the company...  01/21/05 Top Ranking by KLAS Enterprises for Electronic Patient Record Solution Awarded to Quest Diagnostics' MedPlus(TM) Subsidiary TETERBORO, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus healthcare information technology subsidiary was recognized as the number one document management and imaging (DMI) vendor in 2004 for its ChartMaxx(R) enterprise-wide electronic record solution for hospitals, according to KLAS Enterprises' "2004 TOP 20: Year-End Best in KLAS Awards." T...  01/17/05 Annals of Internal Medicine Studies Highlight Urgent Need for More Accurate and Patient-Friendly Colon Cancer Screening Tests - InSure offers a more 'patient-friendly' solution for colorectal cancer screening and is included in the American Cancer Society's guidelines - TETERBORO, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Two studies published in the Jan. 18 issue of Annals of Internal Medicine concluded that fecal occult blood tests in which the physician takes a single sample during a routine digital rectal exam (DRE) is not an acceptable way to screen for colorectal cancer. In an accompanying editorial, Ha...  01/10/05 Quest Diagnostics to Speak at the 23rd Annual JPMorgan Healthcare Conference TETERBORO, N.J., Jan 10, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer, is scheduled to speak at the 23rd Annual JPMorgan Healthcare Conference on Tuesday, January 11, 2005, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 2:30 p...  01/07/05 Quest Diagnostics Gives $250,000 to American Red Cross to Aid Tsunami Relief Effort TETERBORO, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it has given $250,000 to the American Red Cross International Response Fund to help in its effort to aid victims in the aftermath of the tsunami affecting much of South Asia and Eastern Africa. "As the tragedy continues to unfold, its impact is unfathomable," said Surya N. Mohapatra, Ph.D., Chairman...  12/16/04 Quest Diagnostics Calls for Redemption All Outstanding 1-3/4% Contingent Convertible Debentures TETERBORO, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is calling for redemption on January 18, 2005, all of its outstanding 1-3/4% contingent convertible debentures (the "Debentures") due 2021. The aggregate principal amount currently outstanding is approximately $250,000,000. The CUSIP number is 74834LAF7. Holders of the Debentures redeemed for...  12/15/04 Surya N. Mohapatra, Ph.D., Becomes Chairman of Quest Diagnostics - Gary M. Pfeiffer Elected to Board of Directors - TETERBORO, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it completed its previously-announced leadership succession process, with Surya N. Mohapatra, Ph.D., assuming the role of Chairman of the Board in addition to serving as President and Chief Executive Officer. The change became effective after Ken...  12/15/04 Quest Diagnostics Repurchases 2.7 Million of Its Shares from GlaxoSmithKline; Intends to Call 1-3/4% Contingent Convertible Debentures TETERBORO, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it repurchased 2.7 million shares of its common stock for approximately $254 million from GlaxoSmithKline plc (NYSE: GSK). The share repurchase, which was separately authorized by the Board of Directors and does not reduce the company's existing share repurchase authorization, was financed primarily thro...  12/14/04 Quest Diagnostics Declares Quarterly Cash Dividend TETERBORO, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.15 per share, payable on January 26, 2005 to shareholders of record on January 11, 2005. Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services,...  11/29/04 Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference TETERBORO, N.J., Nov. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the Merrill Lynch Health Services Investor Conference on Tuesday, November 30, 2004, at The Waldorf Astoria Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 8:45 a.m. Easter...  11/05/04 Quest Diagnostics to Speak at The CIBC World Markets Fifteenth Annual Healthcare Conference TETERBORO, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that David M. Zewe, Senior Vice President, Diagnostic Testing Operations, is scheduled to speak at the CIBC World Markets Fifteenth Annual Healthcare Conference on Monday, November 8, 2004, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 10:30 a.m. Eastern Time....  10/28/04 Quest Diagnostics Receives Subpoenas Regarding Test Produced By Subsidiary TETERBORO, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it and its test kit manufacturing subsidiary, Nichols Institute Diagnostics (NID), each received a subpoena from the U.S. Attorney's office for the Eastern District of New York late Monday. The subpoenas seek the production of various business records, including documents related to NID's FDA-cleared tes...  10/25/04 Quest Diagnostics Reports Strong Financial Results in Third Quarter 2004 TETERBORO, N.J., Oct 25, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2004, net income increased to $130 million, or $1.26 per diluted share, compared to $120 million, or $1.12 per diluted share, in 2003. Third quarter revenues grew 5.6% over the prior-year level to $1.3 billion. Clinical testing volume, measure...  10/21/04 Surya N. Mohapatra, Ph.D. to Become Next Chairman of Quest Diagnostics TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that Surya N. Mohapatra, Ph.D., who currently is President and Chief Executive Officer, will assume the additional role of Chairman on December 14, 2004. As part of an orderly leadership succession process, Kenneth W. Freeman will step down as Chairman of the Board on that date. "Surya Mohapatra ...  10/15/04 Quest Diagnostics' Care360 eMaxx(R) Physician Portal Now Offers Enhanced Electronic Prescribing Services With Online Access to Patients' Pharmacy Benefit Information -- See the Care360 eMaxx Physician Portal at Booth #2274 at the American Academy of Family Physicians Scientific Assembly in Orlando, Florida, October 14-17, 2004 - TETERBORO, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that its Care360 eMaxx physician portal now offers enhanced electronic prescribing services with online access to patients' pharmacy benefit information. The patient-centri...  09/28/04 Quest Diagnostics Honored as One of Nation's Top 100 Business Technology Innovators By InformationWeek TETERBORO, N.J., Sept. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, has been honored as one of the nation's Top 100 Innovators in the prestigious InformationWeek 500 ranking, published in the September 20 edition of CMP Media's InformationWeek magazine. Quest Diagnostics ranked #87, up from #149 in 2003. "We are pleased to be one of InformationWeek's top innovators and to be in...  09/27/04 Quest Diagnostics Joins Dow Jones Sustainability World Index TETERBORO, N.J., Sep 27, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it has been added to the Dow Jones Sustainability World Index (DJSI World), effective September 20. The Index contains more than 300 companies identified as "sustainability leaders," ranked according to objective benchmarks linked to financial, environmental and social criteria. The D...  09/27/04 Quest Diagnostics to Speak at UBS Global Life Sciences Conference TETERBORO, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the UBS Global Life Sciences Conference on Tuesday, September 28, 2004, at The Grand Hyatt Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 3:00 p.m. Eastern Time. Th...  09/20/04 Quest Diagnostics to Offer New Test to Measure Circulating Tumor Cells in Patients With Metastatic Breast Cancer TETERBORO, N.J., Sept. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has signed an agreement with Veridex, LLC, a Johnson & Johnson (NYSE: JNJ) company, to be the only national commercial reference laboratory to offer a test using Veridex's CellSearch(TM) Circulating Tumor Cell Kit, a new cancer diagnostic technology that identifies and counts circulating tumor ...  09/17/04 Quest Diagnostics to Speak at The Banc of America Securities 34th Annual Investment Conference TETERBORO, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Executive Officer, is scheduled to speak at the Banc of America Securities 34th Annual Investment Conference on Monday, September 20, 2004, at The Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 1...  09/07/04 Quest Diagnostics to Speak at The Thomas Weisel Partners Tailwinds 2004 Conference TETERBORO, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the Thomas Weisel Partners Tailwinds Conference on Wednesday, September 8, 2004, at The Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Easte...  08/23/04 New Services on Quest Diagnostics' eMaxx(R) Web Portal to Help Physicians Participate in Pay-for-Performance Programs and Move Physician Practices Toward Clinical Integration - Quest Diagnostics and The IPA Association of America to Jointly Promote eMaxx to 300,000 IPA-Affiliated Doctors - TETERBORO, N.J. and OAKLAND, Calif., Aug. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced it will begin to offer a suite of new services for its eMaxx Internet-based portal to help physicians participate in government-sponsored and private...  07/28/04 NCQA Receives Three-Year Grant From Quest Diagnostics Grant Supports Health Care Quality Advancements WASHINGTON – The National Committee for Quality Assurance (NCQA) announced today that it received a three-year grant from Quest Diagnostics Incorporated, a national provider of diagnostic testing, information and services. This grant supports NCQA's mission to improve the quality of health care by helping NCQA expand efforts to enhance quality evaluation at the provider level and to implement and evaluate new HEDIS® (Health Plan Employ...  07/22/04 Quest Diagnostics Reports Strong Financial Results in Second Quarter 2004 TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2004, net income increased to $135 million, or $1.28 per diluted share, before $13.2 million in special, pre-tax charges, or $0.08 per share, related to the recently completed CEO succession process and the company's debt refinancing, both of which had been previousl...  07/22/04 Quest Diagnostics Increases Share Repurchase Authority by $300 Million and Declares Quarterly Cash Dividend TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by an additional $300 million. In addition, the Board declared a quarterly cash dividend on Quest Diagnostics common stock of $0.15 per share, payable on October 22, 2004 to shareholders of record on October 8, 2004. Thr...  07/22/04 Increased Use of Amphetamines Linked to Rising Workplace Drug Use, According to Quest Diagnostics' 2003 Drug Testing Index - Opiate Use Increases Noticeably - TETERBORO, N.J., Jul 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- Increased use of amphetamines among general U.S. workforce employees was linked to rising workplace drug use during 2003, according to the semi-annual Drug Testing Index(R), released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. Overall, the drug positivity rate increased to 4.5% in 2003 from 4.4% a y...  07/14/04 Top Ranking By KLAS Enterprises For Electronic Patient Record Solution Awarded To Quest Diagnostics' MedPlus(TM) Subsidiary TETERBORO, N.J., July 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus healthcare information technology subsidiary was recognized as the number one document management and imaging (DMI) vendor for its ChartMaxx(R) enterprise-wide electronic patient record (EPR) solution for hospitals. The ranking was released by KLAS Enterprises in its "Top 20: Mid-Year...  06/23/04 Quest Diagnostics to Speak at The Wachovia Securities' Fourteenth Annual Nantucket Conference TETERBORO, N.J., Jun 23, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President, Chief Financial Officer, is scheduled to speak at the Wachovia Securities' Fourteenth Annual Nantucket Conference on, June 24, 2004, at Harbor House Village, in Nantucket, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at...  06/15/04 Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 6.0 TETERBORO, N.J., June 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Joan E. Miller, Ph.D., Vice President, Hospital Business, and Laure E. Park, Vice President, Investor Relations, are scheduled to speak at the Thomas Weisel Partners Growth Forum 6.0 on Wednesday, June 16, 2004, at The Montage Resort, in Laguna Beach, California. The Quest Diagnostics presentation is sch...  06/09/04 Quest Diagnostics Enters Into an Agreement with Express Scripts to Provide Physicians with Enhanced ePrescribing Capabilities TETERBORO, N.J., June 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, today announced that it has entered into an agreement with Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, to provide physicians with online access to Express Scripts' pharmacy benefit management services. The electronic prescribing, or ePrescribing ...  06/08/04 Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference TETERBORO, N.J., June 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Executive Officer, is scheduled to speak at the Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference on Wednesday, June 9, 2004, at The Ritz Carlton Laguna Niguel, in Dana Point, California. The Quest Diagnostics presentation is scheduled to begin a...  05/18/04 Quest Diagnostics to Speak at the Banc of America Securities Health Care Conference TETERBORO, N.J., May 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Health Care Conference on Wednesday, May 19, 2004, at The Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 2:20 p.m. Eastern Time. ...  05/18/04 Diagnostics Leaders Collaborate to Help Physicians Better Differentiate Allergy-Like Symptoms TETERBORO, N.J., May 18 /PRNewswire-FirstCall/ -- Primary care physicians are learning how they can better manage patients with allergy-like symptoms by obtaining objective evidence to differentiate those who are allergic from those who are not, thanks to a nationwide educational collaboration between Quest Diagnostics (NYSE: DGX) and Pharmacia Diagnostics AB. The collaboration's central message is that expanded use of blood testing for allergy at the primary care level is the key to impr...  05/06/04 Quest Diagnostics Signs Multi-Year Agreement with TriPath Imaging To Launch SurePath(TM) Liquid-Based Pap Test Nationally TETERBORO, N.J. and BURLINGTON, N.C., May 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and TriPath Imaging, Inc. (Nasdaq: TPTH), a leading provider of innovative solutions to improve the clinical management of cancer, announced today an agreement in which Quest Diagnostics will launch TriPath Imaging's SurePath(TM) liquid-based Pap test for cervical cancer screening to its physician cu...  05/05/04 Quest Diagnostics to Speak at The Morgan Stanley Second Annual Global Healthcare Unplugged Conference TETERBORO, N.J., May 5, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that David M. Zewe, Senior Vice President, Diagnostic Testing Operations, and Laure E. Park, Vice President, Investor Relations, are scheduled to speak at the Morgan Stanley Second Annual Global Healthcare Unplugged Conference on Thursday, May 6, 2004, at The Mandarin Oriental Miami, in Miami, ...  05/04/04 Quest Diagnostics Offers Gene-Based Test for Congenital Adrenal Hyperplasia - Visit Quest Diagnostics at the Pediatric Academic Societies' Meeting at the Moscone Convention Center in San Francisco (May 1-4, 2004) at Booth #930 - TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it has developed and is now offering a gene-based blood test to detect genetic mutations associated with congenital adrenal hyperpla...  05/04/04 Surya N. Mohapatra, Ph.D., Appointed CEO of Quest Diagnostics - Kenneth W. Freeman to Continue as Chairman of the Board - - John C. Baldwin, M.D., Elected to Board of Directors - TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that Surya N. Mohapatra, Ph.D., was appointed President and Chief Executive Officer, completing the CEO succession plan announced in November, 2003. Dr. Mohapatra succee...  05/04/04 Quest Diagnostics Declares Quarterly Cash Dividend TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on July 21, 2004 to shareholders of record on July 7, 2004. Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing in...  04/22/04 Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2004 TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2004, net income increased to $116 million from $88 million in the first quarter of 2003. Earnings per diluted share increased 28% to $1.10 from $0.86 in 2003. First quarter revenues grew 14.9% over the prior-year level to $1.3 billion and reflect the acquisi...  04/22/04 Quest Diagnostics to Complete CEO Transition on May 4, 2004 - Surya N. Mohapatra, Ph.D., to Become Chief Executive Officer - - Kenneth W. Freeman to Continue as Chairman Of The Board - TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that Surya N. Mohapatra, Ph.D., will be appointed President and Chief Executive Officer on May 4, 2004, the date of the Annual Meeting of Stockholders...  04/13/04 John C. Baldwin, M.D., Nominated for Election to Quest Diagnostics Board of Directors TETERBORO, N.J., April 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that its Board of Directors has nominated John C. Baldwin, M.D., for election as a Director at its 2004 Annual Meeting of Stockholders. Separately, the company announced that two current Directors, Kenneth D. Brody and Mary A. Cirillo, each of whose terms expires at the 2004 annual meeting, will retire f...  03/15/04 Quest Diagnostics and Medco Health Solutions Launch Initiative to Increase Use of ePrescribing Agreement Provides Physicians with Access to ePrescribing Technology FRANKLIN LAKES, N.J. and TETERBORO, N.J., Mar 15, 2004 /PRNewswire-FirstCall via COMTEX/ -- Medco Health Solutions (NYSE: MHS), one of the nation's leading providers of pharmacy benefit management services, and Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced a new initiative to provide physicians with online access to pharmacy benefi...  02/25/04 Quest Diagnostics' Healthcare Information Technology Subsidiary, MedPlus, Enters Into an Agreement with SureScripts to Provide Physicians With Electronic Prescribing Capabilities TETERBORO, N.J., and ALEXANDRIA, Va., Feb. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that the company's healthcare information technology subsidiary, MedPlus, has entered into an agreement with SureScripts to provide physicians with electronic prescribing capabilities. SureScripts is at the forefront of a growing movement to harness technology to i...  02/23/04 Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference TETERBORO, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Joyce G. Schwartz, M.D., Vice President and Chief Laboratory Officer, and Richard A. Bender, M.D., Medical Director, Hematology/Oncology, are scheduled to speak at the Wachovia Securities Cancer Diagnostics Conference on Tuesday, February 24, 2004, at The New York Palace Hotel, in New York City. The Ques...  02/19/04 Quest Diagnostics Declares Quarterly Cash Dividend TETERBORO, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on April 21, 2004 to shareholders of record on April 7, 2004. Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providin...  02/03/04 Quest Diagnostics to Speak at UBS Global Healthcare Services Conference TETERBORO, N.J., Feb. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, is scheduled to speak at the UBS Global Healthcare Services Conference on Tuesday, February 3, 2004, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern Time. The pr...  01/27/04 Quest Diagnostics Announces Strong Revenue and Earnings Growth For Fourth Quarter and Full Year 2003 TETERBORO, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2003, net income increased to $108 million from $82 million in 2002. Earnings per diluted share increased 24% to $1.02 from $0.82 in 2002. Fourth quarter revenues increased 16.5% over the prior year level to $1.2 billion and reflect the acquisition of Unila...  01/27/04 Quest Diagnostics to Speak at U.S. Bancorp Piper Jaffray Health Care Conference TETERBORO, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, is scheduled to speak at the U.S. Bancorp Piper Jaffray Health Care Conference on Thursday, January 29, 2004, at The Pierre Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 11:30 a.m. Eastern Time. ...  01/09/04 Quest Diagnostics to Speak at the 22nd Annual JPMorgan Healthcare Conference TETERBORO, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, is scheduled to speak at the 22nd Annual JPMorgan Healthcare Conference on Monday, January 12, 2004, at The Westin St. Francis Hotel in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 11:00 a.m. Easte...  12/02/03 Quest Diagnostics to Speak at Merrill Lynch Health Services Investor Conference TETERBORO, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, is scheduled to speak at the Merrill Lynch Health Services Investor Conference on Wednesday, December 3, 2003, at The Waldorf Astoria in New York City. The Quest Diagnostics presentation is scheduled to begin at 9:15 a.m. Eastern Time. ...  11/10/03 Quest Diagnostics Announces Succession Plan; Surya N. Mohapatra, Ph.D., to Succeed Kenneth W. Freeman as CEO in 2004 - Freeman to Remain Chairman of the Board of Directors During Smooth Transition Process - TETERBORO, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its Board of Directors has begun implementing an orderly succession plan in which Surya N. Mohapatra, Ph.D., will succeed Kenneth W. Freeman as Chief Executive Officer by th...  11/07/03 Quest Diagnostics to Speak at the CIBC World Markets 14th Annual Health Care Conference TETERBORO, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, is scheduled to speak at the CIBC World Markets 14th Annual Health Care Conference on Monday, November 10, 2003, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 11:00 a.m. Eastern Time. ...  11/05/03 Drug Use Climbed in the U.S. Workforce in the First Half of 2003, Driven by Continued Growth in Use of Amphetamines, According to Quest Diagnostics' Drug Testing Index TETERBORO, N.J., Nov. 5 /PRNewswire-FirstCall/- Drug use in the general U.S. workforce climbed in the first half of 2003, driven by continued growth in the use of amphetamines, according to the semi-annual Drug Testing Index released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. The Drug Testing Index summarizes the results of workplace drug tests performed by Quest Diagnostics between January and Jun...  10/21/03 Quest Diagnostics Earnings Per Share Increased 29% in Third Quarter 2003 - Earnings Per Share Expected to Grow 12-15% in 2004 - TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2003, net income increased to $120 million from $87 million in the third quarter of 2002. Earnings per diluted share increased 29% to $1.12 from $0.87 in 2002. Separately, the company also announced ...  10/21/03 Quest Diagnostics Initiates Quarterly Cash Dividend And Increases Share Repurchase Authorization by $300 Million TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors has approved the payment of a quarterly cash dividend of $0.15 per share and increased the company's share repurchase authorization by an additional $300 million. The initial quarterly dividend will be payable on January 23, 2004 to shareholders of record on January 8, 2004. ...  10/16/03 Quest Diagnostics Appoints Mervyn A. Sahud, M.D., to Lead Coagulation Laboratory Program TETERBORO, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that it has appointed Mervyn A. Sahud, M.D., F.A.C.P, as Medical Director for Coagulation. Dr. Sahud is responsible for leading Quest Diagnostics' national coagulation laboratory program and enhancing the coagulation testing services provided to healthcare specialists seeking guidance on test inte...  10/08/03 Delbert Fisher, M.D., Vice President for Science and Innovation At Quest Diagnostics, Is Honored by The National Institute Of Child Health and Human Development (NICHD) TETERBORO, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Delbert A. Fisher, M.D., Vice President of Science and Innovation, was honored by The National Institute of Child Health and Human Development (NICHD) for his outstanding scientific contributions to the creation of a screening test for congenital hypothyroidism in newborns. Dr. Fisher was one of 15...  09/30/03 Quest Diagnostics Appoints Renowned Cancer Scientist, Maher Albitar, M.D., Medical Director for Hematopathology TETERBORO, N.J., Sept. 30 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced the appointment of Maher Albitar, M.D., a renowned cancer scientist, to Medical Director for Hematopathology. Previously, Dr. Albitar was a tenured professor at The University of Texas M. D. Anderson Cancer Center in Houston, where he served as Chief of the Leukemia Section in the Department of H...  09/19/03 Quest Diagnostics to Speak at UBS Global Life Sciences Conference TETERBORO, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, President and Chief Operating Officer, is scheduled to speak at the UBS Global Life Sciences Conference on Monday, September 22, 2003, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 10:30 a.m. Eastern Time. The presentation wil...  09/15/03 Quest Diagnostics to Speak at The Banc of America Securities 33rd Annual Investment Conference TETERBORO, N.J., Sept. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Banc of America Securities 33rd Annual Investment Conference on Tuesday, September 16, 2003, at the Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 8...  09/03/03 Quest Diagnostics to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference TETERBORO, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference on Thursday, September 4, 2003, at the Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:00 a....  08/07/03 Quest Diagnostics Offers InSure(TM) Colorectal Cancer Screening Test To Help Physicians Identify Cancer at an Early Stage - Test is Easy for Patients to Use, Non-Invasive, Sensitive and Specific - TETERBORO, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of cancer screening and diagnostic testing, information and services, today announced that it has begun to offer InSure(TM), an FDA-cleared fecal immunochemical test to detect the presence of blood in stool samples. The test is intended to help physicians screen for colorectal cancer at an early s...  08/04/03 Quest Diagnostics Sponsors Distribution of the National Comprehensive Cancer Network's CD-ROM on Cancer Testing Guidelines for Non-Cancer Specialists TETERBORO, N.J., Aug 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of cancer screening and diagnostic testing, today announced its sponsorship to support the distribution of the National Comprehensive Cancer Network's (NCCN) new CD-ROM entitled Cancer Testing: Work up, Staging, and Follow-up within the Complete Library of NCCN Clinical Practice Guidelines in Oncology. The guidelines for cancer testing are intended to acquaint ...  07/24/03 Quest Diagnostics Expands Heart Disease Test Offerings With Lp-PLA2 Test For Cardiovascular Risk Assessment TETERBORO, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of gene-based medical testing, announced that it has begun to offer a test to enable physicians to detect a new risk factor for cardiovascular disease by measuring levels of the enzyme Lp-PLA2 (lipoprotein-associated phospholipase A2). Elevated levels of Lp-PLA2 indicate that a patient is at an increased risk of suffering a cardiovascular event, such as a heart atta...  07/22/03 Quest Diagnostics Earnings Per Share Increased 29% In Second Quarter 2003 TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2003, net income increased to $120.4 million from $87.2 million in the second quarter of 2002. Earnings per diluted share increased 29% to $1.12 from $0.87 in 2002. Second quarter revenues increased 14% over the prior year level to $1.2 billion and reflect the acq...  06/25/03 Quest Diagnostics to Speak at the 2003 Wachovia Securities Nantucket Equity Conference TETERBORO, N.J., June 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer is scheduled to speak at the 2003 Wachovia Securities Nantucket Equity Conference on Thursday, June 26, 2003, at The Harbor House Village in Nantucket, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 10:45 a.m. Eas...  06/17/03 Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 5.0 TETERBORO, N.J., June 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Thomas Weisel Partners Growth Forum 5.0 on Tuesday, June 17, 2003, at The Bacara Resort in Santa Barbara, California. The Quest Diagnostics presentation is scheduled to begin at 11:40 a.m. Pacific Time. The pres...  06/09/03 Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fourth Annual Global Healthcare Conference TETERBORO, N.J., June 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, President and Chief Operating Officer, is scheduled to speak at the Goldman Sachs Twenty-Fourth Annual Global Healthcare Conference on Tuesday, June 10, 2003, at The Ritz-Carlton Laguna Niguel Hotel in Dana Point, California. The Quest Diagnostics presentation is scheduled to begin at ...  06/05/03 Quest Diagnostics and Stop & Shop Partner to Offer QuesTest(TM) Consumer Health Testing Services in Connecticut TETERBORO, N.J. and QUINCY, Mass., Jun 5, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) and the Stop & Shop Supermarket Company today launched QuesTest(TM) consumer health testing services in more than 60 Stop & Shop Pharmacies throughout Connecticut. QuesTest(TM) health testing is a revolutionary concept in consumer-driven health care that now offers Stop & Shop customers an important new way to take charge of their health through commonly ordered sc...  05/27/03 Amphetamine Use Increases In the General U.S. Workforce, According to Quest Diagnostics' 2002 Drug Testing Index - Overall Workplace Drug Use Declines to 14-year Low in 2002 - TETERBORO, N.J., May 27 /PRNewswire-FirstCall/ -- The incidence of positive drug test results attributed to amphetamine use increased substantially among general U.S. workforce employees over the last five years during a time when amphetamines became more widely accessible,(1) according to the annual Drug Testing Index(R), released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug...  05/19/03 Quest Diagnostics and Enterix Enter Into an Agreement to Offer InSure(TM), A Patient-Friendly Immunochemical Test for Colorectal Cancer Screening TETERBORO, N.J., and FALMOUTH, Maine, May 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and Enterix Inc., a privately held colorectal cancer screening company, today announced that they have entered into an agreement to offer InSure(TM), Enterix' proprietary, FDA-cleared test to detect human hemoglobin in fecal samples. Terms of the agreement were not disclosed. Studies show th...  05/13/03 Quest Diagnostics Announces Share Repurchase Plan TETERBORO, N.J., May 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that its Board of Directors has authorized an expenditure of up to $300 million to repurchase shares of its common stock. The company had approximately 105 million shares outstanding as of March 31, 2003. Under the repurchase authority, management has the discretion to repurchase stock in the open market or in privately negotiated transactions. The program is p...  05/06/03 Quest Diagnostics Presentation at Deutsche Bank Securities Healthcare Conference Available on Internet TETERBORO, N.J., May 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that an archived webcast of the presentation by its management at the Deutsche Bank Securities Healthcare Conference earlier today in Baltimore, Maryland, is available on the Quest Diagnostics website: http://www.questdiagnostics.com through Friday, June 13, 2003. The presentation by Robert A. Hagemann, ...  04/22/03 Quest Diagnostics Reports Strong Earnings Per Share Growth In First Quarter 2003 TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2003, net income increased to $88.0 million from $66.7 million in the first quarter of 2002. Earnings per diluted share increased 28% to $0.86 from $0.67 in 2002. The acquisition of Unilab Corporation, which was completed on February 28, 2003, contributed approximat...  04/17/03 Quest Diagnostics and Thermo Electron Launch First Commercial Gene-based Medical Test Using a Biochip Collaboration to Produce Additional Biochips for Various Diseases TETERBORO, N.J. and WALTHAM, Mass., April 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Thermo Electron Corporation (NYSE: TMO) announced that their collaboration has resulted in an automated, biochip-based laboratory test for the detection of cystic fibrosis (CF) gene mutations during prenatal screening. The new biochip array can be used for multiplex testing, which allows multiple DNA ...  04/09/03 Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference TETERBORO, N.J., April 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Lucia Quinn, Senior Vice President, Business Development, and Richard Bender, M.D., Medical Director, Hematology/Oncology, are scheduled to speak at the Wachovia Securities Cancer Diagnostics Conference on Thursday, April 10, 2003, at the Swissotel, in New York City. The Quest Diagnostics presentation is...  03/25/03 Quest Diagnostics Appoints Robert E. Peters Vice President, Sales and Marketing TETERBORO, N.J., Mar 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that Robert E. Peters has been appointed Vice President, Sales and Marketing. Mr. Peters will be responsible for leading Sales and Marketing initiatives driving overall profitable growth through ensuring a comprehensive focus on meeting the needs of customers. In 2002, Mr. Peter...  03/24/03 Quest Diagnostics to Speak at the Banc of America Securities Healthcare Conference TETERBORO, N.J., Mar 24, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Banc of America Securities Healthcare Conference on Tuesday, March 25, 2003, at the Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 12:45 p.m...  03/17/03 Quest Diagnostics to Speak At the SG Cowen 23rd Annual Health Care Conference TETERBORO, N.J., Mar 17, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the SG Cowen 23rd Annual Health Care Conference on Tuesday, March 18, 2003, at the Marriott Copley Place, in Boston, Massachusetts. The Quest Diagnostics presentations are scheduled for 8:00 a.m. to 8:45 ...  03/07/03 Quest Diagnostics Successfully Completes Unilab Debt Tender Offer TETERBORO, N.J., Mar 7, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced that it successfully completed the cash tender offer for all of the outstanding $100.8 million 12-3/4% Senior Subordinated Notes due 2009 of Unilab Corporation (Nasdaq: ULAB). The cash tender offer expired, as scheduled, at 12:00 midnight, New York City time, on Thursday, March 6, 2003, and was settled today. As of the expiration date, 100% of the $100.8 million 12-3/...  03/06/03 Quest Diagnostics to Speak at Wachovia Securities Ninth Annual Convertible Securities Conference TETERBORO, N.J., Mar 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Laure E. Park, Vice President, Investor Relations, and Joseph P. Manory, Vice President and Treasurer, are scheduled to speak at the Wachovia Securities Ninth Annual Convertible Securities Conference on Friday, March 7, 2003, at the Mandarin Oriental-Miami, in Miami, Florida. The Quest D...  03/05/03 Quest Diagnostics Sets Purchase Price in Tender Offer and Consent Solicitation for Unilab 12 3/4% Senior Subordinated Notes Due 2009 TETERBORO, N.J., Mar 5, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today the tender offer consideration and the total consideration to be paid for notes validly tendered in its cash tender offer for all of the outstanding $100.8 million 12 3/4% Senior Subordinated Notes due 2009 of Unilab Corporation (Nasdaq: ULAB). The tender offer is subject to the terms and conditions set forth in the Offer to Purchase and Consent Solicitation Statem...  03/04/03 Quest Diagnostics Announces Final Results of Unilab Exchange Offer TETERBORO, N.J., Mar 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today the final calculations regarding the consideration to be paid to Unilab shareholders who elected cash in the previously announced exchange offer. In the exchange offer, approximately 34.7 million shares were tendered for cash. The cash election feature of the exchange offer was over-...  03/03/03 Quest Diagnostics Announces Preliminary Results of Unilab Exchange Offer TETERBORO, N.J., Mar 3, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today the preliminary calculations regarding the consideration to be paid to Unilab shareholders who had elected cash in the previously announced exchange offer. The deadline for delivering Unilab shares tendered pursuant to notices of guaranteed delivery expired at 5:00 p.m. on Friday, Febru...  02/27/03 Quest Diagnostics Announces Receipt of Requisite Consents in Cash Tender For Unilab 12 3/4% Senior Subordinated Notes Due 2009 TETERBORO, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that, as of 5:00 p.m., New York City time, on February 26, 2003 (the consent date), it had received the requisite consents from the holders of the 12 3/4% Senior Subordinated Notes due 2009 of Unilab Corporation (Nasdaq: ULAB) to certain amendments to the indenture under which the notes were issued. Specifically, Quest Diagnostics received consents from 100% of holde...  02/26/03 Quest Diagnostics Acquires Unilab TETERBORO, N.J., Feb 26, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today it has acquired Unilab Corporation (Nasdaq: ULAB) by accepting for payment all shares of Unilab common stock that were tendered pursuant to the previously announced cash election exchange offer. As of 12:00 midnight, New York City time, on February 25, 2003, more than 36 million shares...  02/25/03 Quest Diagnostics Updates 2003 Guidance TETERBORO, N.J., Feb 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced updated guidance for its 2003 financial performance to reflect the acquisition of Unilab Corporation (Nasdaq: ULAB) and the impact of severe winter weather. On Wednesday, February 26, the company expects to accept for payment all shares validly tendered in the exchange offer for Unilab...  02/21/03 Quest Diagnostics Extends Consent Date for Cash Tender Offer to Purchase All Outstanding Unilab 12 3/4% Senior Subordinated Notes TETERBORO, N.J., Feb 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced that it has extended the consent date for its previously announced cash tender offer to purchase all outstanding 12 3/4% Senior Subordinated Notes Due 2009 of Unilab Corporation. The consent date was extended by three business days and will now expire at 5:00 p.m., New York City time, on Wednesday, February 26, 2003, unless extended. The expiration date of the tender of...  02/21/03 Quest Diagnostics Receives FTC Clearance to Proceed With Acquisition of Unilab TETERBORO, N.J., Feb 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) confirmed that it has received clearance from the Federal Trade Commission (FTC) to proceed with its previously announced acquisition of Unilab Corporation (Nasdaq: ULAB). The cash election exchange offer will expire at 12:00 midnight, New York City time, on Tuesday, February 25, 2003. If all the conditions to the exchange offer are satisfied on February 26, 2003, Quest Diagnosti...  02/19/03 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Feb 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by five business days and will now expire at 12:00 midnight, New York City time, on Tuesday, February 25, 2003, unless extended. The acquisition of Unilab is subject to approval by the...  02/13/03 James F. Flaherty III Elected to Quest Diagnostics Board of Directors TETERBORO, N.J., Feb 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that its Board of Directors has elected James F. ("Jay") Flaherty III to serve as a Director, expanding the Board to 12 members. Mr. Flaherty, 45, is the President and Chief Operating Officer and a member of the Board of Directors of Health Care Property Investors (NYSE: HCP), a self-admini...  02/11/03 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Feb 11, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by five business days and will now expire at 12:00 midnight, New York City time, on Tuesday, February 18, 2003, unless extended. The acquisition of Unilab is subject to approval by the...  02/10/03 Quest Diagnostics Launches eMaxx(R) Web Portal, Giving Physicians Access to Lab Tests and Other Clinical Information On-Line - See eMaxx at Booth #5025 at the HIMSS Conference In San Diego, Feb. 10 - 13, 2003 - TETERBORO, N.J., Feb 10, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that it has launched its innovative eMaxx Internet portal to physicians nationwide. The eMaxx web portal, developed by Quest Diagnostics' MedPlus(TM) subsidiary, enables doctors to order...  02/06/03 Quest Diagnostics Incorporated Commences Cash Tender Offer for Unilab Corporation 12-3/4% Senior Subordinated Notes Due 2009 TETERBORO, N.J., Feb 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it has commenced a cash tender offer for any and all outstanding $100.8 million principal amount of Unilab Corporation 12-3/4% Senior Subordinated Notes due 2009. The tender offer is in connection with Quest Diagnostics' previously announced agreement to acquire Unilab Corporation (Nasdaq: ULAB). The tender offer will be financed with a combination of cash on ...  02/06/03 Top Ranking by KLAS Enterprises for Electronic Patient Record Solution Awarded to Quest Diagnostics' MedPlus(TM) Subsidiary TETERBORO, N.J., Feb 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its MedPlus subsidiary was recognized for the second consecutive year as the number one document management and imaging (DMI) vendor for its ChartMaxx(R) enterprise-wide electronic patient record (EPR) solution in a study released by KLAS Enterprises. MedPlus develops state-of-the-...  02/04/03 Quest Diagnostics to Sell Certain Assets in Northern California to LabCorp - Quest Diagnostics Extends Exchange Offer for Shares of Unilab - TETERBORO, N.J., Feb 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced that it had executed an agreement, subject to approval by the Federal Trade Commission, to sell certain assets in Northern California to Laboratory Corporation of America (NYSE: LH) (LabCorp(R)) for $4.5 million in cash. In addition, Quest Diagnostics announced that it has extended the expiration date for its previously announced cash election exchange offer for all outs...  01/31/03 Quest Diagnostics to Speak at UBS Warburg Global Healthcare Services Conference TETERBORO, N.J., Jan. 31 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Warburg Global Healthcare Services Conference on Monday, February 3, 2003, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 11:30 a.m. Eastern Time. ...  01/27/03 Quest Diagnostics to Speak At U.S. Bancorp Piper Jaffray Health Care Conference TETERBORO, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the U.S. Bancorp Piper Jaffray Health Care Conference on Tuesday, January 28, 2003, at The Pierre Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern Time. ...  01/24/03 Quest Diagnostics Discloses Guidance on Webcasted Investor Call TETERBORO, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) discussed guidance for 2003 on its webcasted investor call this morning. As discussed on the call, for the full year 2003, Quest Diagnostics expects earnings per diluted share to increase to between $4.00 and $4.20, excluding the impact of the planned acquisition of Unilab. Revenues are expected to grow approximately 8% to 10%. Volume, as measured by the number of requisitions, is expe...  01/23/03 Quest Diagnostics Announces Increased Revenues and Earnings For Fourth Quarter and Full Year 2002 TETERBORO, N.J., Jan. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2002, net income increased to $82 million, or $0.82 per diluted share, from $51 million, or $0.52 per diluted share, in the fourth quarter of 2001. Earnings per diluted share increased 34% from $0.61 in 2001, adjusted for the required change in goodwi...  01/21/03 Quest Diagnostics Extends Exchange Offer for Shares of Unilab -Quest Diagnostics and Unilab to File Supplementary Disclosure Materials With SEC- TETERBORO, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business...  01/17/03 Quest Diagnostics and Unilab to Distribute Materials Regarding Changes to Exchange Offer TETERBORO, N.J. and TARZANA, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Unilab Corporation (Nasdaq: ULAB) announced today that Quest Diagnostics and Unilab plan to file with the Securities and Exchange Commission and disseminate to Unilab's stockholders on January 21, 2003 the supplementary disclosure materials describing the amended terms of the exchange offer made by Quest Diagnostics for all of Unilab's outstanding shares. Bec...  01/07/03 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Monday, January 20, 200...  01/07/03 PAREXEL and Quest Diagnostics Establish Collaboration to Co-Market Clinical Trials Services BOSTON, and TETERBORO, N.J., Jan. 7 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading, worldwide biopharmaceutical outsourcing company, and Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic testing, information and services, announced a collaboration in which PAREXEL and Quest Diagnostics Clinical Trials will co-market their services to pharmaceutical and biotechnology companies worldwide. Financial terms of the agreement wer...  01/06/03 Quest Diagnostics and Unilab Amend Merger Agreement FTC is Reviewing Proposal by Quest Diagnostics and Third Party Buyer Regarding Sale of Assets in Northern California - TETERBORO, N.J., and TARZANA, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Unilab Corporation (Nasdaq: ULAB) announced that they have executed the amendment of their previously announced Merger Agreement under which Quest Diagnostics would acquire Unilab. In addition, Quest Diagnostics announced...  01/06/03 Quest Diagnostics to Speak at the 21st Annual JPMorgan H&Q Healthcare Conference TETERBORO, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the 21st Annual JPMorgan H&Q Healthcare Conference on Tuesday, January 7, 2003, at The Westin St. Francis Hotel in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 9:30 a...  12/20/02 Quest Diagnostics Extends Exchange Offer For Shares Of Unilab TETERBORO, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Monday, January 6, 200...  12/19/02 Quest Diagnostics to Provide Central Laboratory Services Exclusively To GlaxoSmithKline to Support Clinical Trials and Early Stage R&D TETERBORO, N.J., Dec. 19 /PRNewswire-FirstCall/ --Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced that it has signed a long-term agreement with GlaxoSmithKline plc (NYSE: GSK). Under the agreement, Quest Diagnostics will be the exclusive provider of central laboratory testing services to support GlaxoSmithKline's global clinical trials testing requirements in North America and Eur...  12/17/02 Quest Diagnostics Is First to Offer New Roche Diagnostics ELECSYS proBNP Assay to Aid In Congestive Heart Failure Diagnosis TETERBORO, N.J., Dec. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it is the first commercial reference laboratory to offer the new FDA-cleared ELECSYS(R) proBNP assay to aid in the diagnosis of Congestive Heart Failure.(1) The assay is available to physicians nationwide through the Quest Diagnostics Nichols Institute esoteric testing laboratory in Sa...  12/06/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Dec. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Thursday, December 19, 2...  12/03/02 Quest Diagnostics to Speak at Merrill Lynch Health Services Investor Conference TETERBORO, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Merrill Lynch Health Services Investor Conference on Wednesday, December 4, 2002, at The Waldorf Astoria in New York City. The Quest Diagnostics presentation is scheduled to begin at 12:00 noon Eastern Ti...  12/02/02 Quest Diagnostics and Unilab in Discussions to Amend Terms of Merger Agreement - Companies in Divestiture Discussions with a Third Party TETERBORO, N.J., and TARZANA, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Unilab Corporation (Nasdaq: ULAB) announced that they are in discussions to amend the terms of their previously announced transaction in conjunction with discussions with a third party to sell certain assets in Northern California to address concerns of the Federal Trade Commission regarding the transaction. The proposed changes would include reducin...  11/21/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Nov. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Thursday, December 5, ...  11/18/02 Quest Diagnostics is the First Laboratory to Commercially Offer Improved HIV-1 Viral Load Test From Roche Diagnostics TETERBORO, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated, (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it is the first reference laboratory to commercially offer Roche Diagnostics' new, FDA- approved AMPLICOR HIV-1 MONITOR(R) Test, Version 1.5 for HIV-1 viral load testing. The test is available to physicians through Quest Diagnostics Nichols Institute in San Juan Capistrano, Californi...  11/12/02 Quest Diagnostics to Speak at the Credit Suisse First Boston Health Care Conference TETERBORO, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Credit Suisse First Boston Health Care Conference on Wednesday, November 13, 2002, at The Arizona Biltmore Resort & Spa in Scottsdale, Arizona. The Quest Diagnostics presentation is scheduled to begin a...  11/07/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Wednesday, November 20,...  11/06/02 Correlogic Systems Licenses Ovarian Cancer Diagnostic Test to Quest Diagnostics and LabCorp(R) BETHESDA, Md., Nov. 6 /PRNewswire/ -- Correlogic Systems, Inc., a leading bio IT company, today announced that it has signed licensing agreements with Quest Diagnostics Incorporated (NYSE: DGX and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) for the commercialization of Correlogic's ovarian cancer protein pattern blood test. Quest Diagnostics and LabCorp are the only two companies licensed by Correlogic. Under the terms of the agreement, Correlogic will receive sig...  11/01/02 Quest Diagnostics to Speak at the CIBC World Markets 13th Annual Health Care Conference TETERBORO, N.J., Nov 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, is scheduled to speak at the CIBC World Markets 13th Annual Health Care Conference on Monday, November 4, 2002, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eas...  10/30/02 Surya N. Mohapatra, Ph.D. Elected to Quest Diagnostics Board of Directors TETERBORO, N.J., Oct 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that its Board of Directors has elected Surya N. Mohapatra, Ph.D., to serve as a Director. The appointment of Dr. Mohapatra, 53, the President and Chief Operating Officer of Quest Diagnostics, expands the Board to 11 members, the majority of whom are independent Directors. Dr. Mohapatra is ...  10/25/02 Quest Diagnostics to Speak at the Salomon Smith Barney 2002 Global Health Care Conference TETERBORO, N.J., Oct 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Salomon Smith Barney 2002 Global Health Care Conference on Monday, October 28, 2002, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 10:15 a.m. Eastern...  10/24/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Oct 24, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Wednesday, November...  10/17/02 Quest Diagnostics Announces Increased Revenues And Earnings for Third Quarter 2002 TETERBORO, N.J., Oct 17, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2002, net income increased to $87 million, or $0.87 per diluted share, from $50 million, or $0.51 per diluted share, in the third quarter of 2001. Earnings per diluted share increased 45% from $0.60 in 2001, adjusted for the required change in g...  10/16/02 Quest Diagnostics Introduces CF Complete(TM) Test To Provide Sequencing of Complete Cystic Fibrosis Gene BALTIMORE, Oct 16, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today introduced its new CF Complete(TM) test at the 52nd Annual Meeting of The American Society of Human Genetics. The CF Complete test enables physicians to identify rare mutations that cause cystic fibrosis (CF) by sequencing the complete coding sequence of the cystic fibrosis gene. Developed at Quest Di...  10/10/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Oct 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Wednesday, October ...  10/09/02 Quest Diagnostics Revenues and Earnings to Exceed Expectations For Third Quarter 2002 TETERBORO, N.J., Oct 9, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that it expects to report stronger financial results than previously anticipated for the third quarter ended September 30, 2002. While the company plans to report its results on October 17, it is making this announcement in response to recent questions concerning the competitive dynamic...  10/07/02 Quest Diagnostics to Speak at UBS Warburg Global Life Sciences Conference TETERBORO, N.J., Oct 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer and Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, are scheduled to speak at the UBS Warburg Global Life Sciences Conference on Tuesday, October 8, 2002, at The Plaza Hotel, New York, New York. The Quest Diagnost...  10/02/02 Quest Diagnostics and Celera Diagnostics to Collaborate in Cardiovascular Disease and Diabetes TETERBORO, N.J. & ALAMEDA, Calif., Oct 2, 2002 (BUSINESS WIRE) -- Quest Diagnostics Incorporated (NYSE:DGX) and Celera Diagnostics, a joint venture between the Applied Biosystems Group (NYSE:ABI) and the Celera Genomics Group (NYSE:CRA) of Applera Corporation, today announced an agreement to collaborate in establishing the clinical utility of laboratory tests based on novel diagnostic markers for cardiovascular disease and diabetes. This collaboration will support current and future d...  09/26/02 Quest Diagnostics and Unilab Extend Merger Agreement Until November 30 - Quest Diagnostics Extends Exchange Offer for Shares of Unilab - TETERBORO, N.J., and TARZANA, Calif., Sep 26, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Unilab Corporation (Nasdaq: ULAB) announced today that they have extended the termination date of their Merger Agreement to November 30, 2002. All other provisions of the agreement remain in effect. Previously, the Merger Agreement between Quest Diagnostics and Unilab could have been terminated by either party at any time after September 30, 2002, if the ...  09/23/02 Quest Diagnostics to Speak at Banc of America Securities 32nd Annual Investment Conference TETERBORO, N.J., Sep 23, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Banc of America Securities 32nd Annual Investment Conference on Monday, September 23, 2002, at the Ritz Carlton, San Francisco, California. The Quest Diagnostics presentation is scheduled to beg...  09/20/02 Quest Diagnostics Announces Delay in Unilab Transaction TETERBORO, N.J., Sep 20, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is continuing discussions with the Federal Trade Commission regarding its proposed acquisition of Unilab Corporation (Nasdaq: ULAB). Quest Diagnostics now expects that these discussions, which include settlement discussions, will extend beyond September 30, 2002. Accordingly, the pro...  09/12/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Sep 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Wednesday, Septembe...  08/28/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Aug 28, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Wednesday, Septembe...  08/14/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Aug 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Tuesday, August 27,...  08/13/02 Quest Diagnostics CEO and CFO File Sworn Statements With The SEC Certifying The Accuracy of Company Financial Reports TETERBORO, N.J., Aug 13, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, and Robert A. Hagemann, Chief Financial Officer, submitted unqualified sworn statements to the Securities and Exchange Commission certifying the accuracy of the company's recent SEC filings. The certifications, which were also...  08/06/02 Quest Diagnostics Offers QuesTest(TM) Health Testing Services In CVS Stores in Columbus, Ohio COLUMBUS, Ohio, Aug 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that it has begun to offer laboratory testing services directly to consumers in the Columbus, Ohio, area through 71 conveniently located CVS stores. Shoppers will be able to check their cholesterol, screen for specific medical conditions, and receive other valuable health test...  08/05/02 Quest Diagnostics Offers QuesTest(TM) Health Testing Services In CVS Stores in Tampa and St. Petersburg TAMPA, Fla., Aug 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, announced today that it has begun to offer laboratory testing services directly to consumers in the Tampa-St. Petersburg area through several CVS pharmacy locations. Shoppers will be able to check their cholesterol, screen for specific medical conditions, and receive other valuable health testin...  07/31/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Jul 31, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Tuesday, August 13,...  07/22/02 Quest Diagnostics Announces Increased Earnings for Second Quarter 2002 TETERBORO, N.J., Jul 22, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2002, net income increased to $87.2 million, or $0.87 per diluted share, from $50.7 million, or $0.52 per diluted share, before special items in the second quarter of 2001. The special items represented an extraordinary loss and a special charge ass...  07/18/02 Correction -- Quest Diagnostics Incorporated Correction -- Quest Diagnostics Incorporated In the news release, Quest Diagnostics (NYSE: DGX) Extends Exchange Offer for Shares of Unilab, issued yesterday, July 17, by Quest Diagnostics Incorporated over PR Newswire, we are advised by the company that based upon a corrected report received from the company's exchange agent, the second paragraph should read: "30 million shares of Unilab Corporation common stock had been tendered, representing 89.5% of the outstanding Unilab Corporation common...  07/02/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Jul 2, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Tuesday, July 16, 20...  07/01/02 Quest Diagnostics Announces That Proposed Revisions to 2003 Medicare Payment Policies Will Not Materially Impact Its Financial Results TETERBORO, N.J., Jul 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that the proposed revisions to the 2003 Medicare payment policies under the physician fee schedule, as currently proposed by the Centers for Medicare & Medicaid Services (CMS), an agency within the U.S. Department of Health and Human Services, are not expected to have a material impact ...  06/28/02 Workplace Drug Use Decreased After September 11, 2001, According to Quest Diagnostics' Drug Testing Index TETERBORO, N.J., Jun 28, 2002 /PRNewswire-FirstCall via COMTEX/ -- Workplace drug use decreased after the events of September 11, 2001, according to the semi-annual Drug Testing Index released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading employer of drug testing services in the United States. The drug positivity rate for the combined U.S. workforce, which is the number of positive test results compared to the total number of drug tests performed by Quest Diagnostic...  06/18/02 Quest Diagnostics Extends Exchange Offer for Shares of Unilab TETERBORO, N.J., Jun 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has extended the expiration date for its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The offer was extended by 10 business days and will now expire at 12:00 midnight, New York City time, on Monday, July 1, 200...  06/10/02 Quest Diagnostics to Speak at Goldman Sachs 23rd Annual Global Healthcare Conference TETERBORO, N.J., Jun 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Goldman Sachs 23rd Annual Global Healthcare Conference on Tuesday, June 11, 2002, at the Ritz-Carlton Laguna Niguel in Dana Point, California. The Quest Diagnostics presentation is scheduled to ...  05/24/02 Federal Trade Commission Requests More Information From Quest Diagnostics and Unilab on Pending Acquisition TETERBORO, N.J., and TARZANA, Calif., May 24, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX) and Unilab Corporation (Nasdaq: ULAB) announced that they have received a request for additional information (commonly referred to as a "second request") from the Federal Trade Commission (FTC) under the Hart-Scott-Rodino Antitrust Improvements Act (the "HSR Act") in connection with Quest Diagnostics' pending acquisition of Unilab. The waiting period under th...  05/15/02 Quest Diagnostics Launches Exchange Offer for Shares of Unilab Corporation TETERBORO, N.J., May 15, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it commenced today its previously announced cash election exchange offer for all outstanding shares of Unilab Corporation common stock. The exchange offer is scheduled to expire on June 17, 2002. A copy of Quest Diagnostics' prospectus and letter of transmittal, together with Unilab's S...  05/07/02 Quest Diagnostics to Speak at Deutsche Bank Securities 27th Annual Health Care Conference TETERBORO, N.J., May 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth R. Finnegan, Vice President Business Development, is scheduled to speak at the Deutsche Bank Securities 27th Annual Health Care Conference on Wednesday, May 8, 2002, at the Baltimore Marriott Waterfront, Baltimore, Maryland. The Quest Diagnostics presentation is scheduled to begi...  05/03/02 Quest Diagnostics Offers Gene-Based Cancer Tests to Help Physicians Manage and Treat Patients with Bladder and Breast Cancer TETERBORO, N.J., May 3, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of gene-based medical testing, with laboratories across the country, today announced that it has begun offering Abbott Laboratories' Vysis UroVysion(R) DNA Probe Assay, a non-invasive method for monitoring the recurrence of bladder cancer in patients previously diagnosed with the disease. In March 2002, the U.S. Food and Drug Administration (FDA) cle...  04/18/02 Quest Diagnostics Announces Increased Earnings for First Quarter 2002 TETERBORO, N.J., Apr 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2002, net income increased to $66.7 million, or $0.67 per diluted share, from $35.7 million, or $0.37 per diluted share in the first quarter of 2001. Earnings per diluted share increased 46% compared to the 2001 level, adjusted for the required change...  04/02/02 Quest Diagnostics to Acquire Unilab Corporation In Transaction Valued at $1.1 Billion -- Combination to enhance customer service and access for physicians, hospitals and patients -- TETERBORO, N.J., and TARZANA, Calif., Apr 2, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and Unilab Corporation (Nasdaq: ULAB), the leading provider of diagnostic testing services in the California market, announced today that they have entered into a definitive agreeme...  04/02/02 Multimedia Available: Quest Diagnostics to Acquire Unilab Corporation in Transaction Valued at $1.1 Billion Apr 02, 2002 (BUSINESS WIRE) -- Quest Diagnostics Incorporated (NYSE:DGX) and Unilab Corporation (NASD:ULAB) announced that they have entered into a definitive agreement under which Quest Diagnostics will acquire all outstanding shares of Unilab common stock in a transaction valued at $1.1 billion, including approximately $200 million of Unilab debt. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?5544 This multimedia news story is for...  04/02/02 Quest Diagnostics to Speak at Banc of America Securities Healthcare Conference TETERBORO, N.J., Apr 2, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth R. Finnegan, Vice President Business Development, is scheduled to speak at the Banc of America Securities Healthcare Conference on Tuesday, April 2, 2002, at the Four Seasons Hotel, Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 1:30 p.m. Pacific Tim...  04/01/02 Quest Diagnostics Acquires American Medical Laboratories, Inc. TETERBORO, N.J., Apr 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today it had completed the previously-announced acquisition of American Medical Laboratories, Inc. (AML). The all-cash transaction is valued at $500 million, including the assumption of approximately $160 million in debt, which will be retired in connection with the closing. The acquisition wil...  03/01/02 Quest Diagnostics Announces Improved HEPTIMAX Hepatitis C Viral Load Test, First to Use Roche Diagnostics' TaqMan Real-Time PCR Technology TETERBORO, N.J., Mar 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leader in gene-based medical testing, announced a newly improved version of its ultra-sensitive HEPTIMAX(TM) hepatitis C viral load test using Roche Diagnostics' COBAS TaqMan(R) platform. Quest Diagnostics is the first laboratory to use the state-of-the-art testing system to determine and report patient results, which will speed the turnaround time for hepatitis C vira...  02/27/02 Rosanne Haggerty Elected to Quest Diagnostics Board of Directors TETERBORO, N.J., Feb 27, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that its Board of Directors has elected Rosanne Haggerty to serve as a Director, expanding the Board to ten members. Ms. Haggerty, 41, is the Founder and Executive Director of Common Ground, a not-for-profit housing development and management organization in New York City providing innovative...  02/07/02 Quest Diagnostics to Acquire American Medical Laboratories, Inc. For $500 Million, Expanding Esoteric and Hospital Testing Services TETERBORO, N.J., Feb 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today it has signed a definitive agreement to acquire the stock of American Medical Laboratories, Incorporated (AML), in an all-cash transaction valued at $500 million, including the assumption of approximately $160 million in debt. AML is a national provider of esoteric testing to hospitals an...  02/05/02 Quest Diagnostics to Speak at UBS Warburg Global Healthcare Services Conference TETERBORO, N.J., Feb 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Warburg Global Healthcare Services Conference on Tuesday, February 5, 2002, at The Plaza Hotel, New York City. The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern Time. ...  01/30/02 Quest Diagnostics to Speak at U.S. Bancorp Piper Jaffray Health Care Conference TETERBORO, N.J., Jan 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the U.S. Bancorp Piper Jaffray Health Care Conference on Wednesday, January 30, 2002, at The Pierre New York. The Quest Diagnostics presentation is scheduled to begin at 12:00 p.m. Eastern Time. The con...  01/28/02 Quest Diagnostics Net Income Increases 80% in Fourth Quarter 2001 TETERBORO, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2001, net income increased 80% to $50.9 million, or $0.52 per diluted share, compared to income before an extraordinary loss in 2000 of $28.3 million, or $0.29 per diluted share. Cash earnings, or earnings before amortization of intangible assets, increased to $0.62 pe...  01/08/02 Quest Diagnostics Receives FDA Clearance For New Bio-Intact PTH Parathyroid Hormone Test Kit SAN JUAN CAPISTRANO, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that its test manufacturing unit, Nichols Institute Diagnostics, received clearance from the U.S. Food and Drug Administration to market its new Bio-Intact PTH (1-84) proprietary diagnostic test kit to measure parathyroid hormone, essential in the assessment of calcium metabolism and bone hea...  01/07/02 Quest Diagnostics To Speak At JPMorgan H&Q Healthcare Conference TETERBORO, N.J., Jan 7, 2002 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the JPMorgan H&Q 20th Annual Healthcare Conference on Tuesday, January 8, 2002, at the Westin St. Francis Hotel in San Francisco. The Quest Diagnostics presentation is scheduled to begin at 8:30 a.m. Pacific Time. The...  12/12/01 Pharis Biotec Grants Exclusive Patent License to Nichols Institute Diagnostics For Method of Detecting Active Parathyroid Hormone HANNOVER, Germany, and SAN JUAN CAPISTRANO, Calif., Dec. 12 /PRNewswire/ German-based therapeutic developer Pharis Biotec GmbH, and Nichols Institute Diagnostics, a wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that Pharis Biotec has granted an exclusive license to Nichols Institute Diagnostics for patented technology needed to develop a diagnostic test to measure parathyroid hormone, essential in the assessment of calc...  12/03/01 Quest Diagnostics Completes Acquisition of Clinical Diagnostic Services, Inc. TETERBORO, N.J., Dec 3, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it had completed the previously announced acquisition of Clinical Diagnostic Services, Inc. Terms of the transaction were not disclosed. CDS is based in Englewood, N.J., and operates a diagnostic testing laboratory and more than 50 patient service centers in New York and New Jersey. "Bring...  12/03/01 Quest Diagnostics Successfully Completes Contingent Convertible Debentures Offering, Totaling $250 Million TETERBORO, N.J., Dec 3, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced the successful completion of its public offering of 1.75% Contingent Convertible Debentures Due 2021. The aggregate principal amount of debentures offered reached $250 million, due to the underwriters' exercise of the $25 million over-allotment option. The debentures will pay a fixed rate of interest ...  11/30/01 Drug Use in the General U.S. Workforce Increased in First Half of 2001 According to Quest Diagnostics' Drug Testing Index TETERBORO, N.J., Nov 30, 2001 /PRNewswire via COMTEX/ -- Drug use in the general U.S. workforce increased in the first half of 2001, according to the semi-annual Drug Testing Index released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. In spite of the continuing trend toward lower drug use among federally- mandated, safety-sensitive workers, as well as continued low positivity rates for pre-employment d...  11/26/01 diaDexus Grants License to Quest Diagnostics for Novel Genomics- Based Osteoporosis Diagnostic Test. SOUTH SAN FRANCISCO, Calif., and TETERBORO, N.J., Nov. 21 /PRNewswire/ -- diaDexus, Inc., a privately-held biotechnology company, and Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of gene-based medical testing, announced today that diaDexus has licensed its novel proprietary Cathepsin K genomics-based diagnostic blood test to Quest Diagnostics for the detection and monitoring of osteoporosis. Quest Diagnostics exercised its option under a previou...  11/19/01 Quest Diagnostics Announces Sale of $225 Million In 1.75% Contingent Convertible Debentures Due 2021 TETERBORO, N.J., Nov. 19 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has sold to the public $225 million of 1.75% Contingent Convertible Debentures Due 2021. The debentures will pay a fixed rate of interest and are convertible into Quest Diagnostics common shares at an initial conversion price of $87.50 per share. The last reported sales price of Quest Diagnostics s...  11/19/01 Quest Diagnostics Offers $225 Million in Convertible Notes TETERBORO, N.J., Nov. 19 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced an offering of $225 million of 20-year contingent convertible bonds. In connection with the offering, Quest Diagnostics has granted a $25 million over-allotment option to the underwriter. The notes will pay a fixed rate of interest and will be convertible into Quest Diagnostics common stock if th...  11/13/01 Quest Diagnostics to Speak at Credit Suisse First Boston Health Care Conference TETERBORO, N.J., Nov 13, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Credit Suisse First Boston Thirteenth Annual Health Care Conference tomorrow at the Arizona Biltmore Resort and Spa in Phoenix. The conference is not being webcast, and to comply with the Securities & Exchange Co...  11/07/01 Quest Diagnostics And Vasogen Form Stragic Alliance To Jointly Commercialize Immune Modulation Therapy TETERBORO, N.J., and TORONTO, Ont., November 7, 2001 -- Quest Diagnostics Incorporated (NYSE: DGX) , the leading provider of diagnostic testing, information and services in the U.S., and Vasogen Inc. (TSE: VAS; AMEX: MEW), a developer of immune modulation therapies for the treatment of inflammatory disease, today announced the formation of a strategic alliance to jointly commercialize Vasogen's immune modulation therapy in the United States. Vasogen's immune modulation th...  11/01/01 Quest Diagnostics Completes Acquisition Of MedPlus, Inc TETERBORO, N.J., Nov. 1 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it has completed the acquisition of MedPlus, Inc., which develops clinical integration products designed to enhance patient care, as well as MedPlus' wholly-owned subsidiary Universal Document Management Systems, Inc., which creates workflow solutions used by many Fortune 500 companies to crea...  10/29/01 Quest Diagnostics to Present at Investor Conference TETERBORO, N.J., Nov 2, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Corporate Vice President and Chief Financial Officer, is scheduled to speak at the CIBC World Markets Twelfth Annual Health Care Conference 2001 on Monday, November 5, 2001 in New York City. The Quest Diagnostics presentation is scheduled to begin at approximately 9:30 A.M. E...  10/19/01 Quest Diagnostics to Acquire Clinical Diagnostic Services, Inc. TETERBORO, N.J., Oct 19, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it had signed a definitive agreement to acquire Clinical Diagnostic Services, Inc. Terms of the transaction were not disclosed. CDS operates a diagnostic testing laboratory and over 50 patient service centers in New York and New Jersey. The transaction is subject to review and clearance by th...  10/18/01 Quest Diagnostics Earnings Per Share Increase 70% in Third Quarter 2001 TETERBORO, N.J., Oct. 18 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2001, net income was $50.1 million, or $0.51 per diluted share, up 70% from the $28.7 million, or $0.30 per diluted share, reported in 2000. The company estimates that earnings were reduced by $0.03 per diluted share as a result of the tragic events of Septem...  10/16/01 Quest Diagnostics' CEO Kenneth W. Freeman Talks to The Wall Street Transcript NEW YORK--(BUSINESS WIRE)--Oct. 16, 2001--The Wall Street Transcript has published an in-depth interview with Kenneth W. Freeman, Chairman and CEO of Quest Diagnostics (NYSE:DGX), in which he talks at length about the company's future. The entire 3,800-word interview is available free online at http://www.twst.com/ceos.htm. Mr. Freeman gives an overview of the company and highlights how Quest Diagnostics has delivered break-out performance. "We've come a long wa...  10/16/01 Quest Diagnostics Appoints Lucia Luce Quinn As Senior Vice President, Advanced Diagnostics TETERBORO, N.J., Oct. 16 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that Lucia Luce Quinn has been appointed Senior Vice President, Advanced Diagnostics. In this newly created position, Ms. Quinn will be responsible for leading Quest Diagnostics' efforts in aligning strategy, business development and innovation. She will draw upon her experience in mark...  10/08/01 Quest Diagnostics to Present at Investor Conference TETERBORO, N.J., Oct 8, 2001 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Warburg Global Life Sciences Conference on Tuesday, October 9, 2001 in New York City. The Quest Diagnostics presentation is scheduled to begin at approximately 9:20 A.M. Eastern Time. The public is invited ...  09/24/01 Quest Diagnostics Reaffirms Outlook for Fourth Quarter and 2002 - National Tragedy to Have Temporary Impact on Third Quarter - TETERBORO, N.J., Sep 24, 2001 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it experienced a decrease in patient specimens following the attack on the United States on September 11, 2001. The decrease in specimen volume, primarily in the New York City metropolitan area, is expected to negatively impact results for the third quarter ending September 30 by approximately $10 million in ...  07/31/01 Workplace Drug Use Reversed Decade-Long Decline in 2000, According To Quest Diagnostics' Drug Testing Index TETERBORO, N.J., July 31 /PRNewswire/ -- Workplace drug use increased during 2000, reversing a steady, decade-long decline, according to the semi-annual Drug Testing Index released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of employer drug testing services in the United States. From 1988, when the survey began, through the end of 1999, the annual positivity rate-the proportion of positive test results to all drug tests performed by Que...  07/23/01 Quest Diagnostics Earnings Per Share Increase 58% Before Special Items in Second Quarter 2001 TETERBORO, N.J., Jul 23, 2001 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2001, income before special items increased to $50.7 million, or $0.52 per diluted share, from $31.4 million, or $0.33 per diluted share, in the second quarter of 2000. In connection with its recent debt refinancing, the company reported an extraordinary loss and a specia...  07/23/01 Quest Diagnostics Announces Availability of HEPTIMAX Ultra-Sensitive Quantitative Hepatitis C Virus Test TETERBORO, N.J., Jul 23, 2001 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of gene-based medical testing, information and services, announced the availability of a new ultra-sensitive viral load test for hepatitis C virus (HCV) that is approximately 10 times more sensitive than any other commercially available test. The test detects the level of hepatitis C virus based on an innovative application of transcription mediated amplification (TMA) te...  07/18/01 Quest Diagnostics Announces Laboratory Services Agreement With Empire Blue Cross Blue Shield of New York TETERBORO, N.J., Jul 18, 2001 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of clinical laboratory testing, information and services, announced it has entered into a new agreement with Empire Blue Cross Blue Shield to provide laboratory services to its members in the New York/New Jersey metropolitan area. The new agreement will take effect November 1, 2001, and replaces prior contracts covering Quest Diagnostics and the former SmithKline Beecham ...  07/17/01 JELD-WEN Employees Improve Health, Reduce Costs With Quest Diagnostics' Lifestyle-Health Assessment, Blueprint For Wellness(TM TETERBORO, N.J., July 17 /PRNewswire/ -- JELD-WEN, one of the world's largest manufacturers of doors, windows, millwork and specialty wood products, is offering employees and their spouses a chance to improve their health and reduce their health care costs by participating in Blueprint for Wellness, a comprehensive lifestyle and health assessment offered by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services....  06/28/01 Quest Diagnostics Completes Debt Refinancing TETERBORO, N.J., June 28 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it has received $725 million from the public offering of senior notes and a new term loan, thereby completing its previously announced debt refinancing. The refinancing is expected to lower annual interest expense by approximately $23 million. Interest expense for the second half of the year ending December 31, 2001 is expected to be reduced by approximately $11 million as a...  06/25/01 Quest Diagnostics Sets Purchase Price in Tender Offer and Consent Solicitation For Its 10-3/4% Senior Subordinated Notes Due 2006 TETERBORO, N.J., June 25 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today the tender offer consideration and the total consideration to be paid for notes validly tendered in its cash tender offer for all of its outstanding $150,000,000 10-3/4% Senior Subordinated Notes due 2006. The tender offer is subject to the terms and conditions set forth in the company's Offer to Purchase and Consent Solicitation Statement dated May 24, 2001, and will expire...  06/20/01 Quest Diagnostics Announces Pricing of Public Offering of Senior Notes TETERBORO, N.J., June 20 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that its public offering of $550 million of senior notes has been priced in two tranches: $275 million 6-3/4% senior notes due 2006, and $275 million 7-1/2% senior notes due 2011. The size of this offering was increased from the $500 million originally announced. The offering is part of an overall plan to refinance a majority of the company's existing indebtedness to reduce ove...  06/20/01 New Pricing Strategy Helps Quest, But Rivals Also Get A Little Relief -- Investor’s Business Daily By Gloria Lau Investor’s Business Daily It’s not often companies can thank a rival for giving them a boost. But that’s what’s happened in the lab testing business. Quest Diagnostics Inc., the nation’s top lab testing firm, helped the entire industry last year when it strong-armed large managed-care clients into accepting price increases. Those clients include Aetna Inc. and UnitedHealth Group. They agreed to pay more per lab test analyzed by Quest. The result of Quest’s...  06/18/01 QuestDirect(TM) Launches Retail Sites in Shopping Centers For Self-Directed Consumer Health Tests SALT LAKE CITY, June 20 /PRNewswire/ -- Tucked between a neighborhood dry cleaner and vitamin shop is QuestDirect(TM), a revolutionary new concept in consumer-driven health care conveniently located in a shopping center near you. QuestDirect(TM) now offers people an important new way to take charge of their health through health tests that they choose for themselves, without first having to see their own physician. QuestDirect(TM) is being launched in Salt Lake ...  06/13/01 Quest Diagnostics Announces Proposed $500 Million Public Offering Of Senior Notes TETERBORO, N.J., June 13 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it intends to raise approximately $500 million through a public offering of senior notes. The expected net proceeds from the offering, together with cash on hand and the expected proceeds from the company's planned senior unsecured credit facility, will be used to make payments required under the previously announced cash tender offer and consent solicitation o...  06/08/01 Quest Diagnostics Announces Receipt of Requisite Consents With Respect to Its 10-3/4% Senior Subordinated Notes Due 2006 TETERBORO, N.J., June 8 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that, as of 5:00 p.m., New York City time, on June 7, 2001, (the consent date), it had received the requisite consents from the holders of its 103/4% Senior Subordinated Notes due 2006 to certain amendments to the indenture under which the notes were issued. Specifically, the company received consents from holders of approximately $146.5 million in aggregate principal amount, or ...  05/24/01 Quest Diagnostics Incorporated Commences Cash Tender Offer for Its 10-3/4% Senior Subordinated Notes Due 2006 TETERBORO, N.J., May 24 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) announced today that it has commenced a cash tender offer for any and all of its outstanding $150 million principal amount of 10-3/4% Senior Subordinated Notes due 2006. The tender offer is part of the company's plan to refinance a majority of its long-term debt in order to reduce its overall interest costs. The company has received commitments, subject to certain conditions, for $650 million of...  05/08/01 Quest Diagnostics Announces Two-For-One Stock Split TETERBORO, N.J., May 8 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its stockholders had approved an increase in the number of authorized shares of common stock needed to effect a two-for-one stock split. The stock split will be effected by the issuance on May 31, 2001 of a stock dividend of one new share of common stock for each share of common stock held...  04/26/01 Quest Diagnostics to Acquire Medplus, Inc TETERBORO, N.J., and CINCINNATI, April 26 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, and MedPlus, Inc. (Nasdaq: MEDP), a health care information technology company, announced today the execution of a definitive purchase agreement whereby Quest Diagnostics will acquire the remaining 82% of voting shares of MedPlus stock it does not currently own at the price of $2 per share in cash. In ad...  04/23/01 Quest Diagnostics Doubles Earnings in First Quarter 2001 Earnings Guidance for 2001 Revised Upward - TETERBORO, N.J., April 23 /PRNewswire Interactive News Release/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2001, net income increased to $35.7 million, or $0.74 per diluted share, from $17.8 million, or $0.39 per diluted share, in the first quarter of 2000. Cash earnings, or ...  03/29/01 Quest Diagnostics to Present at Investor Conferences TETERBORO, N.J., March 29 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to make presentations at two investor conferences during the next week. Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Healthcare Conference on Thursday, March 29, 2001 at the Four Seasons Hotel in Las Veg...  03/07/01 Quest Diagnostics Introduces New Cytopathology Procedure For Early Breast Health Evaluation TETERBORO, N.J., March 7 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, including anatomic pathology services, and ProDuct Health, Inc., a provider of medical devices to fight breast cancer, announced that Quest Diagnostics is the first commercial reference laboratory to accept "ductal lavage" specimens for analysis. Ductal lavage is a procedure for collecting pre-cancerous and cancerous cells from milk ducts...  02/27/01 Quest Diagnostics to Offer Laboratory Testing Services To More Than 500 Acute-Care Hospital Customers of Broadlane TETERBORO, N.J., and MOUNTAIN VIEW, Calif., Feb. 27 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic laboratory testing, information and services, and Broadlane Inc., a leader in delivering supply chain services to the healthcare industry, today announced a long term agreement in which Quest Diagnostics will provide a range of laboratory services to Broadlane's customer base of more than 500 acute care hospita...  02/22/01 Quest Diagnostics Proposes Two-for-One Stock Split TETERBORO, N.J., Feb. 22 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that its Board of Directors has approved a two-for-one stock split, subject to stockholder approval of an increase in the number of authorized shares of common stock. The stock split is expected to make the company's common stock more attractive to a broader spectrum of investors. The stock sp...  02/01/01 Quest Diagnostics Acquires Denver Laboratory And Agrees to Manage Five Denver Hospital Labs